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The baseline prevalence of common mental disorders (CMDs) and symptoms of distress, 
depression, anxiety and hazardous alcohol use prior to the receipt of a HIV diagnosis is unknown. 
The primary aim of this research was to determine the prevalence of CMDs, such as major 
depression, persistent depressive disorder, generalized anxiety, and alcohol use disorders among a 
sample of people seeking HIV testing. The second aim was to determine the extent of general 
distress among the sample of HIV test seekers. The third aim of the study was to determine the 
ability of the Hopkins Symptom Checklist (HSCL), Beck Depression Inventory (BDI), Beck 
Anxiety Inventory (BAI) and the Alcohol Use Disorder Identification Test (AUDIT) to discriminate 
between CMD caseness and non-caseness.  
Utilizing a cross-sectional design, 500 participants were recruited while seeking HIV testing 
at five non-medical testing sites in the Western Cape, South Africa. The research version of the 
Structured Clinical Interview for the DSM-5 (SCID-RV) was administered to assess the CMDs. 
Furthermore, the extent of distress, depression, anxiety and hazardous alcohol use was assessed 
using the HSCL-25, BDI, BAI, and AUDIT, respectively. Descriptive statistics were used to 
evaluate the prevalence of CMDs and receiver operating characteristic (ROC) curve analysis was 
used to determine the effectiveness of the screening instruments in predicting CMD caseness 
against the SCID as gold standard.  
The results demonstrated that 28.4% (95% CI [24.45, 32.35]) of the sample had at least one 
common mental disorder. Elevated prevalence rates for major depression (14.4%; 95% CI [11.32, 
17.48]), persistent depressive disorder (7.2%; 95% CI [4.93, 9.47]), generalized anxiety disorder 
(3.4%; 95% CI [1.81%, 4.99%]) and alcohol use disorder (19.6%; 95% CI [16.12, 23.08]) were 
reported. The results further showed that the HSCL-25, BDI, BAI, and the AUDIT were effective in 





identifying CMD caseness. Even the subscales of the HSCL-25 were successful in detecting most of 
the cases of depression (MDD, and PDD) and generalized anxiety. Of the sample, 41.2% were 
psychologically distressed, while 21% had moderate depression, 13.6% had moderate anxiety and 
34.6% reported hazardous alcohol use.  
The findings of the research indicated that it is important to screen people for CMDs and 
distress prior to communicating an HIV diagnosis as these disorders may have a negative impact on 
quality of life and adherence to ART. A further contribution of the study is that the screening 
instruments may be used as proxies in identifying people seeking HIV testing with a CMD. Given 
that HIV testing and mental health services are available independently, fragmented services are 
provided in public health facilities in South Africa. Future research may need to focus on the 
integration of referral trajectories with routine screening and HIV testing. 
  






Die basislynvoorkoms van algemene geessteurings en simptome van depressie, angs en 
gevaarlike alkoholgebruik voor die ontvangs van ’n MIV-positiewe diagnose is nie bekend nie. Die 
primêre doelstelling van hierdie navorsing was om die voorkoms van algemene geessteurings te 
bepaal onder 'n steekproef van mense wat MIV-toetsing aanvra met insluiting van depressiewe 
versteuring, aanhoudende depressiewe versteuring, algemene angsversteuring, en 
alkoholgebruikversteuring. Die tweede doelstelling was om die vlakke van sielkundige nood onder 
mense wat ’n MIV-toets aanvra, te bepaal. Die derde doelstelling van die studie was om die 
effektiwiteit van die ‘Hopkins Symptom Checklist (HSCL)‘, ‘Beck Depression Inventory (BDI)’, 
‘Beck Anxiety Inventory (BAI)’ en die ‘Alcohol Use Disorder Identification Test (AUDIT)’ in die 
bepaling van algemene geestesiekte ‘gevalmatigheid’ en ‘nie-gevalmatigheid’ te ondersoek.  
Die navorsing het ’n deursneenavorsingsontwerp gebruik. Vyfhonderd deelnemers is gewerf 
ten tyde van aanmeliding vir MIV-toetsing by vyf nie-mediese toetsplekke in die Wes-Kaap, Suid-
Afrika. Die navorsingsweergawe van die gestruktureerde kliniese onderhoud vir die DSM-5 (SCID-
5), is gebruik om algemene geestessteurings te assesseer. Verder is die vlakke van sielkundige 
nood, depressie, angs en gevaarlike alkoholgebruik bepaal met behulp van onderskeidelik die 
HSCL-25, BDI, BAI en AUDIT. Beskrywende statistiek is gebruik om die voorkoms van algemene 
geessteurings te bepaal en ‘Ontvanger bedryfseienskapkurwe’ (OBE – ROC) analise is gebruik om 
die doeltreffendheid van die self-rapporteringsinstrumente te bepaal in die voorspelling van 
algemene geessteuring ‘caseness’ teen die SCID as goudstandaard. 
Die resultate het getoon dat ten minste 28.4% (95% vertrouensinterval (VI) [24.45, 32.35]) 
van die steekproef ’n algemene geessteuring het. ’n Verhoogde voorkoms van depressie (14.4%; 
95% VI [11.32, 17.48]), aanhoudende depressie (7.2%; 95% VI [4.93, 9.47]), algemene 





angsversteuring (3.4%; 95% VI [1.81%, 4.99%]) en alkoholgebruikversteuring (19.6%; 95% VI 
[16.12, 23.08]) is aangemeld. Die resultate het verder getoon dat die HSCL-25, BDI, BAI, en die 
AUDIT effektief was vir die identifisering van gemeenskaplike geessteuring ‘caseness’. Selfs die 
subskale van die HSCL-25 was suksesvol met die opsporing van depressie (MDD en PDD), en 
algemene angs. Van die steekproef het 41.2% van die deelnemers sielkundige nood gehad, terwyl 
21% matige depressie, 13.6% matige angs en 34.6% gevaarlike alkoholgebruik gehad het. 
Die bevindinge van die navorsing het aangedui dat dit belangrik is om mense vir algemene 
geessteurings en sielkundige nood te toets voor die bekendmaking van hulle MIV-diagnose, 
aangesien hierdie versteurings ’n negatiewe invloed op lewensgehalte en die nakoming van ARB 
kan hê. ’n Verdere bydrae van die studie is dat die graderingsinstrumente gebruik mag word vir die 
identifisering van mense met ’n hoe risiko vir algemene geessteurings wat MIV-toetsing ondergaan. 
Gegewe dat MIV-toetsing en geestesgesondheidsdienste onafhanklik is van mekaar, verskaf 
openbare gesondheidsfasiliteite in Suid-Afrika gefragmenteerde dienste. Toekomstige navorsing 
mag nodig wees om te fokus op die integrasie van verwysingstrajekte met roetine sifting en MIV-
toetsing. 
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Chapter 1: Introduction 
This research aimed to determine the prevalence of common mental and substance use 
disorders among adult men and women seeking testing for the human immunodeficiency virus 
(HIV) in the Western Cape, South Africa. A second aim is to examine the level of general distress 
among this sample of HIV test-seekers. A third aim is to determine the effectiveness of specific 
self-report measures in determining caseness for psychological disorders using the Structured 
Clinical Interview for the DSM (SCID) as a gold standard.  
Common mental disorders 
Common mental disorders (CMDs) refer to non-psychotic psychiatric disorders in the general 
population (Tomson & Shiers, 2003). This term was coined by Goldberg and Huxley (1992) to 
describe “disorders which are commonly encountered in community settings, and whose occurrence 
signals a breakdown in normal functioning” (pp. 7-8). These include depressive, anxiety and post-
traumatic stress disorders (PTSD), all of which cause significant morbidity and disability in primary 
care settings (Patel & Kleinman, 2003). CMDs have been shown to negatively affect a wide range 
of health, economic and social outcomes (Moussavi et al., 2007). Comorbidity, which refers to the 
occurrence of more than one disorder simultaneously (Maj, 2005), accounts for a significant 
percentage of mental disorder cases. For example, in the US National Comorbidity Survey 
Replication, which is a nationally representative study, the WHM-CIDI was used to determine the 
extent of comorbidity of 12-month DSM-IV anxiety, mood, impulse control, and substance 
disorders (Kessler, Chiu, Demler, & Walters, 2005). In the NSC-R, comorbidity accounted for more 
than 40% of the 12-month DSM-IV disorder cases (Kessler et al., 2005).  
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Mental and behavioural disorders represent 183.9 million disability-adjusted life years 
(DALYs) around the globe (Whiteford et al., 2013). The DALY is a measure of the burden of 
disease and is an assessment of the number of years lost to disability, illness or death (Whiteford et 
al., 2013). In general, mental and behavioural disorders account for 7.4% of the global burden of 
disease (Murray et al., 2012; Whiteford et al., 2013). According to Murray et al. (2012), the 
following mental disorders contributed to more than 15 million DALYs in 2010: major depressive 
disorders (2.5%), anxiety disorders (1.1%), drug use disorders (0.8%), alcohol use disorders (0.7%), 
and schizophrenia (0.6%). In sub-Saharan Africa, mental disorders contribute to 3.1% of DALYs 
(Lopez, Mathers, Ezzati, Jamison, & Murray, 2006). In South Africa, specifically, the 12-month 
prevalence of DSM-IV mental disorders was found to be 16.5% (Williams, et al., 2008). Williams 
et al. (2008) also found that 28% of their sample with a severe or moderately severe mental disorder 
received treatment, compared to 24.4% of those with mild cases. The most common treatment for 
depression includes antidepressants or psychological interventions such as cognitive-behavioural 
therapy and interpersonal therapies (Patel et al., 2007). Alcohol dependence can be treated 
effectively with pharmacological tools such as acamprosate, which lessens the frequency of 
drinking, and psychosocial interventions (Patel et al., 2007). Cognitive behavioural therapy has 
been effective in the treatment of anxiety disorders (Patel et al., 2007). Furthermore, the burden of 
CMDs in South Africa relates to stressors such as gender inequality, poverty, unemployment, 
conflict, high rates of HIV and AIDS (Stein et al., 2008; Hirschowitz & Orkin, 1997; Dunkle et al., 
2004; Patel & Kleinman, 2003). Evidence suggests that gender, specifically the stressors that 
women experience, are linked to poverty (Patel & Kleinman, 2003). Compared to men, women may 
have less access to education, experience intimate partner violence, and have fewer job 
opportunities, which are subsequently associated with CMDs (Patel & Kleinman, 2003). For 
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example, in a population-based study of 2 494 women aged between 18 and 50 years, poorer 
women were found to suffer from difficult life events, have less job opportunities, and to have 
chronic illnesses (Patel, Kirkwood, Pednekar, Weiss, & Mabey, 2006).  
Common mental disorders and HIV 
Globally, it has been estimated that nearly 36.7 million people were living with HIV in 2015 
(WHO, 2015). In Sub-Saharan Africa, the HIV prevalence was 4.4% in 2015, which accounts for 
nearly 70% of the people living with HIV globally (WHO, 2015). Moreover, in 2015 the estimated 
prevalence of HIV in South Africa was 11.2% (Statistics South Africa, 2015). The challenges 
related to HIV include stigma, loss of employment, and mortality (Simbayi et al., 2007). HIV 
testing has become readily available in South Africa. The most frequently used HIV test is the 
Rapid test, in a person’s blood is tested in a small disposable container using an aseptic technique 
(Mkhulisi, 2010). The person usually receives the test result in about two minutes. If positive, more 
blood is drawn and a confirmatory test is run (the ELISA test). In this case, the test results are 
usually available in about seven days (Mkhulisi, 2010).  
The major determinants for HIV testing include gender, age, education level, HIV status and 
marital status (Ziraba et al., 2011). Ziraba et al. (2011) for instance claim that there is evidence that 
women are in contact with the health care system more than men (Ziraba et al., 2011). 
Consequently, more women than men would be willing to have a HIV test. Mayston et al. (2016) 
further report that CMDs were related to increased odds of a delay of more than a month in testing 
for HIV.  
Several studies (for example by Clucas, Sibley, Harding, Liu, Catalan, & Sherr, 2011; and 
Sherr, Clucas, Harding, Sibley, & Catalan, 2011) have suggested that disorders such as depression 
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and anxiety can be diagnosed prior to an HIV infection, but can also follow an HIV diagnosis. 
Furthermore, CMDs can result in high risk behaviour, for example, unprotected sex, multiple sex 
partners, and contracting sexually transmitted diseases, which increase the risk of contracting HIV 
(Sterk, Theall, & Elifson, 2006; Hutton, Lyketsos, Zenilman, Thompson, & Erbelding, 2004).  
Common mental disorders are prevalent among the subset of people living with HIV 
(PLWH), most commonly depression, anxiety and substance abuse (Bing et al., 2001; Ciesla & 
Roberts, 2001; Mayston et al., 2013; Nakasujja et al., 2010; Nakimuli-Mpungu, Musis, Katabira, 
Nachega, & Bass, 2013). Moreover, chronic depression, stressful life events and trauma may 
negatively affect HIV progression (Farinpour et al., 2003; Lesserman, Jackson, et al., 1999). These 
risk factors may adversely affect medication adherence, which may lead to a decrease in the CD4 
(Cluster of Differentiation 4) cell count and an increase in viral load, both of which are markers of 
disease progression (Lesserman, 2008).  
Problem statement and rationale  
In South Africa, CMDs are understudied among persons seeking HIV testing. When persons 
with mental disorders and HIV report for healthcare, it is usually unknown whether a mental 
disorder existed prior to the receipt of an HIV-positive test result, or whether an HIV diagnosis 
stimulated the onset of a CMD. It is also not known whether screening for mental disorders is 
effective in identifying CMD caseness among individuals seeking HIV testing. However, due to 
poor screening routines and limited access to resources, most CMDs go undetected and therefore 
untreated (Siddiqi, & Siddiqi, 2007; Lusskin, Pundiak, & Habib, 2007). It can therefore be argued 
that adequate detection is necessary for access to treatment (Siddiqi, & Siddiqi, 2007; Lusskin, 
Pundiak, & Habib, 2007). Data regarding positive and negative predictive values and optimal cut-
off points on self-report measures among HIV test-seekers are limited. 
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A number of studies (for example, Bing et al., 2001; Freeman, Nkomo, Kafaar, & Kelly, 
2008a; Israelski et al., 2007; and Olley, Seedat, & Stein, 2006) have explored the prevalence of 
CMDs among PLWH. However, few studies have assessed the prevalence of CMDs and CMD 
caseness among persons seeking HIV testing. Only four such studies have been found in both local 
and international literature (e.g., Rochat et al., 2006; Sahay et al., 2007; Ramirez-Avila et al.; 2012; 
Cholera et al., 2014).  
Three of these aforementioned studies (Rochet et al., 2006; Ramirez-Avila et al., 2012; 
Cholera et al., 2014) probed the prevalence of depression and depressive symptoms prior to the 
receipt of an HIV test in South Africa, whereas one study in Pune, India, measured the symptoms of 
depression and anxiety prior to the receipt of an HIV test (Sahay et al., 2007). In the most recent 
work by Ramirez-Avila et al. (2012) and Cholera et al. (2014), the prevalence rates of depressive 
symptoms were investigated among HIV test-seekers in Durban and Johannesburg, South Africa, 
respectively. Ramirez-Avila et al. (2012) reported that the prevalence of depressive symptoms was 
55% among 1 545 participants seeking HIV testing (patient and provider initiated) using the five-
item Mental Health Index (MHI-5), a domain of the SF-36. Cholera et al. (2014), on the other hand, 
found that 32 % of the study sample (n= 397) had no depression; 18 % reported moderate 
depression; 5 % had severe depression; and 1 % reported very severe depression on the Patient 
Health Questionnaire (PHQ). These authors also found that 11.8 % of their sample could be 
diagnosed with a current major depressive episode according to the MINI International 
Neuropsychiatric Interview (MINI) (Cholera et al., 2014). The reported prevalence rates of 
depression are diverse due to the design of the studies, the sample size, the use of different self-
report measures and diagnostic criteria. Also, the diagnosis of these psychiatric disorders and of 
elevated distress among HIV test-seekers can have a negative impact on quality of life, family 
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functioning, adherence to ART, and even case management (Kagee, & Freeman, 2008; Sterk, 
Theall, & Elifson, 2006; Sahay et al., 2007).  
Prior diagnosis of CMDs among HIV test-seekers can contribute to enhanced case 
management, in which the individual is linked to support services so that psychological counselling, 
psychosocial support and suitable clinical care may be provided to persons in need of such services. 
These findings may highlight the need for providing appropriate treatment services and coping 
strategies. The current study seeks to address the gap in evidence on the extent of CMDs among 
persons seeking HIV testing and to provide data on the utility of common screening instruments to 
detect CMDs prior to the receipt of a HIV positive test result. 
Research Questions  
The study addresses the following research questions: 
1 What is the prevalence of the following CMDs: major depressive disorder (MDD), 
generalized anxiety disorder (GAD) and alcohol use disorders among people who are 
seeking an HIV test? 
2 What is the reported level of psychological distress among people seeking HIV testing?  
3 What are the optimal cut-off scores for specific self-report measures: Beck Depression 
Inventory (BDI), Beck Anxiety Inventory (BAI); the Hopkins Symptom Checklist 
(HSCL); and Alcohol Use Disorder Identification Test (AUDIT), in predicting caseness for 
MDD, GAD, depression and anxiety, and alcohol use, respectively? 
Research Aims and objectives  
The objectives of this research project are as follows: 
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1 To determine the prevalence of the following CMDs: major depressive disorder (MDD), 
generalized anxiety disorder (GAD) and alcohol use disorders among people who are seeking 
an HIV testing; 
2 To determine the level of general distress among people seeking HIV testing.  
3 To determine the optimal cut-off scores for the following scales with respect to the gold 
standard of the structured clinical interview for the DSM (SCID): BDI for major depression; 
the BAI for anxiety; HSCL for depression and anxiety; AUDIT for alcohol use and DUDIT 
for drug use; and 
Significance of the Research 
The study has the potential to represent a baseline for CMDs and distress among HIV test-
seekers, so that statements can be made about whether or not an HIV diagnosis contributes to the 
development of CMDs. Individuals who might benefit from psychological treatment can also be 
identified and referred for such treatment. The findings of this study could also potentially 
contribute to the modification of treatment interventions and making these available to those 
individuals who have met the diagnostic criteria for a psychiatric disorder.  
Scope/Limitations of the Research 
In view of time constraints, the diagnostic interview excludes a number of mental disorders. 
The Diagnostic and Statistical Manual of Mental Disorders, 5th edition (DSM-5), criteria are used in 
the current study (APA, 2013). In an attempt to shorten the interview, several DSM-5 disorders 
were not assessed, for example, psychotic disorders, antenatal depression, postnatal depression, and 
child mental disorders. Additionally, as the study forms part of a larger research project, which 
included posttraumatic stress disorder, acute stress disorder, adjustment disorder among others, 
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these trauma-related disorders were not included in the present study. The common DSM-5 and 
ICD-10 mental disorders that are explored in the current study are major depression, generalized 
anxiety disorder and substance use disorders (e.g. alcohol use disorders).  
Chapter Conclusion 
Those individuals seeking HIV testing usually go undetected and untreated for common 
mental disorders. This research therefore aimed to determine whether individuals seeking HIV 
testing might have a common mental disorder before their receipt of their HIV test result. Following 
this chapter is the literature review, which provides information that serves as a context within 
which to understand and explain the results.  
Thesis Layout 
Chapter 1 of the thesis includes the background of the study, the research questions, problem 
statement and the research aims and objectives. Chapter 2 provides both international and South 
African literature pertaining to CMDs. The diagnostic features of CMDs are discussed and the 
prevalence of CMDs in HIV-positive persons are highlighted. The theoretical framework for the 
study is also examined.  
Chapter 3 details the research design and methodology used, including the identification of 
participants, the demographic profile of the sample, the research procedures and measures used, and 
the method of data analysis. The results of the study are presented in Chapter 4. Chapter 5 
comprises a discussion of the results, including implications of the study findings and the 
limitations of the study. Chapter 6 presents the conclusions and recommendations for future 
research.
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Chapter 2: Literature Review 
Introduction 
This chapter gives an overview of relevant literature on common mental disorders and 
substance use disorders. Literature searches included the following databases: Medline, Science 
Direct, Google scholar, EBSCO Host, Scopus, Sciverse, SUNscholar, and Psych Info. Searches 
focused on empirical, peer reviewed, and published studies in English between 1987 and 2016. The 
period was chosen to include as many studies as possible related to common mental disorders 
(CMD’s) and substance use disorders.  
Initial literature searches focused on the following broad areas:  
1 Common mental disorders, including key words such as ‘depression’, ‘anxiety’ AND/OR 
‘prevalence’, ‘common mental disorders’, ‘screening’, ‘psychiatric epidemiology’;  
2 HIV/AIDS and HIV testing, which included keywords such as, ‘diagnosis’, ‘HIV test 
seekers’, ‘mental disorders’, ‘mental health problems’, and ‘PLWH’. In reviewing the 
resulting articles and abstracts, the reference lists of these publications were examined to 
identify further publications relevant to the thesis subject area. 
All studies reporting on epidemiological data on common mental disorders and relationships 
between them in adults were included for review. The literature reviewed in this chapter is 
organized into two parts, namely, taxonomy and nosology of CMD and CMDs in the global and 
South African context.  
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Common Mental Disorders (CMDs) 
Common mental disorders are described as “depressive (depression) and anxiety disorders 
that are classified in ICD-10 as neurotic, stress-related and somatoform disorders and mood 
disorders” (Patel & Kleinman, 2003, p. 609). Common mental disorders include the following: 
major depression, generalized anxiety disorder, post-traumatic stress disorder, panic disorder, 
obsessive-compulsive disorder (OCD) and social anxiety disorder (National Institute for Health and 
Care Excellence (NICE), 2011).  
With regard to the prevalence of common mental disorders, the rates may vary depending on 
whether the numbers refer to point prevalence, period prevalence or lifetime prevalence (World 
Health Organization [WHO], 2001). Point prevalence refers to an individual having the illness or 
disorder at a particular point in time (WHO, 2001). Period prevalence refers to the person having 
the condition at any point during a period of time. Lifetime prevalence refers to the person having 
the condition any time during their life (WHO, 2001). Even though point prevalence has been 
documented in the literature, lifetime and 12-month prevalence rates of CMDs is more appropriate 
for providing a clear picture of the number of people who may benefit from mental health services 
in a year (WHO, 2001). The prevalence of CMDs among primary healthcare attendees ranges from 
10% to 40% (Goldberg & Lecrubier, 1995). Furthermore, CMDs may affect up to 15% of the 
general population (NICE, 2011). In South Africa, it is estimated that the lifetime prevalence of 
anxiety, mood or substance-related disorders are 16%, 10% and 13%, respectively (Stein et al., 
2008).  
The symptoms of CMDs also appear to fluctuate in severity over time, which can thwart the 
assessment when it comes to reaching the threshold for a diagnosis of a mental disorder. Although 
subthreshold psychosocial symptoms may not be suitable for formal diagnosis, it may nevertheless 
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be associated with negative health outcomes, significant impairment and disability (Gask, 
Klinkman, Fortes, & Dowrick, 2008).  
Recognition and management of common mental disorders in primary care 
Previous research has found that common mental disorders (CMDs) go undetected and 
untreated at primary care facilities because of poor screening routines and the scarcity of resources 
(Siddiqi & Siddiqi, 2007; Lusskin et al., 2007). Tomson and Shiers (2003) have found that the non-
treatment of common mental disorders (CMDs) can result in significant social and economic burden 
for families, friends and superiors. Several reasons have been suggested for the non-treatment of 
CMDs, which include physician-related factors, patient-related factors and challenges associated 
with clinics.  
First, physician recognition of CMD rates is influenced by the high number of patients 
attending primary healthcare facilities, poor training of health professionals, as well the association 
between stigma and mental illness (Patel et al., 2008). Stigma refers to an attribute that 
characterizes people as different and that leads to a ruined and discounted person (Goffman, 1963). 
When stigma is applied to individuals with psychiatric disorders, it can have an effect on the 
individual at different levels, namely public stigma, self-stigma and label avoidance (Ben-Zeev, 
Young, & Corrigan, 2010). Public stigma refers to a group of people advocating stereotypes about 
and consequently acting against the stigmatized group of people (Ben-Zeev et al., 2010). Self-
stigma, on the other hand, refers to the loss of “self-esteem and self-efficacy” when the individuals 
internalize public stigma (Ben-Zeev et al., 2010, p.319). Label avoidance refers to people not 
looking for or attending mental health services in order to escape a stigmatizing label (Ben-Zeev et 
al., 2010). Strümpher, Van Rooyen, Topper, Andersson and Schierenback (2014) report that 
professional nurses, especially those working in primary healthcare clinics, lack the necessary 
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knowledge and skills related to diagnose mental illness. Furthermore, data from previous research 
has shown a large treatment gap between psychologically disordered individuals in need of 
treatment, and those individuals already receiving treatment (Lund et al., 2015). A possible reason 
for this large treatment gap may be the severe shortage of mental health care professionals 
(Strümpher et al., 2014). Given this large treatment gap ranging between 75%-90% (Williams et al., 
2008; Alem et al., 2009), mental health care specialists may not be able to meet the treatment needs 
of psychologically disordered patients (Lund et al., 2015). Consequently, persons with mental 
illness are sometimes misdiagnosed and, as a result, may be given inadequate treatment.  
Secondly, patient-related factors include attitudinal/evaluative barriers and structural barriers. 
Attitudinal/evaluative barriers refer to the patient’s unwillingness to access treatment (Elhai, 
Voorhees, Ford, Min, & Fruech, 2009), the presence of stigma or low perceived efficacy of 
treatments (Mojtabai et al., 2011). Stigma and discrimination, for example, may threaten people’s 
personal lives, reputation and status within their communities. As a result, many people with mental 
illnesses worldwide may be reluctant to seek help (Saxena et al., 2007; Strümpher et al., 2014). The 
structural barriers, on the other hand, include lack of access to treatment, inability to obtain an 
appointment (Motjabai, 2005; Sareen et al., 2007) and/or lack of transportation (Motjabai, 2005). 
For example, many patients are unable to afford transport to and from the clinics, or to purchase 
medication from a private healthcare facility when the public healthcare facilities’ drug supplies are 
depleted (Strümpher et al., 2014). 
Lastly, the major challenge within clinics is that of high patient loads (Avashti et al., 2008). 
According Strümpher et al. (2014), most clinics experience a shortage of professional nurses and 
other healthcare professionals, namely psychiatrists, psychologists, medical doctors and social 
workers. These staff shortages can lead to a heavy workload for professional nurses and long 
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waiting periods for people with mental illnesses (Strümpher et al., 2014). Therefore, professional 
nurses become overwhelmed and insensitive when caring for individuals with mental disorders. As 
a result, individuals with mental disorders become despondent and leave the healthcare facility 
without treatment (Strümpher et al., 2014). Access to mental health services is a major challenge for 
many people in low and middle-income countries, which affects the detection of CMDs (Strümpher 
et al., 2014).  
Screening for common mental disorders 
Psychiatric screening questionnaires (SQs), such as self-reported measures, are useful in 
improving the recognition of CMDs (Berg et al., 2004). Screening is usually recommended as a way 
to identify individuals with “psychiatric morbidity” that would otherwise be undetected or untreated 
(Coyne, Palmer, Shapiro, Thompson, & DeMichele, 2004, p. 124). The effectiveness of screening 
measures can be assessed in terms of sensitivity (the proportion of people accurately recognized 
with the disorder) and specificity (the proportion of people accurately recognized without the 
disorder) (Halverson & Chan, 2004). Sensitivity and specificity are independent of the prevalence 
of the condition being screened for, in this instance CMDs (Zou, Liu, Bandos, Ohno-Machado, & 
Rockette, 2012). Screening is also associated with an instrument’s positive-predictive and negative-
predictive values (Coyne, Thompson, Palmer, & Kagee, 2000). The positive-predictive value (PPV) 
refers to the proportion of people who score above the optimal cut point on a screening instrument 
and therefore actually have the condition. The negative-predictive value (NPV), on the other hand, 
refers to the proportion of people who scored below the optimal cut point on a screening instrument 
who actually do not have the condition (Coyne et al., 2000; Zou, O'Malley, & Mauri, 2007). 
Notably, the PPV is dependent on the prevalence of the condition, in this case CMDs (Coyne et al., 
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2000; Zou et al., 2007). Therefore, if the prevalence of CMDs were high, then the PPV would be 
high, while the NPV would be low.  
Furthermore, according to Ali, Ryan and the De Silva (2016), screening instruments can help 
motivate researchers or healthcare providers to screen for CMDs early enough in their population of 
interest. This will more accurately inform them of the impact of untreated CMDs. The possible 
benefits of screening include increasing quality of life, reducing morbidity and mortality, and 
overall health costs (Halverson & Chan, 2004).  
The major risk of screening, however, is the possibility of detecting high false positive and 
false negative cases (Coyne, Thompson, Palmer, Kagee, Maunsell, 2000). While the false negative 
cases go undetected, the false positive cases are unnecessarily referred for treatment (Kagee, 2012). 
The most commonly used screening instruments include the Edinburg Postnatal Depression Scale 
(EPDS), General Health Questionnaire (GHQ), Self-Reporting Questionnaire (SRQ), Hospital 
Anxiety and Depression Scale (HADS), Kessler Mental Distress Scale (K-10), Hopkins Symptom 
Checklist (HSCL-25), Becks Depression and Anxiety Scales (BDI and BAI), Patient Health 
Questionnaire (PHQ), Center for Epidemiological Studies Depression Scale (CES-D) and the 
Alcohol Use Disorder Identification Test (AUDIT) (Sweetland, Belkin, & Verdeli, 2014).  
However, most self-reported measures assess whether or not respondents endorse emotional 
symptoms and therefore do not instantly measure the diagnostic criteria of a psychiatric disorder. 
Clinical and epidemiological studies make use of a “gold standard” in determining whether a 
psychiatric disorder is present or absent (Myer et al., 2008). In this context, the “gold standard” is a 
structured diagnostic instrument, such as the Structured Clinical Interview for the DSM (SCID) 
(Myer et al., 2008) that can be utilized to recognize cases of CMDs (Kagee, 2012). The limitation of 
the SCID is that it is resource- and time-intensive. The “gold standard” also includes the 
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unstructured clinical interviews, MINI International Neuropsychiatric Interview (MINI), Composite 
International Diagnostic Interview (CIDI), Clinical Interview Schedule (CIS), Present State 
Examination (PSE), and the Comprehensive Psychopathological Rating Scale (CPRS) (Sweetland 
et al., 2014). Previous research has found that the prevalence estimation of self-reported measures is 
higher than that of diagnostic interviews (Coyne et al., 2000; Lustman et al., 2000). In a systematic 
review, for example, Anderson, Freedland, Clouse, and Lustman (2001) found that when using 
diagnostic interview methods, 11.4% of diabetic patients were diagnosed with a depressive 
disorder, while self-report measures yielded elevated depressive symptoms of 31.0%. 
Comparison of Self-Report Measures with Structured Diagnostic Tests 
Major depressive disorder. The predictive values of the Beck Depression Inventory (BDI) 
for the detection of depression in the general population in the UK were assessed using the 
Schedules for Clinical Assessment in Neuropsychiatry (SCAN) (Lasa, Ayuso-Mateos, Vazquez-
Barquero, Diez-Manrique, & Dowrick, 2000). Lasa et al. (2000) reported that the AUC of 0.99 in 
their study showed that the BDI is a screening tool with good accuracy for identifying depression. 
Diagnostic accuracy describes the level of agreement between the findings from the diagnostic 
interview and the self-report measure (Bossuyt et al., 2003; van Stralen et al., 2009). Furthermore, it 
was found that the optimal cut-off point of 12/13 yielded sensitivity of 100% and specificity of 99% 
(Lasa et al., 2000). Therefore, these authors conclude that the BDI is a useful instrument for 
identifying depression in community settings (Lasa et al., 2000). In contrast, Nuevo, Lehtinen, 
Reyna-Liberato, and Ayuso-Mateos (2009) found that with a higher cut-off score of 17/18, the 
sensitivity (70.1%) and specificity (73.7%) values of the BDI-I against the SCAN as gold standard 
was lower than that of Lasa et al. (2000). However, the AUC value 0.81 was indicative that the BDI 
was a moderately useful scale in identifying depression in the Finnish community (Nuevo et al., 
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2009). In Germany, Forkmann et al. (2009) investigated the performance of the BDI in detecting 
depression among cardiac inpatients.  
According to Hedayati, Bosworth, Kuchibhatla, Kimmel, and Szczech (2006), the Center for 
Epidemiological Study of Depression (CESD) cut-off point with the best diagnostic accuracy of 
80% was determined to be 18. Using the SCID as gold standard, this cut-off score of 18 yielded a 
sensitivity of 69%, specificity of 83%, PPV of 60%, and NPV of 88%. On the other hand, the BDI 
cut-off point of 14 yielded a sensitivity of 62%, specificity of 81%, PPV of 53%, NPV of 85% 
(Hedayati et al., 2006). When compared with the CESD and the SCID, the agreement between this 
BDI cut-off against the SCID as gold standard was modest (Hedayati et al., 2006). 
It has also been shown that among Australian 891 men and 1086 women, the sensitivity of the 
self-report medical condition questionnaire compared to the SCID-I/NP was 61.0%, specificity was 
89.5%, PPV was 61.9%, NPV was 89.2% and the overall level of agreement (kappa) was 0.5 (Stuart 
et al., 2014). Therefore, the overall level of agreement between self-report depression and clinically 
determined depression using the SCID-I/NP was moderate to good (Stuart et al., 2014).  
Furthermore, within a nationally representative study in Australia (ages 32-37, and 52-58), the 
performance of the Patient Health Questionnaire (PHQ-9) was assessed against the WMH CIDI as 
gold standard. In the PATH study, the findings showed that the PHQ-9 cut-off point of 8 yielded 
sensitivity and specificity values of 0.79 and 0.86, respectively (Kiely & Butterworth). These 
authors reported that this cut-off point of 8 was lower than that found in medical studies (Kiely & 
Butterworth, 2015). For example, similar results of sensitivity and specificity were found using the 
PHQ cut point of 11, which is usually identified to be the optimal cut-off point in medical settings 
(Löwe et al., 2004). Considering that the PHQ-9 was designed to be used in medical populations, 
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the diagnostic accuracy of the PHQ-9 in the PATH study appears to be somewhat poorer (Kiely & 
Butterworth, 2015).  
The validity of the K-10 has been assessed among 429 HIV-positive individuals near Cape 
Town, South Africa, against the MINI as gold standard (Spies et al., 2009a). These authors showed 
that the K-10 was a useful screening measure for current major depression with an AUC value of 
0.77, with a slightly declined AUC of 0.75 for past major depressive disorders (Spies et al., 2009). 
Moreover, the scale was able to correctly differentiate between true cases and non-cases of current 
major depression (sensitivity of 0.67; specificity of 0.77) and past major depression (sensitivity of 
0.72; specificity of 0.75). For this reason, these authors established that the K-10 was an effective 
measure in determining both current and past major depressive episodes (Spies et al., 2009a). 
Among 129 pregnant women in the Western Cape, South Africa, the performance of the K-10 in 
detecting major depression was assessed against the SCID as gold standard (Spies et al., 2009b). 
The performance of the K-10 was found to be acceptable with an area under the curve of 0.66. The 
best cut-off point in identifying major depression (21.5), yielded optimal sensitivity (0.75) and 
specificity (0.54) values. Therefore, the K-10 was a useful screening tool in discriminating between 
major depression caseness and non-caseness in pregnant women (Spies et al., 2009). Spies et al. 
(2009b) argue that the small sample size of pregnant women restricted the K-10 in displaying 
higher sensitivity and specificity values.  
Persistent depressive disorder. The performance of the depression subscale of the Hospital 
Anxiety and Depression scale (HADS-D) in recognizing dysthymia was assessed using the MINI as 
gold standard (Bunevicius, Peceliuniene, Mickuviene, Valius & Bunevicius, 2007). These authors 
showed that among 503 primary care patients in Lithuania, the HADS-D is not an optimal screening 
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instrument for dysthymia. The AUC value of 0.60 indicated poor accuracy of the HADS-D for 
dysthymia.  
Generalized anxiety disorder. The performance of the K-10 in discriminating between 
generalized anxiety disorder caseness and non-caseness was also assessed within a sample of 429 
HIV-positive persons in Cape Town, South Africa (Spies et al., 2009a). Consistent with other K-10 
validation studies (e.g. Baillie, 2005; Cairney et al., 2007; Furukawa, Kessler, Slade & Andrews, 
2003; Kessler et al., 2002), the K-10 against the MINI as gold standard was a useful proxy measure 
for generalized anxiety disorder with an AUC of 0.78 (Spies et al., 2009a). These authors found that 
a cut-off score of 30 yielded the best sensitivity (0.72) and specificity (0.80) values.  
Alcohol use disorder. Using the AUDIT against the MINI as gold standard, the area under 
the curve of the AUDIT was 0.96, which suggests that the AUDIT was a useful screening tool in 
identifying alcohol abuse or dependence (Myer et al., 2008). Myer et al. (2008) also reported that 
with a sensitivity of 100%, all the individuals (n = 465) have met the diagnostic criteria for alcohol 
abuse or dependence. The AUDIT, however, only identified 79% of those individuals who did not 
meet the diagnostic criteria of alcohol abuse or dependence, in other words, true non-cases (Myer et 
al., 2008).  
Taxonomy and Nosology of Common Mental Disorders 
In this part of the chapter, the classification of the common mental disorders, namely major 
depressive disorder, persistent depressive disorder, generalized anxiety disorder, and alcohol use 
disorder, are outlined. An examination of the paradigm of nosology will also be presented. 
Major depressive disorder (MDD): Single and recurrent episodes. Major depressive 
disorder, which is also known as clinical depression, major depression, unipolar depression and 
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unipolar disorder, is considered a common mental disorder with episodes of low mood, and a loss of 
interest or pleasure in typically pleasurable activities. The lifetime prevalence of major depressive 
disorder (MDD) ranges from 10% to 18.5% within American samples (Kessler, & Walters, 1998; 
Lewinsohn, & Essau 2002; Lewinsohn, Hops, Roberts, & Seeley, 1993; Rohde, Beevers, Stice, & 
O’Neil, 2009) and the age of onset is in adolescence or early childhood for MDD (Zisook, Lesser, 
Stewart, et al., 2007). Specifically, as indicated by longitudinal studies, the age of onset for MDD is 
almost 15 years, with episodes lasting six months (Lewinsohn, Clarke, Seeley, & Rhode, 1994).  
The criteria used for the diagnosis of current major depressive episode are the same as the 
diagnostic criteria for a recurrent major depressive episode. The diagnostic criteria for a major 
depressive disorder are outlined in the DSM-5 (American Psychiatric Association (APA), 2013). 
Persistent depressive disorder (PDD) (Dysthymia). Persistent depressive disorder, also 
known as dysthymia, is associated with depressed mood and loss of sexual interest nearly every 
day, for at least two years (APA, 2013). During these two years, the intervals with no depression 
last no longer than two months (APA, 2013). Additionally, the persistently depressed mood is 
accompanied by two (or more) of the following: appetite disturbance, sleep disturbance, low 
energy, poor self-esteem, insufficient concentration or experiencing a challenge in making 
decisions, and feelings of hopelessness (APA, 2013). Episodes of MDD may come before PDD and 
occur during PDD; in which case, both are diagnosed (APA, 2013). Patients should report 
significant impairment in their lives to be diagnosed, and this impairment must not be due to 
cyclothymic disorder, bipolar disorder, a psychotic disorder, substance use disorder or any other 
medical condition. Those individuals who experience major depressive disorder symptoms for two 
years may be diagnosed with “double depression”, therefore, they have met the diagnostic criteria 
for both persistent depressive disorder and major depressive disorder. Additionally, the age of onset 
Stellenbosch University  https://scholar.sun.ac.za
 20 
 
for PDD is in childhood, adolescence, or early adult life. The median age of onset is 31.1 (Kessler, 
Chiu, Demler, Walters, 2005). The diagnostic criteria for PDD are outlined in the DSM-5 (APA, 
2013). 
Generalized anxiety disorder (GAD). Previous research has shown that GAD is common in 
primary care facilities (Maier et al., 2000; Roy-Byrne, Katon, Broadhead, et al., 1994; Üstün, & 
Sartorius, 1995). According to the DSM-5, GAD is defined as severe anxiety and worry about 
events nearly every day for at least six months (APA, 2013) and the individual finds it difficult to 
control the worry. Generalized anxiety disorder is characterized by the following somatic 
symptoms: muscle tension, irritability, difficulty falling asleep or staying asleep and restlessness 
(APA, 2013). Psychical symptoms are also associated with GAD, including feelings of nervousness, 
fear, tremors, sweating, tension and light-headedness (Casey & Byng, 2011).  
With regard to age of onset, Kessler et al. (2007) found that the distribution of ages of onset 
of GAD, with ages ranging between 24 and 50 years, was much later compared to MDD. In 
addition, the diagnostic criteria of GAD are delineated in DSM-5 (APA, 2013). 
Substance use disorder. The DSM-5 (APA, 2013) category for substance use disorders lists 
combined substance abuse and substance dependence as one disorder. Substances can be classified 
as separate disorders, for example, alcohol use disorders, cannabis use disorders and stimulant use 
disorders. The abovementioned substances share similar overarching criteria (APA, 2013). A 
substance use disorder is diagnosed when an individual has two or three symptoms from a list of 11 
for a 12-month period. Examples of such symptoms include the following:  
1 recurrent substance use in situations that cause physical danger to the user;  
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2 social impairment in school or work situations, or after these, resulting in social, interpersonal 
or legal problems; and 
3 craving for the substance, which manifests itself in a persistent desire for the substance (APA, 
2013). 
The age of onset for substance use has been shown to be between 14 and 15 years (Richter et 
al., 2006).  
In South Africa, the lifetime prevalence of substance use disorders is high, with 13.3% of the 
population meeting the diagnostic criteria for a substance use disorder (Herman et al., 2009). In 
addition, the most frequently used substance in South Africa, excluding the Western Cape and the 
Northern region (Mpumalanga and Limpopo), is alcohol. The percentage of patients in treatment for 
alcohol abuse in the Western Cape is 20%, compared to 51% of patients in the Central Region, 
which includes Gauteng, Free State, Northern Cape, and North-West (Dada et al., 2013). Also, the 
criteria used for the diagnosis of alcohol used disorder are delineated in the DSM-5 (APA, 2013). 
Psychological distress. Psychological distress is associated with depression and anxiety and 
further refers to the emotional state of an individual (Mirowsky & Ross, 2002). Psychological 
distress can be viewed as an emotional state that can negatively influence an individual’s social 
functioning and daily life (Wheaton, 2007). The symptoms commonly associated with 
psychological distress include difficulty sleeping, feeling sad or down, lack of excitement, 
hopelessness about the future and feeling emotional (e.g., crying easily) (Burnette, & Mui, 1997; 
Decker, 1997; Lincoln, Taylor, Watkins, & Chatters, 2011; Kleinman, 1991; Kirmayer, 1989; 
Drapeau et al., 2012).  
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Therefore, psychological distress is most commonly described as a non-pathological mental 
health condition (Drapeau et al., 2012; Dohrenwend, & Dohrenwend, 1982). Subsequently, ordinary 
non-mentally ill persons also experience distress. Distress is defined by elevated scores on a self-
report measure of mental health symptoms, whereas a CMD is an actual psychiatric diagnosis, in 
other words an illness. 
Classification of Mental Disorders 
The present study rests on the assumption of a nosological understanding of psychiatric 
disorders, that is, that psychiatric conditions are circumscribed and are identifiable as separate from 
one another. Yet, “although DSM-5 remains a categorical classification of separate disorders, we 
recognize that mental disorders do not always fit completely within the boundaries of a single 
disorder” (APA, 2013, p. xIi)  
Psychiatric nosology refers to the classification of mental illnesses and behavioural disorders 
(APA, 2013). In addition, nosology serves several purposes, for example, it is essential for the 
“communication” between clinicians and researchers about what indicates a specific “disease and 
what does not” (Avashti, Sarkar, & Grover, 2014; p. 301). Nosology “is also useful in 
understanding the prevalence of the problems and disorders, so that suitable healthcare planning can 
be done” (Avashti et al., 2014, p. 301). 
The DSM-5 classification of major depression, persistent depressive, generalized anxiety and 
alcohol use disorders is used in the present study. This classification incorporates both a categorical 
and a dimensional approach to nosology, namely a hybrid approach. The categorical approach 
draws clear boundaries between disorders and normality and does not account for clinical 
experience or scientific observations (APA, 2013).  
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The dimensional approach, on the other hand, postulates that the “symptoms of disorder exist 
on a dimension which is a continuum from normal to severely ill” (Avashti et al., 2014, p. 303). The 
dimensional approach transcends the boundaries set by a categorical approach and accommodates 
the notion that the symptoms present in a single disorder may occur in many other disorders (APA, 
2013). An advantage of this approach is an increase in the validity of a diagnosis.  
However, dimensional approaches are converted back to categorical approaches by means of 
cut-points to determine common mental disorder caseness or non-caseness (Nesse & Stein, 2012). 
Patients with scores above a certain cut-off point on a self-report measure may be viewed as having 
a specific disorder, while those with scores below this cut-off point may be viewed as not having 
this condition (Stein, 2012). Therefore, for the purposes of the current study, both dimensional and 
categorical approaches (hybrid approach) are incorporated, as the DSM-5 reflects both.  
Criticism on the Paradigm of Nosology. 
The categorical approach of nosology is confronted with several problems. For example, one 
of the issues is the threshold of a diagnosis. It is not always clear at which threshold the person 
should be diagnosed with the disorder (Avashti et al., 2014). Furthermore, those symptoms that fall 
below the threshold, namely syndromal symptoms, are not diagnosed with the categorical approach 
of nosology. These sub-syndromal symptoms are coupled with dysfunction and disability and 
treatment may improve health outcomes (Avashti et al., 2014).  
The dimensional approach is also confronted with some challenges. For example, it is 
unknown whether a large number of separate dimensions are warranted for each disorder, or if all 
mental health disorders can be explained by means of fewer dimensions (Avashti et al., 2014).  
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The hybrid approach, which combines both the categorical and dimensional approach, also 
faces some challenges as it can be seen as a collaborated approach that does not have distinct 
biological understanding (Avashti et al., 2014). The use of cut-off points to identify an illness or 
disorder relies on the decision of a healthcare professional and therefore does not determine the true 
presence and absence of illness or disorder (Avashti et al., 2014).  
Although the hybrid approach is not without challenges, it is still the most useful approach for 
clinicians in diagnosing an individual with an illness or disorder (categorical approach). 
Furthermore, researchers who are more interested in the dimensional aspect of nosology can 
evaluate an individual’s reaction to a specific treatment and determine aetiology (Avashti et al., 
2014).  
Summary of common mental disorders, recognition, screening and taxonomy.  
The research on common mental disorder uses a wide range of terminology. Literature makes 
use of the following terms regularly: common mental disorders (CMDs), lifetime prevalence, 12-
month prevalence, screening instruments, sensitivity, specificity, positive predictive value, negative 
predictive value, optimal cut-off points, caseness, etc.  
With regard to screening, literature has shown that sensitivity, specificity, PPV, NPV as well 
as optimal cut-off scores can be used to determine the effectiveness of the screening instruments in 
predicting CMD caseness or non-caseness.  
The hybrid approach (e.g., combination of categorical and dimensional approaches) of 
psychological nosology has been adopted for the purposes of the current study. More recent 
evidence suggests that this approach contributes to clinicians being able to determine whether an 
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individual has an illness or not (categorical) and that the symptoms of one illness/disorder can 
overlap with another illness/disorder.  
Common Mental Disorders in the Global and Sub-Saharan Context 
This part of the review presents literature on the prevalence and risks of CMDs in the global 
and sub-Saharan context. 
Prevalence of common mental disorders (CMDs). In the global context, the lifetime 
prevalence rate of CMDs was reported to range between 12.0% and 47.4% across 17 countries 
(Kessler et al., 2007). There was a prevalence of 37% for common mental disorders among 
participants in the United Kingdom (Maginn et al., 2004). Similarly, in a Qatari population 
attending a primary healthcare setting, the overall prevalence of mental disorders was 36.6% 
(Ghuloum, Bener, & Abou-Saleh, 2011). Common mental disorders are also related to considerable 
disability and consequently present a major public health problem (Ormel et al., 1994; Srinivasan, 
Isaacs, Villanueva, Luca & Raghunath, 2010). In addition, in developing countries, high rates of 
CMDs have also been found in several studies (Bradshaw et al., 2003; Desajarlais, Eisenberg, 
Good, & Kleinman, 1995; Herman et al., 2009; Lopez et al., 2006).  
However, a paucity of studies has measured the prevalence of CMDs in sub-Saharan 
countries, even though these countries contribute to a high burden of disease across the globe. A 
previous review of the literature has shown that in Africa the prevalence of CMDs ranges between 
8% and 43% depending on the measuring instrument used and population of interest (Jablensky et 
al., 2001). In Tanzania among 178 primary clinic attendees, the prevalence of CMDs was estimated 
at 24% (Ngoma, Prince, & Mann, 2003). Also, two studies in Zimbabwe found the prevalence of 
CMDs at 25% and 26% respectively in primary care settings (Patel, 1998; Reeler, Williams, & 
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Todd, 1993a). On the other hand, a lower prevalence rate of 3.1% for CMDs was found within an 
urban setting in Tanzania using the Clinical Interview Schedule-Revised (CIS-R) (Jenkins et al., 
2010).  
Few studies have assessed the prevalence, incidence and duration of CMDs in general and 
specifically among those living with HIV in South Africa. The first population-based study of 
psychiatric morbidity was conducted among 4351 adults, the South African Stress and Health Study 
(SASH) (Herman et al., 2009; Seedat et al., 2009; Seedat et al., 2008). The SASH study has shown 
that approximately 30.3% of the sample has been diagnosed with a psychiatric disorder in their 
lifetime that has gone untreated (Herman et al., 2009; Seedat et al., 2009; Seedat et al., 2008). The 
SASH further showed that 16.5% of the sample has experienced a CMD over a twelve-month 
period, but only 25% of the adults were treated for this condition (Seedat et al., 2008). In the SASH 
study, the most common DSM-IV mental disorders among 4351 adults in the general population 
over a twelve-month period, were major depressive disorder (4.9%), agoraphobia without panic 
(4.8%) and alcohol abuse (4.5%) (Herman et al., 2009). These authors also found that women tend 
to report mood and anxiety disorders more often, while men report substance use disorders more 
frequently (Herman et al., 2009). In addition, the prevalence of CMDs among people living with 
HIV is high (Breuer, Myer, Struthers & Joska., 2011; Nakimuli-Mpungu et al., 2012; Breuer et al., 
2014). For example, 43.7% of people living with HIV attending public health facilities had a 
psychiatric disorder as assessed by the CIDI (Freeman et al., 2008).  
Regarding mental health and HIV, there is an assumption that an HIV-positive diagnosis may 
be a risk factor for an individual to become depressed, traumatized or have any of the CMDs 
(Brandt, 2009; Freeman, 2004; Olley et al., 2003). Yet, mental health disorders, such as depression, 
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may precede an HIV-positive test result (Smart, 2009). It is also assumed that among people living 
with HIV (PLWH), the prevalence rates of CMDs are higher than in the general population.  
Furthermore, the representation of CMDs differs according to different study settings, 
screening tools, recruitment procedures, and illness perceptions. For example, in Spain among 5473 
participants attending a general medical practice, 22.5% and 14.8% of the sample met the 
diagnostic criteria for depression and generalized anxiety disorder, respectively (Fernández et al., 
2006). Several studies have acknowledged CMDs in primary care settings in India (Murthy, 
Kuruvilla, Verghese & Pulimood, 1976; Harding et al., 1980; Shamsunder, Krishnamurthy, 
Prakash, Prabhakar & Krishna, 1986; Seshadri, Kumar, Moily & Gangadhar, 1988; Patel et al., 
1998; Pothen, Kuruvilla, Philip, Joseph, & Jacob, 2003). The findings from these studies indicate 
that the prevalence of CMDs ranges from 17% to 46% among patients attending primary care 
facilities. For example, in the study by Pothen et al. (2003), the results indicated that among primary 
care patients, 33.9% were diagnosed with CMDs using a standardized semi-structured interview, 
the Revised Clinical Interview Schedule (CIS-R). The authors further found that depression was the 
most common diagnosis with a high prevalence rate of 83.8% (Pothen et al., 2003). Subsequently, 
in an Israeli study, the CIDI_SF (short form) was administered to evaluate the prevalence of 
psychiatric disorders among primary care patients (n = 976) (Cwikel, Zilber, Feinson, & Lerner, 
2008). These authors found that depression was most prevalent at 20.6%, followed by generalized 
anxiety disorder at 11.2%, and with panic disorder the lowest at 7.2% (Cwikel et al., 2008).  
In the next section, the prevalence of major depression, persistent depressive, generalized 
anxiety, and alcohol use disorder are organized as follows: First in the general population, and then 
among people living with HIV. The World Bank Development Index was utilized to differentiate 
high from low-middle income countries (World Bank, 2016). The studies further deal with a wide 
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range of epidemiological measurements (e.g. structured and self-report instruments) and include 
population, primary care facilities, medical, and people living with HIV (PLWH) samples.  
Prevalence of major depressive disorders (MDD).  
Prevalence of MDD in the general population. In high-income countries, numerous studies 
have reported the prevalence of major depression within the general population (e.g., Kessler et al., 
2005; Bing et al., 2001; Caron et al., 2012; Morrison et al., 2002; Kessler & Bromet, 2013). Kessler 
et al. (2005), for example, found a 12-month prevalence rate of 6.7%% for MDD among an 
American sample of 9 282 respondents in the general population using the World Mental Health 
Survey Initiative version of the World Mental Health Organization Composite International 
Diagnostic Interview (WHO-CIDI). The first Epidemiological Catchment Area Study on mental 
health has been conducted in Canada recently. The prevalence of MDD as assessed by the 
Community Health survey questionnaire (CCHS) 1.2 version of the Composite International 
Diagnostic Interview (CIDI) was 9% (Caron et al., 2012).  
In Australia, data collected as part of the Geelong Osteoporosis Study (GOS), made use of the 
structured clinical interview for the DSM-IV Non-patient edition (SCID-I/NP) to assess major 
depression. In this population-based study, among a total of 1086 women and 891 men, 26.2% of 
the women and 16.4% of the men met SCID-I/NP criteria for lifetime depression; the most common 
being major depressive disorder (87%, n = 375) (Stuart et al., 2014). 
The WHO World Mental Health survey initiative also estimated the prevalence of MDD in 
low- and middle-income countries (Kessler, & Ustun, 2004; Kessler, & Ustun, 2008). For example, 
in Brazil, using the CIDI, 18.4% of the individuals in the community met the diagnostic criteria for 
MDD, while 10.4% of the sample was diagnosed with MDD the 12-months preceding the 
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questionnaire (Kessler; & Üstün, 2004, Kessler; & Üstün, 2008). A lower lifetime and 12-month 
prevalence rate of 13.3% and 6.2% respectively was found within in the general population in 
Columbia (Kessler; & Üstün, 2004, Kessler; & Üstün, 2008). In China, however, using the CIDI, 
the prevalence of MDD was much lower than that in Brazil and Columbia (Shen et al., 2006). Shen 
et al. (2006) found that 2.0% of the sample in the community-based study was diagnosed with 
MDD. The authors conjectured that the low prevalence rate in China might have been because of 
methodological problems, which include the under-reporting of symptoms due to stigma (Shen et 
al., 2006).  
In Nigeria, measurement was done as part of the Nigerian Survey of Mental Health and Well-
being (NSMHW), a population-based survey using the WMH-CIDI (Gureje, Lasebikan, Kola, & 
Makanjuola, 2006). Gureje et al. (2006) indicate that 3.3% of their sample (n = 4 984) had lifetime 
major depressive disorder, whereas the 12-month prevalence was estimated at 1.0%. These authors 
argue that a possible reason for the low prevalence rates might be the variance in the age of onset of 
the population (Gureje et al., 2006). For example, the age of onset of 45 years for any mood 
disorder (Gureje et al., 2006) was higher than the commonly recommended age of onset in 
adolescence or childhood (Zisook et al., 2007). In Uganda, however, using the criteria of the 
Diagnostic and Statistical Manual IV (DSM-IV), the prevalence of MDD was 21% in the general 
population (n = 587) (Bolton, Wilk, & Ndogoni, 2004). Bolton et al. (2004) speculate that this high 
prevalence rate in their sample may be due to poverty rather than HIV. In rural Rwanda, 15.5% of 
the sample (n = 368) in the general population met the DSM-IV diagnostic criteria for major 
depression (Bolton, Neugebauer, & Ndogoni, 2002), while a slightly higher rate of 17.9% for 
depressive symptoms was found using the depression subscale of the HSCL-25 (DHSCL).  
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As previously mentioned, the SASH study, the first population-based study in South Africa, 
reported the lifetime and 12-month prevalence of psychiatric disorder in South Africa (Herman et 
al., 2009) and it forms part of the World Health Organization World Mental Health (WMH) Survey 
Initiative (Kessler, Haro, Heeringa, Pennell, & Ustün, 2006; Demyttenaere et al., 2004). In the 
SASH study, making use of the CIDI, the lifetime prevalence of major depression was 9.8%, while 
the 12-month prevalence was 4.9% (Herman et al., 2009; Tomlinson, Grimsund, Stein, Williams, & 
Myer, 2009). These authors compared the SASH study with the World Mental Health Survey 
(WMH) and found that the 12-month prevalence of mood disorders were higher than in other 
countries in the WMH survey. However, the prevalence rates of mood disorders in some countries 
such as Belgium, Lebanon, France, Ukraine, Israel, New Zealand, and the USA were higher than in 
South Africa (Herman et al., 2009). In the Eastern Cape in South Africa, a cross-sectional 
population-based study was conducted among 977 individuals aged between 18 and 40 (Andersson 
et al., 2013). In this study, it was found that 31.4% of the sample met the criteria for a lifetime 
depression using the MINI. Several explanations have been provided for the high prevalence rate of 
depression. For instance, according to Andersson et al. (2013), the majority of their sample comes 
from poor regions in the Eastern Cape, South Africa, where people are subjected to high levels of 
poverty and economic distress.  
Compared to the above-mentioned community-based studies, the prevalence of MDD in 
South Africa was higher than the sample of Yoruba-speaking Nigerians and higher than most of the 
countries depicted in the WHO WMH project, but lower than the rates in Uganda, and Rwanda 
(Bolton et al., 2004; Bolton et al., 2002, Gureje et al., 2006; Herman et al., 2009; Tomlinson et al., 
2009). 
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Prevalence of MDD among PLWH. The World Health Organization (2008) sees an 
association between mental health and HIV/AIDS. For example, a higher 12-month prevalence rate 
of MDD was found among 2 864 HIV-infected individuals in the USA than in the general 
population (Bing et al., 2001). Bing et al. (2001) reported a prevalence rate of 36.0% in their 
sample, while in the general population a lower prevalence rate of 7.6% was found (Bing et al., 
2001). An even high rate of 45.5% for depression was detected among HIV-infected outpatients in 
the USA (Cohen et al., 2002). Furthermore, Berger-Greenstein et al. (2007) report a high prevalence 
rate of 72.9% for MDD, which was higher than that reported by Bing et al. (2001) and Cohen et al. 
(2002). These authors surmise that this high prevalence rate was likely due to risk factors such as 
traumatic events and intravenous drug use and a poor socio-economic status (Berger-Greenstein et 
al., 2007).  
In a systematic review by Collins, Corcoran, & Perry (2006), the prevalence of mental health 
disorders among PLWHA in low- and middle-income countries (LMIC) were found to range from 
0% to 63.3% (Collins et al., 2006). Collins et al. (2006) concluded that among PLWHA a high 
prevalence of depression was found than in the general population. For example, in Nepal, using the 
CIDI, 14% of the sample (n = 125) met the diagnostic criteria for MDD (Kohrt, Luitel, Acharya, & 
Jordans, 2016).  
In Africa, however, the point prevalence of MDD was shown to be between 3% and 54% 
(Petrushkin, Boardman, Ovuga, 2005; Myer et al., 2008; Olley et al., 2006; Kaharuza et al., 2006; 
Adewaya et al., 2007; Nakasujja et al., 2010). Using the MINI, the prevalence of major depression 
was 27.8% among 360 HIV-positive individuals in Nigeria, while it was 12.8% for HIV-negative 
individuals (Onyebueke, & Okwaraji, 2015). These authors concluded that this high prevalence of 
depression among HIV-positive individuals may not only be attributable to their HIV/AIDS status, 
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but may also be a consequence of the anti-retroviral medication and the burden of illness related to 
HIV/AIDS, which can affect their mood (Onyebueke, & Okwaraji, 2015). A similar MINI-defined 
prevalence rate of 11.3% for MDD was found among 649 TB-and HIV-infected Zambians (Van den 
Heuvel et al., 2013). However, an even higher MINI-defined prevalence rate of 52.2% for MDD 
was found among PLWHA in Nigeria (Sulyman, Abiodun, & Yussuf, 2012).  
In Zimbabwe, it was found that 33% of postnatal women met the criteria for major depression 
and more HIV-positive women than HIV-negative women had mean depressive scores (Chibanda et 
al., 2010). Conversely, among 618 HIV-infected persons in Uganda, the prevalence of MDD was 
8.1% as assessed by the MINI (Kinyanda, Hoskins, Nakku, Nawaz, & Patel, 2011).  
In South Africa, using the MINI, the prevalence of MDD was 34.9% among HIV-infected 
individuals (Olley et al., 2003). The authors found that 6 months later, 26% of their sample met the 
diagnostic criteria for depression (Olley et al., 2006). Conversely, using the same diagnostic 
interview, the MINI, the prevalence of depression was 14% in 465 HIV-positive patients receiving 
treatment in South Africa (Myer et al., 2008). Freeman, Nkomo, Kafaar and Kelly (2007), however, 
using the Composite International Diagnostic Interview (CIDI), found that 11.1% of an HIV-
positive sample of 900 in South Africa was depressed.  
The prevalence of major depression in the above-mentioned studies differs substantially. A 
possible reason for the wide variability in the rates of major depression may be due to the different 
measuring instruments, the demographic factors, such as gender, age and socio-economic status and 
study settings (Kagee, & Martin, 2010; Ramirez-Alvira et al., 2012).  
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Prevalence of persistent depressive disorder (PDD).  
Prevalence of PDD in the general population. According to the DSM-5, the 12-month 
prevalence of persistent depressive disorder (PDD; also, known as dysthymia) in the general 
population was 0.5% in the USA (APA, 2013). A slightly higher prevalence of 2.5% for dysthymia 
has been reported among 9282 persons within the general population in the USA using the CIDI 
(Kessler et al., 2005). Among Finns, the Composite International Interview (CIDI) was used to 
diagnose dysthymia, which derived a slightly higher 12-month prevalence of 4.5% (Markkula et al., 
2015). An even higher rate of dysthymia was estimated among the Seguimiento Universidad de 
Navarra (SUN) project in Spain (Sanchez-Villegas et al., 2008). Using the SCID-I, a prevalence rate 
of 14% was reported for dysthymia (Sanchez-Villegas et al., 2008).  
In Australia, a population-based study, namely the Personality and Total Health (PATH) 
study, the prevalence of dysthymia was assessed (Kiely & Butterworth, 2015) using the WHO-CIDI 
(Kessler et al., 2013; Kessler, & Ustun, 2004). Kiely and Butterworth (2015) found that 2.7% of the 
sample met the diagnostic criteria for dysthymia in the past 12-months (95%CI = 2.0, 3.4). 
Correspondingly, in another community-based study in Australia, namely the 2007 National Survey 
Mental Health and Wellbeing (NSMHWB), the WHO-CIDI (version 3.0) was utilized to evaluate 
the prevalence of psychiatric disorders (Australian Bureau of Statistics, 2009). The NSMHWB 
found a 12-month prevalence rate of 2.1% (95%CI = 1.3, 2.9) for dysthymia (Australian Bureau of 
Statistics, 2009). 
The prevalence of dysthymia (persistent depressive disorder) was also assessed in low- and 
middle-income countries. In São Paulo, Brazil, using the SCID I/P (patient’s edition), the 
prevalence of dysthymia was estimated among psychiatric outpatients (Avrichir & Elkis, 2002). 
Among this sample of psychiatric outpatients, 27.1% of the sample met the diagnostic criteria for 
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dysthymia. An even lower rate of 0.1% for dysthymia was found in China using the CIDI (Shen et 
al., 2006). Shen et al. (2006) speculate that this low prevalence rate may be due to the non-
disclosure of mental health issues as a result of stigma (Shen et al., 2006).  
In the Nigerian Survey of Mental Health and Well-being (NSMHW) a low lifetime prevalence 
rate of 0.2% for dysthymia was found within the community, whereas the 12-month prevalence was 
found to be 0.1% (Gureje et al., 2006). Likewise, the population-based SASH study, a national 
representative survey of 4351 adults interviewed with the WHO-CIDI yielded a low prevalence of 
dysthymia (PDD) of 0.1% (Williams et al., 2008). 
Prevalence of PDD among PLWH. Notably, dysthymia is also common among HIV-infected 
individuals diagnosed with major depression (Gaynes et al., 2015). Gaynes et al. (2015) reported 
that among American HIV-positive individuals diagnosed with MDD (18%), 49% of the sample 
had co-morbid dysthymia as measured by the MINI (n = 304). This co-morbidity of MDD and 
dysthymia was associated with significant HIV-infection severity and poorer quality of life (Gaynes 
et al., 2015). The definition of quality of life in mental health research is not always clear and 
consistent (Mogotsi, Kaminer, & Stein, 2000). Nonetheless, quality of life comprises a person’s 
subjective experience (Mogotsi, Kaminer, & Stein, 2000). Furthermore, quality of life recognizes 
that factors such as life satisfaction, well-being, and perceptions of living conditions play a role in 
the assessment and treatment of psychiatric disorders (Mogotsi, Kaminer, & Stein, 2000).  
Berger-Greenstein et al. (2007) assessed the prevalence of dysthymia among an American 
sample of 85 HIV-infected individuals. The prevalence of dysthymia was only assessed when the 
sample did not meet the diagnostic criteria for MDD (Berger-Greenstein et al., 2007). Considering 
this, the prevalence rate for dysthymia was 4.7% compared to the total sample, while 17.4% of the 
sample had dysthymia in the absence of MDD (Berger-Greenstein et al., 2007). Another study in 
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the USA assessed the prevalence of dysthymia among HIV-positive individuals using the short 
form of the CIDI (CIDI-SF) (Turner & Fleishman, 2006). These authors found that the prevalence 
of dysthymia was higher among women (31%) than among men (17%) (Turner & Fleishman, 
2006).  
In Nigeria, the MINI was utilized among people with HIV/AIDS to assess the prevalence of 
dysthymia (Sulyman et al., 2012). The prevalence of dysthymia was found to be 26.1% among 300 
PLWHA (Sulyman et al., 2012). A lower rate of dysthymia was estimated among 87 HIV-positive 
individuals in Nigeria (Adewuya et al., 2007). Adewuya et al. (2007) report that 9.1% of the sample 
met the diagnostic criteria for dysthymia as assessed with the MINI.  
In South Africa, the prevalence of PDD was also estimated among people living with HIV 
(PLWH). Using the MINI, the prevalence of PDD in HIV-infected individuals was 21.5% (Olley et 
al., 2003). A similar rate of 22.9% for MINI-defined dysthymia was found among 105 HIV-positive 
women in South Africa, while a much lower rate of 2.0% for dysthymia was found at follow-up 
(Olley, 2006). A plausible reason for this decline may be that those women who were more resilient 
and less distressed may have returned for follow-up (Olley, 2006). The prevalence of PDD among 
people seeking HIV testing is not known.  
Prevalence of generalized anxiety disorder (GAD) 
Prevalence of GAD in the general population. Generalized anxiety disorder (GAD) is 
associated with increased health services utilization (Wittchen et al., 2002. The lifetime prevalence 
of GAD was 5.1% in the USA in the general population (Wittchen, Zhao, Kessler, & Eaton, 1994; 
Kessler et al., 2008). Similarly, the prevalence of GAD was 5.7% as estimated by the WMH-CIDI 
among 9282 American respondents (Kessler et al., 2005). In Europe, the 12-month prevalence of 
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GAD ranges between 1.7% and 3.4% (Wittchen et al., 2011), and the lifetime prevalence ranges 
between 4.3% and 5.9% (Wittchen, & Jacobi, 2005). In a national representative sample of primary 
care practices in Germany using the Generalized Anxiety Screening Questionnaire (GAS-Q), a 
modified version of the Anxiety Screening Questionnaire (ASQ), the prevalence of GAD was 5.4% 
(Wittchen et al., 2002).  
Furthermore, in the Australian PATH study, the prevalence of GAD was compared with the 
national survey prevalence estimates (i.e. 2007 National Survey Mental Health and Wellbeing 
(NSMHWB); Kiely & Butterworth, 2015). The PATH study found the 12-month prevalence rate of 
GAD as 4.3% (95%CI = 3.3, 5.1), and the equivalent prevalence estimate in the NSMHWB was 
4.6% (95% CI = 2.85, 6.35) (Kiely, & Butterworth, 2015).  
However, higher prevalence estimates were found in a large primary care study, the Dialogue 
project (Roberge et al., 2015). In Canada, the Dialogue project recruited 373 adults meeting the 
diagnostic criteria for generalized anxiety disorder (GAD) (Roberge et al., 2015). Results from the 
Dialogue project showed that 52.5% of the sample was identified as having GAD in the past 12-
months by a healthcare professional using the Composite International Diagnostic Interview-
Simplified (CIDI-S) (Roberge et al., 2015). These authors suggested that this high prevalence of 
GAD may be attributed to the high utilization of mental health services, persistent GAD symptoms 
and profiles of psychiatric morbidity, specifically with major depression (Roberge et al., 2015).  
In China, the prevalence of GAD was low as assessed by the CIDI (Shen et al., 2006). Shen et 
al. (2006) report that 0.8% of the community sample met the diagnostic criteria for GAD. These 
authors suggested that the low prevalence rate may be because of stigma-related non-disclosure of 
mental health problems (Shen et al., 2006).  
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In Nigeria, the population-based study, the NSMHW, demonstrated a lifetime prevalence of 
0.1% for GAD using the WMH-CIDI (Gureje et al., 2006). These authors however, found that the 
12-month prevalence of GAD was zero (Gureje et al., 2006). Gureje, et al. (2006) argue that a 
possible reason for this finding may be that individuals who had only one source of worry did not 
meet the diagnostic criteria for GAD and were therefore excluded from this module of the WMH-
CIDI.  
In South Africa, results of the SASH study revealed a lifetime GAD prevalence rate of 2.7%, 
while the 12-month prevalence rate of GAD was estimated at 1.4% using the CIDI (Herman et al., 
2009). Herman et al. (2009) conclude that compared with other countries in the World Mental 
Health survey, the 12-month prevalence rate of anxiety disorders were higher in South Africa. They 
also found that the following countries had higher rates of anxiety disorders than South Africa, 
namely, Belgium, France, Germany, New Zealand, the Netherlands, Colombia, Lebanon, and the 
USA (Herman et al., 2009).  
Prevalence of GAD among PLWH. In the USA, 15.8% of HIV-infected individuals met the 
diagnostic criteria for GAD (Bing et al., 2001). Although anxiety disorders were not the focus of 
their study, Berger-Greenstein et al. (2007) made use of the SCID to assess the prevalence of GAD 
among an American sample of HIV-infected individuals. These authors reported a lower rate of 
3.6% for GAD among HIV-positive outpatients in the USA (Berger-Greenstein et al., 2007).  
Conversely, in low- and middle-income countries (LMIC) there is a paucity of research 
reporting on the prevalence of anxiety disorder in PLWHA. Using the MINI, the prevalence rate of 
GAD among HIV-infected individuals in Zambia was 13.3% (Van den Heuvel et al., 2013). 
Likewise, using the MINI, the prevalence of GAD was 11.4% among Nigerian HIV-positive 
individuals (Adewuya et al., 2007). However, the prevalence of GAD of 4.6% was lower among 
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HIV-positive patients in South Africa using the MINI (Fincham, Smit, Carey, Stein, & Seedat, 
2008). Even lower rates of GAD were found among 900 HIV-positive individuals (Freeman et al., 
2007). Using the CIDI, Freeman et al. (2007) report the prevalence of GAD at 0.4%. A literature 
search reveals that no research has been conducted among persons seeking HIV testing to determine 
the prevalence of GAD. This is a gap in the research that this study seeks to address. 
Prevalence of alcohol use disorders (AUD).  
Prevalence of AUD in the general population. In order to report on the prevalence of alcohol 
use disorders, it is imperative to note that the DSM-5 combines the DSM-IV classifications of 
alcohol abuse and alcohol dependence into one specific disorder, namely alcohol use disorder 
(AUD) (APA, 2013). The lifetime prevalence of alcohol abuse as assessed by the DSM-IV Alcohol 
Abuse and Dependence in the USA was 17.8%, while the 12-month prevalence was 4.7% (Hasin, 
Stinson, Ogburn, & Grant, 2007). These authors further reported that the lifetime and 12-month 
prevalence of alcohol dependence was 12.5% and 3.8%, respectively (Hasin et al., 2007). In 
Canada, the prevalence of alcohol dependence in the general population was 4.1% (Caron et al., 
2012). Furthermore, based on a total sample of 5443 drinkers in the Netherlands interviewed with 
the Composite International Interview (CIDI), the 12-month prevalence of DSM-IV and DSM-5 
AUDs were 5.4% and 4.4%, respectively (Tuithof, ten Have, van den Brink, Vollebergh, & de 
Graaf, 2014).  
However, the prevalence of alcohol abuse or dependence was lower in a Chinese population-
based survey (Shen et al., 2006). Shen et al. (2006) utilized the CIDI and found that the prevalence 
for alcohol abuse or dependence was 1.6%. As previously mentioned, this low prevalence may be 
due to stigma-related non-disclosure of mental health problems (Shen et al., 2006). Another study in 
Beijing, China, made use of the CIDI and found that 32.5% of the sample had alcohol use disorder 
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(Xiang et al., 2009). Xiang et al. (2009) further reported that 4.3% of the sample met the diagnostic 
criteria for alcohol dependence in their lifetime, while 1.7% was diagnosed with alcohol 
dependence the previous 12-months (Xiang et al., 2009.  
In the SASH study, the lifetime and 12-month prevalence of alcohol abuse and alcohol 
dependence was estimated using the CIDI within community settings (Herman et al., 2009). These 
authors reported a lifetime prevalence of alcohol abuse and alcohol dependence of 11.4% and 2.6%, 
respectively. Conversely, the 12-month prevalence of alcohol abuse and alcohol dependence was 
4.5% and 1.2%, respectively (Herman et al., 2009). Among a cohort of 4 351 adults, using findings 
from the SASH study, the WHO/CIDI yielded a higher occurrence of alcohol use of 38.7% (Van 
Heerden et al., 2009). 
Prevalence of AUD among PLWH. Several studies showed that the lifetime prevalence of 
alcohol use disorder, ranging between 26% and 60%, is higher among people living with HIV/AIDS 
than in the general population (14-24%) (e.g. Williams, Rabkin, Remien, Gorman, Ehrhardt, 1991; 
Waller, Lyons, Costantini-Ferrando, 1999; Samet, Phillips, Horton, Traphagen, & Freedberg, 2004; 
Kessler et al., 1994; Cook et al., 2001; Sullivan et al., 2008). Berger-Greenstein et al. (2007), 
making use of the SCID, found a high prevalence of 69.4% for alcohol abuse or alcohol dependence 
in 85 HIV-infected patients in the USA. In another study in the USA among 400 PLWHA, making 
use of the CIDI, a lower prevalence of 10% for alcohol dependence was found (Sullivan et al., 
2008). 
Nevertheless, in Lima, Peru, the prevalence rates of alcohol use disorders were lower among 
HIV-infected men who have sex with men (MSM) and transgendered women (TGW) (Ferro et al., 
2015) than in the USA (Berger-Greenstein et al., 2007). Of the 302 Peruvian HIV-infected men who 
have sex with men (MSM) or transgendered women (TGW) screened with the WHO’s validated 10-
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item alcohol use disorder identification test (AUDIT), 43.2% could be diagnosed with alcohol use 
disorders (Ferro et al., 2015).  
In sub-Saharan Africa, it was estimated that among people living with HIV, the prevalence of 
alcohol abuse or dependence and other substances ranges between 7% and 16% (Brandt, 2009; Nel 
& Kagee, 2011). Further, in sub-Saharan Africa, alcohol use has an adverse impact on HIV risk in 
terms of condom use, number of sexual partners, intimate partner violence and the place of drinking 
(Woolf-King, & Maisto, 2011; Baliunas, Rehm, Irving, & Shuper, 2010; Shuper, Joharchi, Irving, 
Rehm, 2009; Chersich & Rees, 2010; Kalichman, Simbayi, Kaufman, Cain, & Jooste, 2007; Pithey 
& Parry, 2009). In a recent study in Zambia, the prevalence of alcohol dependence was assessed 
among TB and HIV-positive men and women making use of the MINI (O’Connell et al., 2013). 
O’Connell et al. (2013) estimated that the prevalence of alcohol dependence of 27.2% among men 
was higher than for women, with a rate of 3.9%. These authors also illustrate some limitations of 
their study and argue that no statements can be made regarding the severity of illness, in this case 
TB/HIV infections, and alcohol dependence, since this information was not reported in their study 
(O’Connell et al., 2013). Conversely, Adewuya et al. (2007) found a prevalence rate of 8.0% for 
alcohol abuse/dependence among their sample of HIV-infected individuals in Nigeria.  
In South Africa, alcohol consumption was also found to be a contributing factor to HIV 
infection (Hahn, Woolf-King, & Muyindike, 2011). According to Myer et al. (2008), 1.0% of 
individuals within a South African sample had MINI-defined alcohol abuse disorder, while 6.0% 
had alcohol dependence.  
Comparing the prevalence rate of alcohol abuse and dependence with other studies may be 
more complex due to differing sociodemographic factors, measuring tools and diverse alcohol 
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measures (O’ Connell et al., 2013). However, the incidence of substance abuse among HIV test-
seekers in South Africa is not known.  
The levels of psychiatric distress, depression, anxiety and alcohol use.  
Psychological distress in the general population. Within the general population, the 
prevalence of psychological distress was found to range between 5% and 27% (Benzeval & Judge, 
2001; Chittleborough et al., 2011, Gispert et al., 2003, Kuriyama et al., 2009: Phongsavan et al., 
2006). For example, among cancer patients in the USA (n = 4496), the prevalence of distress was 
31.5% using the Brief Symptom Inventory (BSI) (Zabora BrintzenhofeScoc, Curbow, Hooker, & 
Piantodosi, 2001). In another study among breast cancer patients in the USA, the prevalence of 
distress was estimated using the HSCL-25 (Coyne et al., 2004). Although the total mean score was 
40.5 on the HSCL-25, which was less than the clinically significant cut-off point of 44, 29.2% of 
the sample scored above this cut-off point (Coyne et al., 2004). In a study conducted by Palmer, 
Taggi, DeMichele, & Coyne, (2012), elevated levels of distress were found using the HSCL-25 
among female breast cancer patients. These authors reported that 33% of their sample scored above 
the recommended clinically significant cut-off point on the HSCL-25 (Palmer et al., 2012). 
Furthermore, using the data from the MacArthur Foundation National Security of Midlife 
Development in the United States (MIDUS, Brim et 1996) Cochran, Sullivan and Mays (2003) 
estimated the prevalence of psychological distress. The prevalence of current distress was higher 
among gay or bisexual men (33.1%) than heterosexual men (12.5%) (Cochran et al., 2003). 
However, no significant difference in levels of distress was found between lesbian or bisexual 
women (18.4%) compared to heterosexual women (18.4%) (Cochran et al., 2003). 
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In South Africa, the symptoms of psychological distress were estimated using the Kessler-10 
item scale (K-10) at two different cut-off scores (Peltzer et al., 2012). For example, in a study done 
by Peltzer et al. (2012) among tuberculosis (TB) patients, 32.9% of the sample reported that the 
symptoms of psychological distress were at or above the cut-off score of 28. However, 81% of the 
sample reported psychological distress at or above the cut-off score of 16 (Peltzer et al., 2012). 
Among hospital outpatients in South Africa, using the K-10, 17% of the patients had severe 
psychological distress and 14% reported moderate distress (Peltzer, Pengpid, & Skaal, 2012). 
Peltzer et al., (2012) also found in their sample that more women (19.4%) than men (15.5%) 
reported psychological distress. The SASH study revealed lower levels of psychological distress 
within community-based settings (Herman et al., 2009). The SASH reported that 11% of the sample 
had moderate levels (scores 20-24), while 8% of the sample showed even higher levels of 
psychological distress using the K-10 (Herman et al., 2009).  
Among political detainees, 14.19% of the sample had elevated symptoms of psychological 
distress using the HSCL-25 (Kagee, 2005). In another study by Kagee (2008), the levels of 
psychological distress among 119 people living with a chronic illness such as diabetes and 
hypertension, were assessed using the HSCL-25. Kagee (2008) reports that 38.5% of the sample 
scored above the clinically significant cut-off point of 44 on the HSCL-25. Those individuals who 
scored above the recommended cut-off point of 44 had a high incidence of psychological distress 
(Kagee, 2008). In conclusion, a possible explanation for the high rates of psychological distress 
may be that desirable responses may have been given when using the K-10. Caution should be 
exercised when interpreting the results of self-report measures (Peltzer et al., 2012).  
Psychological distress among PLWH. In a study done by Blais et al. (2015) in Quebec, 
Canada, the Quebec Population Health Survey (Deschesnes, 1998) was used to determine 
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psychological distress among mothers living with HIV (MLHIV). A total score at or above 26.19 
indicates high levels of distress and the scale had high internal consistency ranging between 0.84 
and 0.87. (Blais et al., 2015). Blais et al. (2015) found that 45% of their sample had psychological 
distress. Cohen et al. (2002) made use of the Distress Thermometer (DT) (Holland, 2000) to 
measure the prevalence of psychological distress among 101 HIV-positive individuals in the USA. 
The Distress Thermometer (i.e., >5, 0-10 scale), validated by the National Comprehensive Cancer 
Network (NCCN) (2010), is a visual analogue scale consisting of one item and have been used in 
various studies among individuals with a medical condition such as breast cancer (Hegel et al., 
2006; Ransom, Jacobsen, & Booth-Jones, 2006). Cohen et al. (2002), report that 72% of the sample 
had high levels of distress. These authors further argue that the level of distress may be due to the 
fact that high prevalence of psychiatric disorders in the population sample were already present 
prior to the evaluation of distress (Cohen et al., 2002).  
In Tanzania, 57% of people living with HIV scored above the recommended cut-off point of 
44 on the HSCL-25, which indicates a high disturbance of psychological distress (Antelman et al., 
2007). In South Africa, the level of psychological distress among people living with HIV was also 
assessed using the HSCL-25 (Kagee, & Martin, 2010). These authors reported that the sample mean 
score of 47.54 on the HSCL-25 was higher than the recommended significant clinical cut-off point 
of 44. Subsequently, 52.9% of their sample scored in the elevated range on the HSCL-25. This high 
prevalence rate of clinically significant distress is a cause for concern as it may have an adverse 
effect on the quality of life of HIV-positive individuals (Kagee, & Martin, 2010). In another study 
in South Africa, 33.4% of the sample of people living with HIV scored in the clinically significant 
range of the EQ5D (Hughes, Jelsma, Maclean, Darder, & Tinise, 2004).  
Stellenbosch University  https://scholar.sun.ac.za
 44 
 
Symptoms of depression in general. Even though major depression has been documented in 
many studies internationally and locally, the symptoms of depression may have an adverse effect on 
the quality of life of individuals (Herrman et al., 2002; Mitchell, & Coyne, 2007; Ramirez-Avila et 
al., 2012). In a population-based study among individuals with epilepsy, the HADS was utilized to 
assess the extent of depression in Cardiff, Wales (Mensah, Beavis, Thapar, & Kerr, 2006). Mensah 
et al. (2006) show that 11.2% of the sample scored at or above the cut-off point of 8 on the HADS, 
which indicates depression. The HADS was used again in a study done by Collins, Corcoran and 
Perry (2008) among diabetic patients in Ireland (n = 1456) to assess the symptoms of depression 
(Collins et al., 2008). These authors found that 12.3% of their sample fell in the mild to moderate 
range on the HADS, while 8.0% of the sample fell in the moderate to severe range (Collins et al., 
2008).  
In India, the prevalence rate of depression was 14.6% as estimated by the Patient Health 
Questionnaire (PHQ-9) community-based sample (n = 1900) (Shidhaye, Gangale, & Patel, 2016). 
Likewise, in a large population-based study conducted in South India, using an adapted version of 
the PHQ, 15.1% of the sample scored above the clinically significant cut-off point on the PHQ 
(Poonothai et al., 2009). In another study in India, the Hospital Anxiety and Depression Scale 
(HADS) was used to determine depression among 150 HIV test seekers (Sahay et al., 2007). Sahay 
et al. (2007) convey that 45% of their sample of HIV-test seekers was depressed. In China, the 
community-based study among adults with type 2 diabetes, the levels of depressive symptoms were 
calculated using the Zung Self-Rating Anxiety and Depression Scales (Sun et al., 2016). These 
authors found that 56.1% of the sample was classified with depressive symptoms (Sun et al., 2016). 
Using the PHQ among 1285 individuals from the Federation of Bosnia and Herzegovina, with the 
majority from Republika Srpska, 17% of the sample had depressive symptoms (Broers et al., 2006).  
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In Uganda, the BDI was utilized to determine the prevalence of depressive symptoms in two 
districts, namely Adjumani and Bugiri (Ovuga, Boardman, & Wasserman, 2005). Overall, 17.4% of 
the sample in the general population scored in the clinically significant range on the BDI (Ovuga et 
al., 2005). Also, in South Africa among chronically ill patients, 19.8% of the sample fell in the 
elevated clinically significant range on the BDI (Kagee, 2008).  
Symptoms of depression in PLWH. In Australia, among 100 people living with HIV/AIDS 
(PLWHA) a cut-off score of 14 or above on the BDI was used to detect depression (Judd & Mijch, 
1996). Judd and Mijch (1996) report that 44% of the sample scored above the cut-off point of 14 on 
the BDI and were diagnosed as depressed. Even higher rates of depressive symptoms were found 
among 289 HIV-positive individuals in Canada, as assessed by the CES-D (Lima et al., 2007). Lima 
et al. (2007) found that 51.0% of the sample was categorized as having depressive symptoms. 
Another study in Australia made use of the Inventory to Diagnose Depression (IDD), a 22-item self-
report measure, to determine syndromal depression (Komiti et al., 2003). These authors found that 
21.7% of the sample of PLWHA met the criteria for syndromal depression (Komiti et al., 2003), 
which was lower than that of Judd and Mijch (1996) and Lima et al. (2007). 
The prevalence rates of depressive symptomatology have also been reported among HIV-
infected patients in the developing world. For example, a study by Campos, Bonolo, & Guimarães, 
(2006), the Adherence to Antiretroviral Therapy (ATAR), made use of the HADS to assess the level 
of depression among HIV-infected individuals in Brazil. Campos et al. (2006) report that 21.8% of 
the sample scored in the moderate to severe range on the HADS before ART treatment. These 
results allowed Campos et al. (2010) to conduct another study among 293 HIV-infected patients to 
determine whether elevated depression symptoms during the onset of an ART treatment regime 
may lead to non-adherence. A high prevalence rate of 40.6% for depression symptoms was found in 
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the sample using the HADS (Campos et al., 2010). These authors further found no significant 
relationship between depression and non-adherence, which may be a consequence of low statistical 
power considering a sample size of 17. 
In Delhi, India, the Centre for Epidemiological Studies Depression (CES-D) scale was 
utilized to determine the levels of depression among 160 people living with HIV and receiving ART 
treatment (Bathia, & Munjal, 2014). The results indicated that 58.75% of the sample met the criteria 
for depression. Furthermore, more females (61.3%) than males (58.1%s) and transgender persons 
(50%) were depressed (Bathia, & Munjal, 2014). In China, the Chinese version of the BDI was 
utilized to determine the severity of symptoms among people living with HIV (Su et al., 2013). Su 
et al. (2013) report that the mean score of the C-BDI-II was 22, which was indicative of moderate 
depression. These authors also found that 24.0% of their sample scored in the moderate range on the 
C-BDI-II (Su et al., 2013). 
For example, in Tanzania, Ramadhani (2007) found that 21% of the sample of HIV-infected 
individuals was diagnosed with depression using the HSCL-25. Ramadhani (2007) further reports 
that those individuals with depressive symptoms were not adherent to ART, whereas those without 
depressive symptoms were probably adherent to ART. In Botswana, the extent of depressive 
symptoms was assessed with the BDI and 31.8% of the sample scored in the moderate to severe 
range (Do et al., 2010). Using the BDI-I, rates of depressive symptoms were estimated among HIV-
infected individuals to be 37.6%, suggesting that the sample of HIV-positive patients scored in the 
moderate range of the measure (Kagee & Martin, 2010).  
In South Africa, the symptoms of depression were assessed using the BDI-I among people 
living with HIV (Kagee & Martin, 2010). On the BDI, the mean score of 16.45 indicated that the 
sample fell in the mild to moderate range. These authors further indicated that 24.70% of their 
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sample scored in the mild to moderate range on the BDI (Kagee & Martin, 2010). It is likely that 
these elevated levels of depression may negatively impact adherence to antiretroviral therapy 
(Walkup, Wei, Sambamoorthi, & Crystal, 2008; Kagee & Martin, 2010). In fact, it has previously 
been shown that those HIV-positive individuals who have received treatment for their depression 
were more adherent than those who did not receive treatment (Dalessandro et al., 2007; Kagee & 
Martin, 2010, Safren et al., 2012). 
Furthermore, few studies have assessed the prevalence of major depression among persons 
seeking HIV testing (e.g. Rochat et al., 2006; Sahay et al., 2007). Notably, Rochat et al. (2006) 
investigated the prevalence of major depression among pregnant women before the receipt of an 
HIV test result in Kwa-Zulu Natal. Using the EPDS, the prevalence of MDD was 41% among their 
sample (Rochat et al., 2006). The more recent studies of Ramirez-Avila et al. (2012) and Cholera et 
al. (2014) examined the prevalence of depressive symptoms rather than obtaining a clinical 
diagnosis among persons seeking HIV testing. Both of these studies used self-report screening tools 
to measure the presence and intensity of depression symptoms, but did not assess the diagnostic 
criteria for major depression. Therefore, little is known about whether individuals are already 
psychologically distressed prior to the receipt of their HIV-positive result. 
Symptoms of anxiety in general. In the context of the symptoms of anxiety, a study done by 
Wittchen (2002) in Germany made use of the Generalized Anxiety Screening questionnaire (GAS-
Q). Wittchen (2002) reported that 21.7% of their sample had elevated levels of anxiety. Among a 
sample of 133 individuals recruited from an anxiety and treatment centre in the USA, the BAI was 
used to assess the extent of anxiety symptoms (Leyfer, Ruberg, & Woodruff-Borden, 2005). The 
total mean score of the BAI was 12.3, which indicated minimal anxiety (Leyfer et al., 2005). In 
Ireland, the HADS was used to measure anxiety among diabetic patients (n =1 456) (Collins et al., 
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2008). According to Collins et al. (2008), 16.9% of the sample fell in the mild to moderate range on 
the HADS, whereas 10.3% of the sample fell in the moderate to severe range on the HADS.  
In China, among type 2 diabetic patients, the Zung Self-Rating Anxiety and Depression 
Scales were utilized to assess the symptoms of anxiety (Sun et al., 2016). Sun et al. (2016) found 
that in their community-based study that the level of anxiety was 43.6%, which was lower than that 
of Sahay et al. (2007). These authors argue that the discrepancy may be due to varied sampling 
methods or screening instruments and different living habits (Sun et al., 2016). In Nepal, among a 
specialized group of internally displaced persons (IDPs), 80.7% of the sample scored above the 
recommended cut score on the HSCL-25 which indicate elevated levels of anxiety (Thapa & Hauff, 
2005). The factors associated with these anxiety symptoms include feeling unhappy when arriving 
at a new place and illiteracy (Tapa et al., 2005). Although anxiety appears to have an adverse effect 
on the quality of life, personal welfare and health outcomes of individuals, it is an under-researched 
psychological disturbance (Antony & Stein, 2009; Kagee, Coetzee, Saal, & Nel, 2015). 
Furthermore, using the anxiety subscale of the HSCL-25, the mean score of 20.95 indicated that the 
sample of South African chronically ill patients reported elevated symptoms of anxiety (Kagee, 
2008).  
Symptoms of anxiety among PLWH. Numerous studies have reported the symptoms of 
anxiety as assessed by a range of measuring instruments among HIV-positive patients. For instance, 
an earlier study among African American HIV-positive sample found that the levels of anxiety were 
moderate when assessed with the Spielberger State-Trait Anxiety Scale (Coleman & Holzemer, 
1999).  
Using the Hospital Anxiety and Depression Scale, 43.2% of the HIV-positive outpatients in a 
hospital in Quebec, Canada was regarded as likely cases of anxiety with scores of 8 and above on 
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the scale (Savard, Laberge, Gauthier, Ivers, & Bergeron, 1998). On the HADS, a score of 15 and 
above indicated that 21.6% of the sample was probable cases of anxiety disorder (Savard et al., 
1998). Comparably, in a more recent study than the above two, the levels of anxiety were measured 
using the Beck Anxiety Inventory (BAI) among 98 HIV-infected individuals in Vermont, New 
Hampshire (Gonzalez, Solomon, Zvolensky, & Miller, 2009). Among this sample, a total mean 
score of 16.21 was indicative of mild to moderate anxiety symptoms (Gonzalez et al., 2009).  
The levels of anxiety were also reported in LMIC among people living with HIV. For 
example, among a sample of people seeking HIV testing in Goa, India (Mayston et al., 2013), the 
levels of generalized anxiety were measured using a modified version of the Patient Health 
Questionnaire in combination with the Generalized Anxiety Scale and the panic disorder module 
(Spitzer, Kroenke, & Williams, 1999). The prevalence of generalized anxiety symptoms among this 
sample of people coming for HIV/AIDS testing was 1.1% (Mayston et al., 2013). Furthermore, 
Sahay et al. (2007) have shown that a higher prevalence of anxiety was found among a sample of 
150 HIV test seekers in India. They found that 62% of the sample had anxiety as assessed by the 
HADS (Sahay et al., 2007). 
Little research has been done to assess the extent of anxiety symptoms among people living 
with HIV in sub-Saharan Africa. In addition, a limited number of self-report measures have been 
used in sub-Saharan to identify the elevated levels of anxiety among HIV-infected individuals. The 
screening instruments included are the EPDS (e.g. Rochat et al., 2006), the HSCL-25 (Kagee, 
2010), and the Center for Epidemiological Studies Depression Scale (CESD) (e.g. Myer et al., 
2008). The BAI, on the other hand, is the least documented screening instrument in sub-Saharan 
Africa.  
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A possible explanation for this may be that treatment for HIV has become more accessible in 
recent years. Consequently, HIV has become less life threatening, which may explain the lower 
rates of anxiety symptoms among HIV-positive individuals (Kagee et al., 2015). However, data 
regarding the rates of anxiety among people seeking HIV testing in South Africa are limited. 
Symptoms of alcohol use in general. In Ireland, the prevalence of hazardous alcohol 
consumption (HAC) was assessed among university students using the Alcohol Use Disorder 
Identification Test for Consumption (AUDIT-C) (Davoren, Siely, Byrne, & Perry, 2015). Among 
the Irish university students (n = 2275), the prevalence of HAC was 66.4% (Dovoren et al., 2015).  
In the general population, it has also been shown that the identification of alcohol use 
disorders is poor on the LMIC (Pal, Yadav, Joy, Mehta, & Ray, 2003; Patel et al., 2007). For 
example, a study among 1 285 individuals from the Federation of Bosnia and Herzegovina and from 
Republika Srpska assessed the levels of alcohol use using the PHQ (Broers et al., 2006). Broers et 
al. (2006) reported that the levels of alcohol use were 5.0%.  
In an urban hospital in South Africa, harmful or hazardous drinking was assessed using the 
AUDIT (Pengpid, Peltzer, & Van Den Heever, 2011). Among the sample of 1532 patients, the 
findings showed that 41.2% of men, while 18.3% of women were hazardous drinkers. 
Symptoms of alcohol use among PLWH. In the context of alcohol use and HIV, previous 
studies have showed that an infection with HIV is associated with alcohol use (e.g., Ayisi et al., 
2000; Shishana et al., 2005). In a rural town in Louisiana, USA, the CAGE (Cut down, Annoy, 
Guilty and Eye-opener) index was used to assess the number of PLWHA with a problem with 
drinking (Mohammed et al., 2004). Mohammed et al. (2004) found that 12.8% of the PLWHA were 
binge drinkers and 12.8% were problem drinkers. Similarly, among an Indian sample of people 
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coming for HIV/AIDS testing, the level of harmful alcohol use was 12.8% as assessed by the 
AUDIT (Mayston et al., 2013).  
A systematic review of published research by Fisher, Bang, and Kapiga (2007), established 
that alcohol drinkers in Africa had considerably higher odds of being HIV-positive. In Nigeria, the 
levels of hazardous drinking in HIV-positive individuals were assessed using the AUDIT (Farley et 
al., 2010). Farley et al. (2010) report that 12% of their sample scored above the recommended cut-
off score of eight on the AUDIT, which suggests hazardous or harmful alcohol use (Farley et al., 
2010). This prevalence rate was higher than that demonstrated in a study assessing MINI-defined 
alcohol abuse or dependence among HIV-positive individuals (Myer et al., 2008) rather than 
harmful/hazardous drinking (Farley et al., 2010). Another study in South Africa made use of the 
AUDIT to assess harmful or hazardous alcohol use among 1503 HIV-infected patients attending 
HIV clinics in the Western Cape, South Africa (Kader, Seedat, Govender, Koch, & Parry, 2014). 
Kader et al. (2014) reported that 37% of the sample was hazardous or harmful alcohol drinkers. A 
plausible reason for this high prevalence rate may be that South Africa, compared to the rates 
worldwide, has one of the highest rate of per capita consumption per drinker (Kader et al., 2014).  
Risk factors associated with CMDs. It has been shown that poverty and high levels of 
economic stress has consistently been associated with depression in LMIC (Husain, Creed, & 
Tomenson, 2000; Mirza & Jenkins, 2004; Patel et al., 2007; Rahman & Creed, 2007). A recent 
systematic review (Lund et al., 2010) of poverty and CMDs in low and middle income countries 
indicates that poverty, as shown by social exclusion, high stressors, reduced social capital, 
malnutrition, and increased violence and trauma can be positively linked to increased risk of CMDs 
(Lund et al., 2010).  
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It has also been found that more men tend to report low levels of CMDs than women do 
(Cohen, 2001; Cwikel et al., 2008; Havenaar, Geerlings, Vivian, Collinson, & Robertson, 2008; Lu 
et al., 2008; Sawyer, Pfeiffer, & Spence, 2009). Cohen (2001) found that the potential vulnerability 
of women in Pakistan, have CMD rates ranging between 45% up to 66%, whereas men have rates 
ranging between 15% up to 25%. These studies are, however, related to several factors. For 
instance, a study in Uganda found that women in polygamous marriages are more likely to be 
distressed than their male partners, for whom the presence of more than one partner is protective 
(Abbo et al., 2008). However, a study in India found no association between gender and rates of 
CMDs (Pothen et al., 2003). Furthermore, several factors related to gender have been found to be 
associated with psychiatric morbidity. These factors include worries over employment and finances 
in men, while in women the worries are more likely to be about troubled family relationships and 
infertility (Cohen, 2001; Hall & Williams, 1987). 
Literature suggests that a lack of education or poor education is a risk factor for CMDs in low 
and middle-income countries (Patel & Kleinman, 2003). The reason for this is that lack of education 
or poor education are related to unemployment, low paying jobs and poverty, which are 
consequently associated with CMDs. The prevalence of psychiatric disorders is also associated with 
the social drift and social causation hypotheses (Dohrenwend, 1998). The social drift hypothesis 
indicates that elevated rates of psychiatric disorders are high in low socioeconomic status (SES) 
groups because of the ability of these individuals to change their status. In contrast, the social 
causation theory suggests that the risk for a mental disorder is high in low SES individuals because 
of the stressful social environments in which they live (Dohrenwend, 1998).  
Research in South Africa has shown an increasing vulnerability amongst women generally 
and specifically during pregnancy. Studies have shown high rates of gender inequality and intimate 
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partner violence during pregnancy (Dunkle et al., 2004), related in turn to depression and risk of 
HIV (Jewkes et al., 2008). In a South African study, women were more likely to have mood and 
anxiety disorders, whereas men showed an elevated risk for depression (Stein et al., 2008). Men 
were also more likely associated with substance use disorders, such as alcohol use disorder, than 
women (Stein et al., 2008). 
Summary of common mental disorders in the global and sub-Saharan context. Despite 
the epidemiological research on common mental disorders, there is still ambiguity about the 
numbers of adults who have these disorders among people seeking HIV testing. There are also 
limited studies that have assessed the prevalence of common mental disorders in low-and middle-
income countries.  
Yet, it appears that people in low- and middle-income countries have a greater likelihood of 
being diagnosed with common mental disorders compared to high-income countries. Therefore, 
further research is needed to expand on the knowledge of prevalence and incidence of CMDs in the 
current study’s population of interest.  
The majority of the studies in the review indicate that self-report measures yielded higher 
prevalence estimates than diagnostic interview schedules such as the SCID. However, it is more 
difficult to compare the results because of the varying measurement techniques used, or the duration 
of the assessments. Additionally, the study populations also ranged from primary care or medical 
population-bases and HIV samples, which have an impact on the prevalence rates as well. 
Methodology-comparable research studies and the use of common, standardized instruments are 
warranted so that comparisons can be made among samples. In this way, the evidence can be used 
for mental health policy reform, and implementation of appropriate psychosocial interventions 
(Collins et al., 2010; Petersen & Lund, 2011; Brandt, 2009).  
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Regarding gender, women tend to report CMD symptoms more often than men do. The higher 
prevalence rate of CMDs among women ranges between 45% and 60% in Pakistan compared to 
15% and 25% among men (Cohen et al., 2001).  
The majority of the studies documented were cross-sectional, therefore more longitudinal 
studies are needed to report the causal relationship between mental health disorders and HIV. The 
studies reported in the review have examined the prevalence of CMDs prior to the receipt of a HIV-
positive test results, and CMDs after an HIV diagnosis (Martin & Kagee, 2011, Olley, 2006). 
However, it is not known whether a psychiatric disorder or alcohol use disorder may be a risk factor 
for becoming HIV infected or if an HIV diagnosis is a risk factor for developing a psychiatric 
disorder.  
Research Gaps 
A review of the literature shows that a great number of epidemiological studies identifying 
common mental disorders such as depression and anxiety often include people living with HIV. 
However, limited knowledge is available that may contribute to the detection and treatment of these 
individuals seeking HIV testing. Furthermore, imperfect research is available in South Africa 
regarding the effectiveness of self-report measures in predicting CMD caseness or non-caseness. In 
this way, the current study will be informative on whether self-report measures can be used as 
proxies in identifying psychiatric disorders.  
Given the above background, the study now proceeds to answer the question whether CMDs 
among people seeking HIV testing are higher than in the general population. In answering this 
question, several sub-questions also have to be answered (refer to Chapter 1, p.6). The next chapter 
discusses the methodology of the current study. 
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Chapter 3: Research Methodology 
Introduction 
This chapter describes the research design and methodology used to examine the prevalence 
of common mental disorders, the effectiveness of the BDI, BAI, HSCL-25 and AUDIT against the 
SCID as gold standard, and the prevalence of general distress among persons seeking HIV testing. 
The procedures of data collection (i.e. measurement instruments), capturing and data analysis are 
presented here.  
Research design 
The study was cross-sectional and involved the use of quantitative research methods.  
Study sites 
The study was conducted among individuals seeking HIV testing at five non-profit 
organizations (NPOs) in the Cape Metropole district of the Western Cape, South Africa.  
Cape Metropole district. The research was conducted in the Cape Metropole district, also 
known as the City of Cape Town Metropolitan Municipality in the Western Cape, South Africa 
(Figure 1). The Western Cape, situated in the southwestern part of the country, consists of six 
municipal districts. The Cape Metropole district is estimated to have a population of 3 740 026 
(Statistics South Africa, 2011). The biggest group within the population is Coloured (42.4%), 
followed by Black African (38.6%), White (15.7%) and Indian (1.4%). The predominant language 
is Afrikaans (35.7%), followed by Xhosa (29.8%) and English (28.4%). The Cape Metropole region 
has an annual population growth of 2.57% (Statistics South Africa, 2011). 
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The unemployment rate is estimated at 23.9%, with an average household income between 
R38 201 - R76 400 per annum. In addition, 38.2% of these households are female-headed 
households (Statistics South Africa, 2011).  
 
Figure 1 Map of the City of Cape Town Metropolitan Municipality 
The five NGO sites. Testing is organized by the Department of Health and outsourced to five 
non-profit organizations (NPOs) in the Cape Metropole districts. These include Living Hope, 
Masincedane, Reliable Action, Sizophila, and Phambili.  
Living Hope. Living Hope wellness centre is located in Mfuleni and is staffed by a registered 
nurse and four counsellors. The centre is funded by the Desmond Tutu TB Centre (DTTC) at 
Stellenbosch University. The healthcare services provided to the surrounding communities include 
HIV and tuberculosis (TB) testing, and sexually transmitted infections (STIs) screening. In order to 
assist the government in their efforts to promote HIV awareness and education, the counsellors are 
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required to test a minimum number of new patients every month. Last year, 17 630 people were 
tested, of which 2.2% tested HIV positive.  
Below is a picture of the Living Hope premises in Mfuleni. 
 
Figure 2 Living Hope, Mfuleni  
Masincedane. Masincedane wellness centre, also funded by the Desmond Tutu TB Centre 
(DTTC), is located in Somerset West. The services provided to the surrounding community include 
HIV testing and counselling, TB screening, blood glucose examining, youth support sessions, blood 
pressure testing, condom distribution, pregnancy testing, and family planning. During the last six 
months of 2013, the staff provided HIV VCT services to 1 746 clients. The majority of these clients 
were men.  




Figure 3 Masincedane, Somerset West  
Reliable Action. Reliable Action is a non-profit organization operating in Eersterivier that 
focuses on prevention and awareness, voluntary testing, counselling and support. The staff members 
consist of five lay counsellors and a registered nurse. Reliable Action is funded by the Department 
of Health of the Western Cape. The healthcare services provided are trauma counselling, blood 
pressure testing, blood glucose testing, BMI (Body Mass Index), pregnancy testing, family 
planning, outreaches at schools, corporate companies and shopping malls. In 2014, 95 025 people 
were tested for HIV as opposed to 59 777 in 2013.  
Please see below images of the site. 




Figure 4 Reliable Action, Eersteriver  
Sizophila. Sizophila (meaning “we will have life!”) is located at the Methodist Church 
Building in Broadlands, Strand. Services delivered include HIV testing and counselling, eye 
screening, TB screening, family planning, blood pressure testing, blood glucose and cholesterol 
monitoring, pregnancy testing and condom distribution. Sizophila Wellness Centre is in 
collaboration with the Masincedane Community Services and the Western Cape Department of 
Health. The staff members engage in regular outreach to communities by means of door-to-door 
visits.  




Figure 5 Sizophila, Strand  
Phambili. Phambili centre in Broadlands Park, Strand, provides health and wellness services 
to all individuals in the wider Broadlands Park community. The services rendered by Phambili 
include the following: dental care, HIV testing and counselling and eye testing. The Department of 
Health and 11 Rotary clubs, some local and some international, fund this centre. They also received 
a grant from Rotary International 2012.  
 
Figure 6 HIV-testing campaign  
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These sites were selected because they provide HIV counselling and testing to individuals 
seeking an HIV test result. Furthermore, the proximity of the sites to the residential areas in the 
Cape Metropole district made it accessible to the residents. Potential participants access healthcare 
services at the abovementioned testing sites or during routine outreach activities, such as caravans 
and tents that are set up by the counsellors in the community. These caravans and tents are also 
placed at shopping centres, train and taxi ranks, in business settings and in open spaces in public.  
Preparation of the healthcare environment. Prior to the start of the research, steps were 
taken to confirm that the healthcare environment was adequately prepared for the study. This 
included reaching agreement on how the research process could be implemented within the 
wellness centres with minimal interference. For example, it was decided that refreshments such as 
coffee, juice or biscuits as a token of appreciation would not be appropriate because it can create 
false expectations of what the practice would be after the research has concluded. The individuals 
may believe that this is a normal daily routine of the testing sites. However, after much deliberation 
with the staff members and with consideration of ethical measures, it was decided that a grocery 
voucher may be given to prospective participants. The research team also had to make it abundantly 
clear that participants will only receive the grocery vouchers at the end of the interview process and 
those individuals who decline to take part will not receive a voucher.  
Study Preparation  
Training of the interviewers. Qualified clinical interviewers in the persons of Prof S.A. 
Kagee and Dr J. Bantjes, trained all the data collectors in administering the structured clinical 
interview for the DSM-V (SCID). The data collectors consisted of five postgraduate psychology 
students, including myself. A significant focus of the training was on developing interview skills so 
that interviewers would be able to elicit information from patients about their psychiatric symptoms. 
Stellenbosch University  https://scholar.sun.ac.za
 62 
 
Interviewers were also trained to use their clinical judgement to make decisions about whether each 
symptom was present or not.  
The research team, of which I was a member, attended a two-day training workshop to view 
SCID training DVDs. It was an eleven-hour course on using the Structured Clinician Interview for 
DSM-IV Axis I Disorders. We only viewed the DVDs relevant to the SCID modules used in our 
study.  
Following this, group SCID sessions were conducted periodically, where the SCID was 
administered by one interviewer, while the other SCID interviewers observed. These exercises 
helped to ensure that all of the SCID interviewers were in agreement with respect to their 
understanding of the DSM-5 diagnostic criteria and SCID methodology.  
Pilot testing. For the purposes of piloting, ten men and women seeking HIV testing were 
recruited from five non-profit HIV testing sites through convenience sampling. The revised version 
of the SCID was administered to the participants. Those participants who consent to participate in 
the study were required to give written consent and were supplied with an information leaflet 
explaining the project. The participants in the pilot study were assured of their anonymity and the 
confidentiality of their participation in the pilot study. 
The purpose of the pilot testing was multiple:  
 It afforded the research assistants learning opportunities to practice the full assessment battery 
and to monitor through observation and supervision. They practiced aspects such as mastery 
of interview skills for all assessment items, probing skills and they could gauge the time it 
took to deliver the assessment battery. 
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 The researchers could detect and correct errors and ambiguities in the SCID and the self-
report questionnaires, for example, grammatical errors, notes to the interviewers that were not 
clear enough and technical errors associated with the electronic version of the SCID (i.e., the 
skip out function not working properly), etc. 
 The interviewers had a chance to detect layout and presentation problems that could lead to 
the misinterpretation of questions or statements. 
 The researchers could evaluate the feasibility of the study within the wellness centres. 
 The researchers were able to determine the amount of time it takes to conduct the interview. 
 The researchers could determine the receptivity of participants to the interview questions. 
The pilot study was considered important in improving the degree to which the interview 
questions could obtain the required information from the participants. 
1 An introductory sentence was included in the beginning of the interview to establish a 
repertoire between the interviewer and the interviewee. 
2 Notes to the interviewer were included to inform the interviewer on how to handle that 
specific question. 
Study Procedure 
Participants. Participants were enrolled in the study by means of convenience sampling prior 
to undergoing HIV testing at the five above-mentioned non-medical HIV-testing sites in the 
Western Cape region of South Africa. The type of HIV testing accessible was the finger-prick rapid 
test, which is very fast and convenient to use. Convenience sampling is an example of non-
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probability sampling, in which the participants are conveniently available to participate in the study 
(Cant et al., 2008). Cant et al. (2008) observe that the advantage of convenience sampling is that it 
is convenient, cost effective and the least time consuming sampling method. The biggest 
disadvantage of convenience sampling, on the other hand, is the possibility for sampling bias in that 
those participants recruited may not be reflective of the population of interest (Cant et al., 2008). An 
example of sampling bias in the current study would be if only young female participants were 
approached. A possible way to manage sampling bias would be to recruit as many diverse sub-
groups as possible (i.e. different genders, age groups, etc.) from the population of interest (Cant et 
al., 2008). Probability sampling, on the other hand, means that participants have an equal chance of 
being selected. Probability sampling was not used in the current study since it is more time 
consuming and costly than non-probability sampling (Tyler & Heyman, 2016). In this study, the 
participants were eligible to participate in the study based on the following inclusion and exclusion 
criteria: 
Inclusion criteria 
i At least 18 years and older; 
ii Testing for HIV (first time test-seekers and repeat test-seekers), and willingness to receive 
their HIV results; 
iii A comprehensible understanding of English; 
iv Also, a sufficient capacity to consent. 
Exclusion criteria 
i. Not meeting the minimum age criteria of 18 years and older to consent to participate; 
ii. Not willing to test for HIV, or not willing to receive their HIV results; 
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iii. Already aware of their HIV-positive status prior to consent, or receiving ART treatment; 
iv. Not having sufficient capacity to consent. 
v. Floridly psychotic 
Recruitment procedure. After registration at reception, those individuals coming for HIV 
testing received a flyer briefly describing the research and encouraging them to meet with the 
researcher in a private room or a tent or caravan at each testing site. Those who were interested in 
meeting with the researcher were informed about the study in more detail and were asked to 
participate in the study before undergoing HIV testing. Although English was not the first language 
of a majority of the participants, all but a few HIV test-seekers who were interested in meeting with 
the researcher were able to understand English. If a potential participant was not conversant in 
English, he or she was excluded from the study. In this context, 40 potential participants were not 
included in the study. The participants were expected to complete an informed consent form. 
Thereafter, they were administered the SCID together with a battery of self-report questionnaires. 
These measures were administered by the researchers after they had undergone training. The 
recruitment procedure was structured in this way to maximize the use of the participant’s available 
time, without disruption of the healthcare services.  
Ethical considerations. The study was granted ethical clearance by the Health Research 
Ethics Committee (HREC) at Tygerberg Hospital. The researcher informed the participant that any 
information given would be treated as confidential and that participation was completely voluntary. 
Participants could therefore refuse to take part in the study at any time during the course of the 
interview. After being given the opportunity to ask questions about the study, those who agreed to 
participate were asked to sign a consent form, indicating informed consent. The participants 
received a grocery voucher to the value of R50 as a token of appreciation for their participation. In 
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line with ethics requirements, a referral protocol was developed to respond to moderate to severe 
cases of mental disorders. They were provided with referral letters with numbers of Stellenbosch 
facilities that provide mental health services. The following contact details were provided: (a) Idas 
Valley: Sister C. Nothling (psychiatric nurse) at 0218872721 or 
chanel.nothling@westerncape.gov.za; (b) Cloetesville: Sister N. Toffar (psychiatric nurse) at 021 
883 2676 or ntoffar@westerncape.gov.za; (c) Stellenbosch Provincial Hospital - 021 887 0310; (d) 
Vlottenburg Mobile Clinic - 021 888 5825; (e) Kylemore Clinic - 021 885 2504; (f) Jamestown 
clinic - 021 880 1390. 
Data collection methods and data analysis 
Data collection. All questionnaires and the structured interview were administered in English. 
The interview and questionnaires took approximately sixty to ninety minutes to complete. The 
SCID was administered before the administration of the self-report questionnaires (demographic 
information, HSCL-25, BDI, BAI, and AUDIT). This sequence was chosen to account for the 
duration of the SCID modules to elicit more detailed responses. In this regard, the participants were 
able to understand their own mental health better. The participants also had the opportunity to ask 
for more clarity in the likelihood that they did not understand the terminology used. Although the 
SCID questions may have had an influence on the responses to the self-report measures, the 
participants’ understanding of the questions on the self-report measures improved due to the SCID. 
Socio-demographic questionnaire. The demographic questionnaire consisted of items that 
provide information on age, gender, race, marital status, education level, living situation, family 
income, first language, and employment status. This specific demographic information was helpful 
to determine whether some of the socio-demographic determinants are in association with the 
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prevalence estimates of CMDs. Furthermore, due to time constraints and resources available, 
variables such as previous HIV testing or past psychiatric treatment were not assessed.  
Structured Clinical Interview for the DSM. The research version of the structured clinical 
interview for the DSM (SCID-R) (refer to Appendix I through Appendix K), developed by Spitzer 
et al. (1980), is a structured diagnostic interview used to establish DSM-IV Axis I disorders (major 
mental disorders) and Axis II personality disorders (First et al., 1997). The SCID-R has been 
utilized as the ‘gold standard’ in several studies to ascertain the precision of clinical diagnoses 
(Shear et al., 2000; Steiner et al., 1995). 
The reliability of the SCID-R is reported in terms of Kappa statistic, which is a measure of 
inter-rater reliability or agreement (Lobbestael, Leurgans, & Arntz, 2010; Williams et al., 1992). 
Kappa statistic values above 0.70 are indicative of good inter-rater agreement, whereas values from 
0.50 to 0.70 show moderately good agreement. Kappa values below 0.50 are suggestive of poor 
inter-rater agreement (Lobbestael, Leurgans, & Arntz, 2010; Williams et al., 1992). Williams et al. 
(1992) have found negative reliability results using the SCID due to poor inter-rater agreement on 
CMDs such as depression and substance abuse. However, recent studies (such as Zanarini & 
Frakenburg, 2001; Zimmerman & Mattia, 1999) have shown more consistent and positive results. 
The highest inter-rated agreement values were found by Skre, Onstad, Torgersen and Kringlen 
(2007) for the following different mental disorders: schizophrenia (0.94), MDD (0.93), dysthymia 
(0.88), GAD (0.95), panic disorders (0.88), alcohol use disorders (0.96) and other psychoactive 
substance use disorders (0.85). 
The relevant modules of the existing SCID, which were anchored in the DSM-IV, were 
adapted by Professor S.A. Kagee and Dr J. Bantjes to match the diagnostic criteria of the DSM 5. 
This adapted version was compared with a draft version of the new SCID used by Dr M. First, with 
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whom Professor S.A. Kagee has been in contact, and the language of the interview questions was 
further adapted. The final modified version of the SCID includes the following modules: screening 
questions, MDD (current and past); persistent depressive disorder; post-traumatic stress disorder 
(PTSD); acute stress disorder; GAD and adjustment disorder. For this thesis, only the following 
modules of the SCID-RV were used: major depressive disorder (current and past), persistent 
depressive disorder, generalized anxiety disorder, and alcohol use disorder (current and past). An 
electronic version of the SCID has been constructed for utilization on a web page 
(http://surveys.sun.ac.za). The interview data were recorded on Lenovo tablets and were then 
instantaneously imported into an Excel file and saved. 
Hopkins Symptom Checklist. The 25-item Hopkins Symptom Checklist (HSCL-25) was used 
to determine psychological distress among the sample (refer to Appendix D). The HSCL-25 was 
obtained from the 90-item Symptom-Checklist (Derogatis, Lipman, Rickels, Ulenhuth, & Covi, 
1974; Parloff, Kelman & Frank, 1954). The first ten items on the HSCL-25 assess symptoms of 
anxiety, while the remaining fifteen items on the scale assess depression (Mollica, Wyshak, de 
Marneffe, Khuon, & Lavelle, 1987). The depression score is correlated with major depression as 
delineated by the DSM-5 (APA, 2013; Mollica et al., 1987).  
The level to which each symptom has upset the participant in the past month was rated on a 
four-point Likert-type scale, with 1 indicating “not at all”, 2 indicating “a little”, 3 being “quite a 
bit” and 4 “extremely” (Derogatis et al, 1974) and a mean score of 44 has been defined as the cut-
off point to indicate clinically significant distress (Winokur et al., 1984). A high total score of the 
HSCL-25 is suggestive of significant levels of distress. The internal consistencies of the total scale 
(α = 0.93), the depression subscale (α = 0.90) and the anxiety subscale (α = 0.85) were high (Kaaya 
et al., 2002). 
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The HSCL-25 was also used in studies conducted in South Africa such as those by Kagee 
(2005) and Van der Merwe (2005). For instance, Kagee (2005) evaluated the levels of 
psychological distress among former political detainees using the HSCL-25. The internal 
consistency of the HSCL-25 among this sample of former detainees as determined by Cronbach’s 
alpha was 0.96 (Kagee, 2005). The same alpha value was found among individuals living with 
diabetes or hypertension (Kagee, 2008) and among people living with HIV (Kagee, & Martin, 
2010). Furthermore, Coyne et al. (2004) reported that among their sample of breast cancer patients 
(n = 113), the HSCL-25 was a significant predictor of MDD (χ 2(1) = 8.83, p< 0.05). The factor 
structure of the HSCL-25 yielded two factors (depression and anxiety) that explained 48% of the 
variance (Ventevogel et al., 2007).  
Beck Depression Inventory. The Beck Depression Inventory (BDI) (refer to Appendix E) is a 
21-item self-report measure that calculates the presence of the following indicators of depression: 
affective, cognitive, motivational, psychomotor and vegetative indicators (Beck, Steer, & Garbin, 
1988; Beck, Ward, Mendelson, Mock, & Erbaugh, 1961). This self-reported inventory has each 
item rated with a set of four possible answers of increasing intensity. Each item is rated on a four-
point scale, ranging from 0 to 3 (Beck, 2001). A total score of 10 or higher is the most widely used 
cut-off for significant depressive symptomology (Beck et al., 1991; Beck, 2001). The severity of 
depressive symptomatology is represented by the following cut-off scores: ˂ 10 indicates none or 
minimal depression, 10-18 indicates mild or moderate depression, 19-29 indicates moderate to 
severe depression; and 30-63 indicates severe depression (Beck et al., 1988). Although the BDI has 
been utilized to assess the severity of depressive symptomatology, it was not created to establish 
clinical diagnosis (Bonilla, Bernal, Santos, & Santos, 2004). 
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The internal consistency coefficient for the BDI as measured by Cronbach’s alpha was high (r 
= 0.80) (Beck et al., 1988; Beck, et al., 1961) with internal consistencies ranging between 0.73 and 
0.92, with a mean of 0.86. (Beck et al., 1988). Regarding psychiatric and non-psychiatric 
populations, high internal consistencies were found, with alpha coefficients of 0.86 and 0.81, 
respectively (Beck et al., 1988). Kagee (2008) also found a high internal consistency of 0.85 on the 
BDI among South African patients living with diabetes or hypertension. A similar internal 
consistency was found among people living with HIV (Kagee, & Martin, 2010). The factor 
structure of the BDI-II was assessed among 185 HIV-positive individuals receiving antiretroviral 
therapy in South Africa using exploratory factor analysis (EFA) (Kagee, Nel, & Saal, 2014). Three 
factors were obtained, which accounted for 47.29% of the variance (Kagee, Nel, & Saal, 2014).  
Beck Anxiety Inventory. The Beck Anxiety Inventory (BAI) (refer to Appendix F) has 21 
items and determines the severity of anxiety in psychiatric patients (Beck, Epstein, Brown, & Steer, 
1988). The items on the BAI are rated due to how much the specific item bothered the individual in 
the past week. The items on the BAI represent the emotional, physical and cognitive symptoms of 
anxiety and can discriminate anxiety from depression (Beck et al., 1988). Each item on the BAI is 
can be categorized in terms of its four subscales: (1) subjective (e.g., “unable to relax”), (2) 
neurophysiologic (e.g., “numbness or tingling”), (3) autonomic (e.g., “feeling hot”) or (4) panic-
related (e.g., “fear of losing control”) (Beck et al., 1988). 
This four-point Likert-type scale ranges from 0 (“not at all”) to 3 (“severely” – I could barely 
stand it) (Beck et al., 1988). The total score for all 21 items ranges between 0 and 63 points (Beck et 
al., 1988; Beck & Steer 1990). A total score of 0 - 7 on the BAI is indicative of mild anxiety, 8 - 15 
is indicative of mild anxiety, 16 -25 indicates moderate anxiety, and 26 - 63 indicates severe anxiety 
(Beck et al., 1988; Beck & Steer, 1990).  
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Furthermore, Beck et al. (1988) demonstrated that the BAI has high internal consistency 
(Cronbach alpha = 0.92). In a study by Kagee et al. (2015) among 101 adults receiving ART in 
clinics in the Western Cape, South Africa, the Cronbach alpha of the BAI was 0.89. The Cronbach 
alpha of a Xhosa version of the BAI was 0.92, indicating high internal consistency (Steele & 
Edwards, 2008). Exploratory factor analysis was used among 101 HIV-positive individuals in South 
Africa receiving ART’s (Kagee et al., 2015). These authors found that a single factor structure 
accounted for 68.7% of the variance (Kagee et al., 2015).  
Alcohol Use Disorders Identification Test. The Alcohol Use Disorders Identification Test 
(AUDIT) (refer to Appendix G) is a 10-item self-report measure designed by the WHO to assess 
hazardous alcohol intake and alcohol abuse and dependence in primary healthcare settings (Babor, 
Higgins-Biddle, Saunders, Monteiro, 2002; Saunders, Aasland, Babor, de la Fuente, & Grant, 
1993). The AUDIT measures three domains, namely: (i) the quantity and occurrence of drinking (ii) 
the symptoms of alcohol dependence; and (iii) negative responses to the results of drinking (Babor 
et al., 2001). On the AUDIT a total score of 8 or more indicates hazardous and risky alcohol use and 
probable alcohol dependence (Babor et al., 2001). Some studies have shown that in both males and 
females, a cut-off score greater than 8 suggest hazardous alcohol dependence/abuse (Aalto, 2009; 
Pradhan et al., 2012; Moussas et al., 2009; Kaarne, Aalto, Kuokkanen, & Seppa, 2010; Saunders et 
al., 1993). Similarly, Babor et al. (2001) reported that a cut-off of 8 is potentially able to detect a 
significant number of hazardous and harmful drinkers. 
The AUDIT has revealed high internal consistency, with a Cronbach alpha coefficient of 0.80 
(Meneses-Gaya, Zuardi, Laureiro, & Crippa, 2009; Reinert & Allen, 2002). The internal 
consistency of the AUDIT was 0.81 among South African clinic attenders in the Cape Metropole 
region in South Africa. (Kadar, 2013). Confirmatory factor analysis among a South African cohort 
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of 314 (77.3%) men and 92 (22.6%) women yielded a two-factor and three-factor model for the 
men (Morojele, Kekwaletswe, Nkosi, Kitleli, & Manda, 2015). However, CFA was unable to yield 
a one-factor, two-factor, or three-factor model for the women (Morojele et al., 2015). 
Data Analysis 
Sample size calculation. The sample size was calculated based on the estimates of previous 
studies. Kessler et al. (2009) found that a lifetime prevalence of mental disorders ranges between 
18.1% and 36.1%, while the prevalence of mental disorders over a period of 12 months is 9.8-
19.1%. Williams et al. (2006) report that the overall prevalence rate for mental disorders is 16.5%. 
Accordingly, by assuming 16.5% as an overall prevalence of mental disorders, a sample size of 348 
was calculated by making use of Creative Research Systems survey software’s sample size 
calculator (https://www.surveysystem.com/sscalc.htm). A margin of error (confidence interval) of 
5%, and a confidence level of 95% were used.  
The sample size of 348 is above the sample size of 150 HIV test seekers suggested by Sahay 
et al. (2007), and more than the sample size of 242 pregnant women used in the study by Rochat et 
al. (2006). The study was part of a longitudinal study that required a larger sample size of 500. This 
sample size of 500 is large enough to ensure sufficient power to produce useful results and to detect 
optimal sensitivity and specificity values.  
Data screening and quality assurance. I set up the SCID and the self-report questions, as 
previously mentioned, on a web-based platform. This electronic version was used to conduct 
interviews with the assistance of a Lenovo tablet. After the interviewers reported the participants’ 
responses on the Lenovo tablet, the data were immediately uploaded to the university’s database to 
be reviewed at a later stage. The data were then exported and stored in an Excel spreadsheet format.  
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An integrity check of the data, for instance, checking for missing values and outliers, revealed 
some missing data. There are several reasons why the data were missing. First, the age of the 
participants was calculated using their ID numbers. Some participants forgot their ID’s and the 
interviewers asked them to provide their ID numbers at a later stage but a few participants did not 
comply. It was then suggested that the interviewers asked the participants for their date of birth if 
they did not know their ID numbers. Second, one item of the GAD module of the SCID was not 
entered into the web-based survey. Fortunately, I was able to rectify this mistake by adding the item 
at a later stage. Third, the past alcohol use disorder (past AUD) module of the SCID was also not 
included in the web-based survey. After deliberation with my supervisor, the past AUD module was 
added at a later stage. Finally, some data were missing because the participants unintentionally 
skipped a few BDI items. Subsequently, data were lost as some of the BDI item responses were 
accidentally deleted when I tried to make changes to the matrix rows or columns of the web-based 
version of the BDI. Furthermore, those participants with no responses to the self-report measures 
were excluded from the study. A possible reason for these missing values could have been that the 
person decided to withdraw from the study in the middle of the interview.  
As can be seen in Table 1, 11.8% of the participants did not have responses for the past AUD 
variable, and some items on the BDI (6.6%), GAD (4.60%) and age (2.8%) variables. The missing 
values were imputed using the Multiple Imputation (MI) procedure. Multiple imputation is a 
Markov Chain Monte Carlo procedure in which the missing values are substituted by m > 1 
(typically small, 3-10) simulated versions (Shafer, 1999). In order to ensure that the repeated 
analysis of the same data would generate the same findings, I considered the Monte Carlo error of 
the results. The Monte Carlo error refers to the “standard deviation across repeated runs of the same 
imputation procedure with the same data” (White, Royston, & Wood, 2011, p. 387). The imputation 
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model should contain all the variables that were in the analysis model (Schafer, 1997) to avoid bias. 
In this context, the variables that were included in the imputation model were the demographic 
variables, MDD (current and past), PDD, AUD (current and past), GAD and all the items of the 
self-report measures.  
Table 1 
Missing data 
Missing variables N_missing %_missing 95% CI 
Age 14 2.80% [1.35, 4.25] 
GAD  23 4.60% [2.76, 6.44] 
Past AUD 59 11.80% [8.97, 14.63] 
BDI Items 33 6.60% [4.42, 8.78] 
 
A complete descriptive analysis was performed on participants’ demographic information. I 
took the following steps to ensure the quality of data collection in preparation for the data analysis: 
(1) All interviews were audio recorded for quality assurance during the course of data collection; 
(2) Several debriefing sessions were held to monitor data quality and to improve item responses; (3) 
following rigorous data preparation, the accuracy of the modified version of the SCID were checked 
for data analysis activities. 
For this thesis, the data collected on the SCID were coded using the DSM algorithms and 
reduced to a CMD case or non-case dichotomous (0/1) score. The DSM algorithm was implemented 
within Excel as a function so that all responses to individual symptoms were reduced to the 
dichotomous score (0/1) labelled as CMD case or non-case. I finalized the algorithm, with the aid of 
a statistician, Dr Martin Kidd, to analyse the data. As the data became available, the algorithm was 
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incorporated to determine whether a person was a case for a common mental disorder or not. 
Therefore, it was important to check and re-check the algorithm to ensure that reliable scores were 
produced. To this extent, the statistician and I ensured that the algorithm correctly coded the 
responses of the participants as either present (threshold) or absent (false). 
Statistical procedure. Table 2 presents each area of investigation, the instruments that were used 
and the analytic approach applied during the data analysis 
Table 2 
Data sources and analytic approaches 
Area of enquiry Instrument Analytic approach 
Prevalence estimates SCID Descriptive statistics  










Sensitivity and specificity 











The data were entered into SPSS version 23. The reliability of the different scales was 
calculated using Cronbach’s alpha. Prevalence estimates for major depressive, past depressive, 
persistent depressive, generalized anxiety and alcohol use disorders were determined using the 
Stellenbosch University  https://scholar.sun.ac.za
 76 
 
SCID and a confidence interval of 95%. The data collected on the SCID were coded using the DSM 
algorithms and reduced to a dichotomous 0 (non-case) or 1 (case) score. The results were calculated 
frequencies (i.e., means and standards deviations). I also utilized a Chi-square test to compare the 
prevalence of major depression, persistent depressive, generalized anxiety and alcohol use disorder 
with gender.  
Receiver operating characteristic (ROC) curve analysis. ROC curve analysis is the curve that 
represents all possible cut points yielding optimal sensitivity and specificity (Hanley, & McNeil 
(1982). ROC analysis was used to examine the ability of self-report measures to discriminate 
between common mental disorder (CMD) caseness or non-caseness (Zou et al., 2012). Thus, the 
ROC area under the curve (AUC) tells us about the appropriateness of the self-report measures, 
specifically the BDI, BAI, AUDIT, and the HSCL to predict caseness for major depressive, past 
major depressive, persistent depressive, generalized anxiety, and alcohol use disorder (Zou et al., 
2012). It is recommended that values between 0.70 and 0.90 are suggestive of a useful screening 
measure (Fisher et al., 2003; Swets, 1988). The positive predictive value (PPV) and the negative 
predictive value (NPV) were also assessed (Zou et al., 2012). The advantage of ROC analysis is that 
the optimal cut-off point can be calculated for each case (Hajian-Tilaki, 2013). Furthermore, the 
AUC is not influenced by a decision criterion (Hajian-Tilaki, 2013). A disadvantage of ROC is that 
the ROC curve that best describes test performance in one population may not be exactly 
transferable to other populations (“Understanding Receiver Operating Characteristics Curves”, 
2014). Therefore, caution should be taken when different populations are compared with each other.  
Sensitivity and Specificity. The data analysis examined sensitivity and the specificity of the 
screening instruments against the SCID as gold standard. Sensitivity and specificity of a 
questionnaire are associated with a random selection of a “decision threshold” or cut-off point (Zou 
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et al., 2007). Sensitivity and specificity values were evaluated to determine the best cut-off point 
that would augment the number of true positive and true negative predictions of mental disorders 
(Zou et al., 2007). Furthermore, those individuals who score below the cut-off point have high 
sensitivity, but low specificity. A high cut-off point, on the other hand, indicates many false 
negative results. The sensitivity refers to the ability of the screening instruments to identify those 
individuals with the condition or disorder correctly (Zou et al., 2007). 
𝑠𝑒𝑛𝑠𝑖𝑡𝑖𝑣𝑖𝑡𝑦 =
True positives
True positives + False negatives
 
An ideal sensitivity of 100% indicates that all the patients have been diagnosed with the 
disease (Zou et al., 2012). A sensitivity of 80% suggests that 80% of the patients have the disease 
(true positives), whereas 20% of the patients go undetected (false negatives) (Zou et al., 2012). In 
the context of identifying those patients with a severe but treatable disease (e.g. cervical cancer), a 
high sensitivity would be of more importance.  
Specificity. Specificity, on the other hand, refers to the capability of the test to correctly detect 
those patients who have not been diagnosed with the disease (Zou et al., 2007). 
𝑠𝑝𝑒𝑐𝑖𝑓𝑖𝑐𝑖𝑡𝑦 =
True negatives
True negatives + False positives
 
Therefore, a specificity of 100% is ideal to detect all patients (Parikh et al., 2008; Zou et al., 
2012). A specificity of 80% suggests that 80% of the patients were correctly identified as not 
having the disease (Zou et al., 2012), while 20% of the patients who were diagnosed with the 
disease, did not have the disease (false positives) (Zou et al., 2007). Even though a test with 100% 
accuracy would be the ideal, a possible alternative would be to administer a subsequent test with 
low sensitivity/high specificity to those patients who screened positive on a screening instrument 
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with high sensitivity/low specificity. In this example, all the false positive cases may be correctly 
identified as not having the condition or disease (Parikh, 2008). Notably, in situations where a test 
has to identify those patients without the disease, a high specificity is of importance (e.g. breast 
cancer).  
Positive predictive value. The positive predictive value (PPV) is the percentage of patients 
with a positive test who score above the cut-off point and have the condition or disease (Parikh, 
2008) 




Negative predictive value. The negative predictive value (NPV) is the percentage of patients 
with a negative test who scored below the cut-off point and truly do not have the condition or 
disease (Parikh, 2008). 




The positive predictive value of the HSCL, BDI, BAI, and AUDIT depends on the prevalence 
of the major depressive, past depressive, persistent depressive and alcohol use disorder. If the 
prevalence rates are very low, even with high sensitivity and specificity values, a high number of 
positive test results will be false positives. For example, if the sample being tested included a high 
proportion of HIV-positive people, then the PPV would be high and the NPV would be low.  
Chapter conclusion 
The research framework used for the data collection was appropriate to address the research 
questions and to meet the aims and objectives of this dissertation. A structured clinical interview 
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and a battery of self-report measures was used to answer the research questions. The next chapter 
presents the results of the thesis. 
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Chapter 4: Results 
Introduction 
This chapter describes the findings of each of the four research questions addressed in this 
study. The chapter begins with the demographic information of the sample. The prevalence of 
current major depressive, past major depressive, persistent depressive, generalized anxiety, and 
alcohol use disorders follows. Next, I compare the ability of the self-report measures to discriminate 
between caseness and non-caseness using the structured clinical interview for the DSM-5 as gold 
standard.  
Multiple imputation for missing data 
The missing values in the generalized anxiety and alcohol use disorder variables and the 
missing values on the Beck Depression Inventory (BDI) were imputed using the Multiple 
Imputation (MI) procedure. The Markov Chain Monte Carlo method of estimation was used to 
impute the missing data. 
I created m = 5 imputations by means of data augmentation runs of 100 cycles each. The 
results of the imputation procedure are shown in Table 3 and Table 4. Both tables contain mean 
scores, the standard deviation values of the original dataset and the complete imputed dataset. 
During each cycle, the means and standard deviations were calculated to verify that the reiterations 
of the same data would produce the same answers (White, Royston, & Wood, 2011). These two 
datasets are very similar due to the low percentages of missing variables.  




Five imputations of the past alcohol use disorder and generalized anxiety disorder variables 
 Original dataset Complete data after multiple imputations 
   Iteration 1 Iteration 2 Iteration 3 Iteration 4 Iteration 5 
 Mean SD Mean SD Mean  SD Mean SD Mean SD Mean SD 
             
AUD_ 
past 
0.40 0.49 0.38 0.51 0.37 0.51 0.40 0.51 0.38 0.50 0.38 0.51 
GAD 0.04 0.19 0.34 0.20 0.03 0.19 0.04 0.19 0.04 0.20 0.04 0.19 
             
  
Stellenbosch University  https://scholar.sun.ac.za




Five imputations of the BDI missing variables 
 Original dataset Complete data after multiple imputations 
   Iteration 1 Iteration 2 Iteration 3 Iteration 4 Iteration 5 
 Mean SD Mean SD Mean  SD Mean SD Mean SD Mean SD 
BDI1 0.82 10.7 0.83 1.07 0.82 1.07 0.83 1.07 0.82 1.07 0.83 1.07 
BDI2 0.97 1.11 0.97 1.12 0.96 1.11 0.97 1.11 0.97 1.11 0.96 1.12 
BDI3 0.82 1.00 0.83 1.01 0.83 1.01 0.83 1.01 0.82 1.00 0.82 1.00 
BDI4 0.78 0.85 0.79 0.85 0.79 0.85 0.79 0.85 0.79 0.85 0.79 0.85 
BDI5 0.74 0.94 0.74 0.94 0.74 0.93 0.74 0.94 0.75 0.94 0.74 0.94 
BDI6 0.97 1.18 0.97 1.18 0.97 1.18 0.97 1.18 0.97 1.18 0.97 1.18 
BDI7 0.56 0.77 0.56 0.77 0.56 0.77 0.56 0.77 0.56 0.77 0.56 0.77 
BDI8 0.98 1.07 0.99 1.08 1.00 1.08 1.00 1.10 0.99 1.08 1.00 1.09 
BDI9 0.35 0.72 0.34 0.71 0.35 0.72 0.35 0.72 0.36 0.73 0.34 0.72 
BDI10 0.87 1.21 0.86 1.21 0.86 1.21 0.86 1.21 0.86 1.21 0.86 1.21 
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 Original dataset Complete data after multiple imputations 
   Iteration 1 Iteration 2 Iteration 3 Iteration 4 Iteration 5 
 Mean SD Mean SD Mean  SD Mean SD Mean SD Mean SD 
BDI11 0.87 1.06 0.87 1.05 0.87 1.06 0.88 1.06 0.87 1.06 0.87 1.05 
BDI12 0.65 0.85 0.65 0.85 0.64 0.85 0.65 0.85 0.65 0.85 0.65 0.85 
BDI13 0.78 1.03 0.78 1.03 0.77 1.03 0.78 1.04 0.78 1.03 0.78 1.03 
BDI14 0.57 0.88 0.57 0.88 0.57 0.88 0.57 0.88 0.57 0.88 0.57 0.88 
BDI15 0.86 0.92 0.86 0.92 0.86 0.92 0.86 0.92 0.86 0.92 0.86 0.92 
BDI16 0.84 0.99 0.84 0.99 0.84 0.99 0.84 0.99 0.84 0.99 0.84 0.99 
BDI17 0.73 0.83 0.73 0.83 0.73 0.83 0.73 0.83 0.73 0.83 0.73 0.83 
BDI18 0.71 0.87 0.71 0.88 0.71 0.87 0.71 0.87 0.71 0.87 0.71 0.87 
BDI19 0.72 1.01 0.72 1.01 0.72 1.01 0.72 1.01 0.72 1.02 0.72 1.01 
BDI20 0.85 1.00 0.85 1.00 0.84 1.00 0.84 1.00 0.85 1.00 0.84 1.00 
BDI21 0.79 0.99 0.79 0.99 0.79 0.99 0.79 0.99 0.79 0.99 0.79 0.99 
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As shown in Table 5, female participants represented 51.6% of the sample, while the male 
participants represented 48.4% of the sample. The ages of the participants ranged from 18 to 71. 
The mean age of the participants was 36 years.  
The majority of the participants (72.6%, 95%CI [68.69, 76.51]) identified themselves as 
mixed race (Coloured), 26.2% (95%CI [22.35, 30.05]) as African and 0.8% (95%CI [0.02, 1.58]) as 
White. With regard to first language, 69.0% (95%CI [64.95, 73.05]) of the participants were 
Afrikaans speaking, followed by 6.0% (95%CI [3.92, 8.08]) English and 19.6% (95%CI [16.12, 
23.08]) Xhosa-speaking individuals. Only those persons who were able to understand and respond 
in English were enrolled in the study. While 46.6% (95%CI [42.23, 50.97]) of the sample are 
unemployed, 41.0% (95%CI [36.69, 45.31]) had a family income of R10 001- R40 000 per annum. 
Table 5 
Socio-demographic characteristics of the sample 
 Number of 
respondents 
(N = 500) 
Percentage 95% CI 
Gender    
     Male 242 48.4 [44.02, 52.78] 
     Female 258 51.6 [47.22, 55.98] 
Age (years)    
     Mean 36   
     18 – 19 27 5.4 [3.42, 7.38] 
     20 – 29 150 30.0 [25.98, 34.02] 
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 Number of 
respondents 
(N = 500) 
Percentage 95% CI 
     30 – 39 139 27.9 [23.97, 31.83] 
     40 – 49 102 20.5 [16.96, 24.04] 
     50 – 71 80 15.9 [12.69, 19.11] 
Race    
     African 131 26.2 [22.35, 30.05] 
     Mixed race (Coloured) 363 72.6 [68.69, 76.51] 
     White 4 0.8 [0.02, 1.58] 
     Other 2 0.4 [-0.15, 0.95] 
First Language    
     Afrikaans 345 69.0 [64.95, 73.05] 
     English 30 6.0 [3.92, 8.08] 
     Xhosa 98 19.6 [16.12, 23.08] 
     Other 27 5.4 [3.42, 7.38] 
Current work situation    
     Employed full-time 97 19.4 [15.93, 22.87] 
     Employed part-time 106 21.2 [17.62, 24.78] 
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 Number of 
respondents 
(N = 500) 
Percentage 95% CI 
     Unemployed 233 46.6 [42.23, 50.97] 
     Homemaker 11 2.2 [0.91, 3.49] 
     Student 29 5.8 [3.75, 7.85] 
     Disabled 7 1.4 [0.37, 2.43] 
     Retired 17 3.4 [1.81, 4.99] 
Annual family income    
     Less than *ZAR 10 000 203 40.6 [36.3, 44.9] 
     ZAR 10 001 – ZAR 40 000 205 41.0 [36.69, 45.31] 
     ZAR 40 001 – ZAR 80 000 57 11.4 [8.61, 14.19] 
     ZAR 80 001 – ZAR 110 000 20 4.0 [2.28, 5.72] 
     ZAR 110 001 – ZAR 170 000 8 1.6 [0.5, 2.7] 
     ZAR 170 001 – ZAR 240 000 4 0.8 [0.02, 1.58] 
     ZAR 240 000 and above 3 0.6 [-0.08, 1.28] 
 
The prevalence of common mental disorders among people seeking HIV testing 
As can be seen in Table 6, the prevalence of major depressive disorder among this sample of 
people seeking HIV testing was 14.40% (95% CI [11.32, 17.48]); the prevalence of past major 
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depressive disorder was 18.20% (95% CI [14.82, 21.58]); the prevalence of persistent depressive 
disorder was 7.20% (95% CI [4.93, 9.47]); the prevalence of generalized anxiety disorder was 
3.40% (95% CI [1.81, 4.99]); the prevalence of alcohol use disorder was 19.60% (95% CI [16.12, 
23.08]); and the prevalence of recurrent alcohol use disorder was 35.40% (95% CI [31.21, 39.59]). 
Table 6 
Prevalence of mood disorders, generalized anxiety, and alcohol use disorder 
 Total population % 95% CI 
Current MDD 72 14.40 [11.32, 17.48] 
Past MDD 91 18.20 [14.82, 21.58] 
MIDD 4 0.80 [0.02, 1.58] 
PDD 36 7.20 [4.93, 9.47] 
GAD 17 3.40 [1.81, 4.99] 
Current AUD 98 19.60 [16.12, 23.08] 
Recurrent AUD 177 35.40 [31.21, 39.59] 
One disorder 142 28.40 [24.45, 32.35] 
Two disorders 84 16.80 [13.52, 20.08] 
Three disorders 39 7.80 [5.45, 10.15] 
 
Gender, unemployment and language comparisons with common mental disorders 
The chi-square analysis showed that there was no significant relationship between gender and 
current major depressive [ᵪ2(1) =0.96, р =0.33], past major depressive [ᵪ2(1) =0.50, р =0.48], 
persistent depressive [ᵪ2(1) =0.24, р =0.62], medication induced depressive [ᵪ2(1) =1.14, р =0.29], 
generalized anxiety [ᵪ2(1) =24.0, р =0.46], current alcohol use disorders [ᵪ2(1) =1.6, р =0.21], or 
past alcohol use disorders [ᵪ2(1) =69.4, р =0.19]. 
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As can be seen in Table 8, there were no significant differences between employment and 
unemployment and the CMD prevalence estimates such as current MDD [ᵪ2(1) =0.76, р =0.38], 
GAD [ᵪ2(1) =0.01, р =0.91], current AUD [ᵪ2(1) =2.46, р =0.12], and past AUD [ᵪ2(1) =1.05, р 
=0.31]. However, significant differences were found between employment and unemployment and 
past MDD [ᵪ2(1) =4.33, р =0.04], PDD [ᵪ2(1) =6.41, р =0.01], and MIDD [ᵪ2(1) =9.76, р =0.01].  
In Table 9, the chi-square analysis further showed that there was no significant association 
between Afrikaans and English and the CMD prevalence estimates such as current MDD [ᵪ2(1) 
=0.83, р =0.36], past MDD [ᵪ2(1) =0.10, р =0.75], PDD [ᵪ2(1) =1.26, р =0.26], GAD [ᵪ2(1) =0.01, р 
=0.92], and past AUD [ᵪ2(1) =13.06, р = 0.67]. Conversely, there was significant differences 
between Afrikaans and English and MIDD [ᵪ2(1) =5.98, р =0.05], and current AUD [ᵪ2(1) =6.17, р 
=0.01]. 
Table 7 
Comparison of the prevalence of major depressive, generalized anxiety, posttraumatic stress and 











Current MDD 43.1 56.9 0.96 0.33 
Past MDD 45.1 54.9 0.50 0.48 
PDD 44.4 55.6 0.24 0.62 
MIDD 75.0 25.0 1.14 0.29 
GAD 35.3 64.7 24.0 0.46 
Current AUD 54.1 45.9 1.6 0.21 
Recurrent AUD 59.9 40.1 69.4 0.19 
*р ˂ 0.05 
  




Comparison of the prevalence of major depressive, generalized anxiety, posttraumatic stress and 











Current MDD 24.6 75.4 0.76 0.38 
Past MDD 18.8 81.3 4.33 0.04 
PDD 9.7 90.3 6.41 0.01 
MIDD 13.7 86.3 9.76 0.01 
GAD 27.3 72.7 0.01 0.91 
Current AUD 21.7 78.3 2.46 0.12 
Recurrent AUD 23.3 76.7 1.05 0.31 
*р ˂ 0.05 
Table 9 
Comparison of the prevalence of major depressive, generalized anxiety, posttraumatic stress and 











Current MDD 88.9 11.1 0.83 0.36 
Past MDD 91.0 9.0 0.10 0.75 
PDD 86.7 13.3 1.26 0.26 
MIDD 89.1 10.9 5.98 0.05 
GAD 92.9 7.1 0.01 0.92 
Current AUD 98.7 1.3 6.17 0.01 
Recurrent AUD 92.9 7.1 13.06 0.67 
*р ˂ 0.05 
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Symptoms of distress, depression and anxiety 
This section report on the symptoms of distress, depression, anxiety, and alcohol use among 
people seeking HIV testing.  
Symptoms of distress. A Cronbach alpha reliability coefficient revealed that the HSCL-25 
had excellent internal consistency (α = 0.95). In Table 10, the mean score of the HSCL-25 was 
44.27. The suggested cut-off point for the use of the HSCL in clinical settings was a score equal to 
or greater than 44 (≥ 44). On the HSCL-25, 41.20% (95%CI [36.89, 45.51]) of the sample fell 
within the clinically significant range.  
Symptoms of depression. The internal consistency for the BDI as assessed by Cronbach’s 
alpha was excellent (0.92). In Table 10, the mean score of 16.20 on the BDI fell in the mild to 
moderate depression range. As can be seen in Table 12, 21.00% (95%CI [17.43, 24.57]) of the 
participants fell in the mild to moderate range, 21.40%(95% CI [17.81, 24.99]) of the sample fell in 
the moderate to severe range and 18.00% (95% CI [14.63, 21.37]) of the participants fell in the 
severe range of depression on the BDI. These findings indicate that a large proportion of the sample 
reported experiencing elevated symptoms of depression. 
Symptoms of anxiety. The internal consistency for the BAI was excellent (0.94). The mean 
score of 12.58 of the BAI fell in the range of minimal anxiety. Table 13 shows that 78.20% (95%C I 
[74.58, 81.82]) of the sample reported minimal anxiety, 13.60% (95% CI [10.6, 16.6]) reported 
moderate anxiety and only 8.20% (95%CI [5.8, 10.6]) reported severe anxiety. The majority of the 
sample reported mild anxiety. 
Symptoms of alcohol use disorders. The internal consistency of the AUDIT was excellent (0.89). 
As can be seen in Table 10, the mean score was 6.61 for the AUDIT. The recommended cut-off 
point of 8 for clinical use indicates harmful alcohol use and likely alcohol dependence. In Table 14, 
using the cut-off point of 8, 65.40% (95% CI [61.23, 69.57]) of the sample scored below the cut-off 
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point on the AUDIT, whereas 34.60% (95% CI [30.43, 28.77]) of the sample fell within the 
clinically significant range.  
Table 10 
Mean scores on the HSCL, BDI, BAI and AUDIT 
Instrument N Mean SD 
HSCL Anxiety 500 17.41 6.39 
HSCL Depression 500 26.87 10.66 
HSCL Total 500 44.27 16.40 
BDI 467 16.20 12.67 
BAI 500 12.58 13.11 
AUDIT 500 6.61 8.15 
 
Table 11 
Percentage of sample scoring above clinical cut-off point of 44 on the HSCL 
 N % 95% ci 
< 44 294 58.80 [54.49, 63.11] 
≥ 44 206 41.20 [36.89, 45.51] 
 
Table 12 
Percentage of sample in each BDI category 
 N % 95% CI 
Normal (0-9) 198 39.60 [35.31, 43.89] 
Mild to moderate (10-
18) 
105 21.00 [17.43, 24.57] 
Moderate to severe 
(19-29) 
107 21.40 [17.81, 24.99] 
Severe (30-50.5) 90 18.00 [14.63, 21.37] 
 




Percentage of sample in each BAI category 
 N % 95% CI 
Mild anxiety (0-21) 391 78.20 [74.58, 81.82] 
Moderate anxiety (22-
35) 
68 13.60 [10.6, 16.6] 
Severe anxiety (36-63) 41 8.20 [5.8, 10.6] 
 
Table 14 
Percentage of sample scoring above clinical cut-off point of 8 on the AUDIT 
 N %  
< 8 327 65.40 [61.23, 69.57] 
≥ 8 173 34.60 [30.43, 28.77] 
 
Screening for Mood Disorders 
This section reports on the performance of the HSCL-25, HSCL-25 depression subscale and 
BDI as screening tools for the accurate detection of current and persistent depressive disorders.  
Receiver operating characteristic curve (ROC) analysis for the HSCL-25 in screening 
for current MDD. The ROC curve in Figure 7 shows the performance of the total HSCL-25 in 
identifying current major depressive disorder (MDD). The area under the curve (AUC) calculates 
the ability of the HSCL-25 to discriminate between those individuals with MDD and those 
individuals without MDD. Swets (1988) suggests that AUC scores greater than 0.9 indicates “high” 
accuracy, while 0.7–0.9 indicates “moderate” accuracy, 0.5–0.7 “low accuracy”, and 0.5 a chance 
result (Fisher et al., 2003; Swets, 1988). The AUC of 85% (AUC = 0.85, 95% CI = 0.802, 0.890) 
shows that the HSCL is moderately accurate in discriminating between MDD caseness and non-
caseness.  




Figure 7 Receiver operating characteristic (ROC) curve for the diagnosis of current MDD 
among the 500 people seeking HIV testing based on the total HSCL-25  
Accuracy of the HSCL-25 cut-off point. In order to increase both sensitivity and specificity, 
the Younden’s index was applied: Youden Index = Sensitivity+ Specificity -1 (Hajian-Tilaki, 
2013). The Youden index J refers to the position on the ROC curve (Fig. 8) further from the 
diagonal line, also called the line of equality (Fig. 8). The value of the ROC-curve statistic selected 
as an optimal cut-off is where the term “Sensitivity + Specificity - 1” is maximal. Thus, the Youden 
index is an accepted measurement for the receiver operating characteristic curve to calculate the 
clinical diagnostic ability of a test (Youden, 1950).  




Figure 8 Youdin’s J statistic (Youdin, 1950; Schisterman, Perkins, Liu, & Bondell, 2005; 
Powers, 2011) 
An examination of the sensitivity (true positives) and specificity (true negatives) values in 
Table 15 shows that a HSCL-25 cut-off point of 51.5 yielded optimal sensitivity (0.79) and 
specificity (0.78).  
  




ROC curve coordinates of the HSCL-25 
Cut-off point Sensitivity 1-Sensitivity Specificity 
23.0000 1.000 1.000 0.000 
24.5000 1.000 0.956 0.044 
25.5000 1.000 0.923 0.077 
26.5000 1.000 0.890 0.110 
27.5000 1.000 0.855 0.145 
28.5000 1.000 0.825 0.175 
29.5000 1.000 0.771 0.229 
30.5000 1.000 0.720 0.280 
31.5000 1.000 0.687 0.313 
32.5000 1.000 0.650 0.350 
33.5000 0.972 0.612 0.388 
34.5000 0.972 0.577 0.423 
35.5000 0.931 0.547 0.453 
36.5000 0.917 0.528 0.472 
37.5000 0.917 0.502 0.498 
38.5000 0.903 0.463 0.537 
39.5000 0.903 0.430 0.570 
40.5000 0.889 0.402 0.598 
41.5000 0.875 0.381 0.619 
42.5000 0.861 0.355 0.645 
43.5000 0.861 0.336 0.664 
44.5000 0.861 0.325 0.675 
45.5000 0.861 0.313 0.687 
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Cut-off point Sensitivity 1-Sensitivity Specificity 
46.5000 0.861 0.287 0.713 
47.5000 0.833 0.273 0.727 
48.5000 0.833 0.252 0.748 
49.5000 0.806 0.243 0.757 
50.5000 0.806 0.234 0.766 
51.5000 0.792 0.224 0.776 
52.5000 0.764 0.210 0.790 
53.5000 0.722 0.196 0.804 
54.5000 0.694 0.173 0.827 
55.5000 0.681 0.164 0.836 
56.5000 0.667 0.154 0.846 
57.5000 0.611 0.145 0.855 
58.5000 0.583 0.138 0.862 
59.5000 0.569 0.129 0.871 
60.5000 0.542 0.129 0.871 
50.5000 0.806 0.234 0.766 
61.5000 0.514 0.124 0.876 
62.5000 0.500 0.112 0.888 
63.5000 0.458 0.103 0.897 
64.5000 0.458 0.098 0.902 
65.5000 0.458 0.086 0.914 
67.5000 0.417 0.072 0.928 
68.5000 0.389 0.063 0.937 
69.5000 0.361 0.051 0.949 
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Cut-off point Sensitivity 1-Sensitivity Specificity 
70.5000 0.347 0.049 0.951 
71.5000 0.333 0.047 0.953 
72.5000 0.333 0.037 0.963 
73.5000 0.306 0.037 0.963 
74.5000 0.292 0.026 0.974 
75.5000 0.250 0.019 0.981 
76.5000 0.236 0.016 0.984 
77.5000 0.222 0.016 0.984 
78.5000 0.208 0.014 0.986 
79.5000 0.139 0.014 0.986 
81.0000 0.139 0.012 0.988 
82.5000 0.083 0.012 0.988 
83.5000 0.069 0.009 0.991 
84.5000 0.069 0.007 0.993 
86.0000 0.056 0.005 0.995 
87.5000 0.042 0.005 0.995 
89.0000 0.028 0.005 0.995 
90.5000 0.028 0.002 0.998 
91.5000 0.014 0.002 0.998 
92.5000 0.000 0.002 0.998 
94.0000 0.000 0.000 1.000 
67.5000 0.417 0.072 0.928 
68.5000 0.389 0.063 0.937 
69.5000 0.361 0.051 0.949 
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Cut-off point Sensitivity 1-Sensitivity Specificity 
70.5000 0.347 0.049 0.951 
71.5000 0.333 0.047 0.953 
72.5000 0.333 0.037 0.963 
73.5000 0.306 0.037 0.963 
74.5000 0.292 0.026 0.974 
75.5000 0.250 0.019 0.981 
76.5000 0.236 0.016 0.984 
77.5000 0.222 0.016 0.984 
78.5000 0.208 0.014 0.986 
79.5000 0.139 0.014 0.986 
81.0000 0.139 0.012 0.988 
82.5000 0.083 0.012 0.988 
83.5000 0.069 0.009 0.991 
84.5000 0.069 0.007 0.993 
86.0000 0.056 0.005 0.995 
87.5000 0.042 0.005 0.995 
89.0000 0.028 0.005 0.995 
90.5000 0.028 0.002 0.998 
91.5000 0.014 0.002 0.998 
92.5000 0.000 0.002 0.998 
94.0000 0.000 0.000 1.000 
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Sensitivity, specificity, and predictive values of the HSCL-25 with reference to the 
optimal cut-off point of 51.5. For this study, 72 (14.40%) participants of the total sample scored 
above the optimal cut-off point of 51.5 on the HSCL-25. Furthermore, of these 72 participants, 57 
(79.17%) also met the diagnostic criteria for major depression using the SCID, in other words they 
were true positives. However, of the 72 participants, 15 (20.83%) participants scored below the 
optimal cut-off point (51.5) on the HSCL-25, but met the diagnostic criteria for major depression on 
the SCID, in other words they were false negatives.  
Furthermore, 428 (85.60%) participants of the total sample scored below the optimal cut-off 
point of 51.5 on the HSCL-25. Of these 428 participants, 334 (78.04%) participants did not meet the 
diagnostic criteria for MDD on the SCID, in other words they were true negatives. Conversely, of 
the 428 participants, 94 (21.96%) participants scored above the optimal cut-off point of 51.5 on the 
HSCL-25, but did not meet the diagnostic criteria for major depression on the SCID, so they were 
false positives. 
In Table 17, the optimal cut-off score of 51.5 yielded a positive predictive value (PPV) of 
38.31%, indicating that only 38.31% of those who scored above the optimal cut-off point on the 
HSCL-25 are confirmed true cases with the SCID as gold standard. Conversely, the optimal cut-off 
point of 51.5 yielded a negative predictive value (NPV) of 96.70%, indicating that 96.70% of those 
who scored below the optimal cut-off point of 51.5 on the HSCL-25 were confirmed true non-cases. 
  














c a+c = 
151 
















Sensitivity, specificity and predictive values of the HSCL-25 with reference to the optimal cut-off 
point of 51.5 
 Formula  n % 95% CI 
Sensitivity  = a / (a+b) 57/72 0.79 79.17% [75.61, 
82.73] 










= d / (b+d) 334/349 0.96 96.70% [95.13, 8.27] 
 
Receiver operating characteristic curve (ROC) analysis for the HSCL-25 depression 
subscale in screening for current MDD. The ROC curve in Figure 9 displays the performance of 
the HSCL-25 depression subscale with the highest sum of sensitivity and specificity against the 
SCID. The AUC of 86% (AUC = 0.86, 95% CI = (0.816-0.898)) indicates that the HSCL-25 
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depression subscale is a useful screening tool to discriminate between major depression caseness 
and non-caseness.  
 
Figure 9 Receiver operating characteristic (ROC) curve for the diagnosis of current MDD 
among the 500 people seeking HIV testing based on HSCL-25 depression subscale 
Accuracy of the cut-off points of the HSCL-25 depression subscale. The Youden index 
maximizes the difference between sensitivity and specificity. As can be seen in Table 18, the 
highlighted HSCL-25 depression subscale optimal cut-off point of 32.5 yielded optimal sensitivity 
(0.76) and specificity (0.79).  
  




ROC curve coordinates of the HSCL-25 depression subscale using the SCID as the gold standard 
Cut-off point Sensitivity 1-Specificity Specificity 
13.0000 1.000 1.000 0.000 
14.5000 1.000 0.930 0.070 
15.5000 1.000 0.871 0.129 
16.5000 1.000 0.827 0.173 
17.5000 1.000 0.759 0.241 
18.5000 1.000 0.685 0.315 
19.5000 0.986 0.643 0.357 
20.5000 0.972 0.579 0.421 
21.5000 0.972 0.514 0.486 
22.5000 0.944 0.460 0.540 
23.5000 0.903 0.428 0.572 
24.5000 0.889 0.397 0.603 
25.5000 0.875 0.364 0.636 
26.5000 0.847 0.334 0.666 
27.5000 0.847 0.320 0.680 
28.5000 0.847 0.278 0.722 
29.5000 0.833 0.252 0.748 
30.5000 0.833 0.231 0.769 
31.5000 0.806 0.224 0.776 
32.5000 0.764 0.210 0.790 
33.5000 0.694 0.196 0.804 
34.5000 0.667 0.173 0.827 
35.5000 0.667 0.154 0.846 
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Cut-off point Sensitivity 1-Specificity Specificity 
36.5000 0.611 .138 0.862 
37.5000 0.597 0.129 0.871 
38.5000 0.569 0.117 0.883 
39.5000 0.528 0.100 0.900 
40.5000 0.514 0.077 0.923 
41.5000 0.500 0.065 0.935 
42.5000 0.458 0.058 0.942 
43.5000 0.403 0.051 0.949 
44.5000 0.347 0.037 0.963 
45.5000 0.319 0.033 0.967 
46.5000 0.250 0.023 0.977 
47.5000 0.222 0.021 0.979 
48.5000 0.208 0.019 0.981 
49.5000 0.167 0.016 0.984 
50.5000 0.153 0.014 0.986 
51.5000 0.069 0.009 0.991 
52.5000 0.056 0.007 0.993 
53.5000 0.042 0.005 0.995 
55.0000 0.028 0.002 0.998 
57.0000 0.000 0.000 1.000 
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Sensitivity, specificity, and predictive values of the HSCL depression subscale with 
reference to the optimal cut-off point of 32.5. As can be seen in Table 19, 72 (14.40%) 
participants of the total sample scored above the optimal cut-off point of 32.5 on the HSCL-25 
depression subscale. Of these 72 participants, 55 (76.39%) participants also met the diagnostic 
criteria for major depression using the SCID, in other words they were true positives. Of the 72 
participants, 17 (23.61%) participants scored below the optimal cut-off point on the HSCL-25 
depression subscale, but met the diagnostic criteria for major depression on the SCID, so they were 
false negatives. 
However, 428 (85.60%) participants of the total sample scored below the optimal cut-off 
point of 32.5. Of these 428 participants, 338 (79.00%) did not meet the diagnostic criteria for MDD 
on the SCID, in other words they were true negatives. Also, of the 428 participants, 90 (21.03%) 
participants who scored above the optimal cut-off point (32.5) on the HSCL-25 depression subscale 
did not meet the diagnostic criteria for depression on the SCID, so they were false positives.  
In Table 20, the positive predictive value was 38.00%, indicating that 38.00% of those 
participants who scored above the optimal cut-off point of 32.5 on the HSCL-25 depression 
subscale, were correctly identified as cases for major depression. The negative predictive value was 
95.21%, indicating that 95.21% of the participants who scored below the optimal cut-off point of 
32.5 were correctly identified as non-cases for major depression.  
  














c a+c = 
145 
















Sensitivity, specificity and predictive values of the HSCL-25 depression subscale with reference to 
the optimal cut-off point of 32.5 
 Formula  n % 95% CI 
Sensitivity = a / (a+b) 55/72 0.76 76.39% [72.67, 
80.11] 










= d / (b+d) 338/355 0.95 95.21% [93.34, 
97.08] 
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Receiver operating characteristic curve (ROC) analysis in determining current MDD 
based on the BDI. The ROC curve in Figure 10 shows the performance of the BDI in accurately 
determining the optimal balance of sensitivity and specificity against the SCID as the gold standard. 
The AUC of 0.77 (77%) (AUC = 0.76, 95% CI = 0.71-0.82) indicates that the BDI is a useful 
screening tool in detecting caseness and non-caseness for major depression.  
 
Figure 10 Receiver operating characteristic (ROC) curve for the diagnosis of current major 
depressive disorder among the 500 people seeking HIV testing 
 
Accuracy of the BDI cut-off points. The Younden’s index can be applied to maximize both 
sensitivity and specificity. As can be seen in Table 21, an assessment of the sensitivity and 
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specificity values shows that a BDI cut-off point of 19.5 yielded optimal sensitivity (0.67) and 
specificity (0.67).  
Table 21 
ROC curve coordinates of the BDI using the SCID as the gold standard 
Cut-off point Sensitivity 1-Specificity Specificity 
-1.0000 1.000 1.000 0.000 
.5000 1.000 0.937 0.063 
1.0425 0.986 0.897 0.103 
1.1942 0.986 0.895 0.105 
1.6517 0.986 0.893 0.107 
2.2138 0.986 0.853 0.147 
2.5011 0.986 0.850 0.150 
2.7872 0.986 0.848 0.152 
3.4326 0.986 0.783 0.217 
3.8925 0.986 0.780 0.220 
3.9599 0.986 0.778 0.222 
4.0247 0.986 0.729 0.271 
4.5247 0.986 0.727 0.273 
5.5000 0.986 0.710 0.290 
6.5000 0.972 0.664 0.336 
7.1165 0.944 0.617 0.383 
7.6165 0.944 0.614 0.386 
8.5000 0.931 0.584 0.416 
9.5000 0.931 0.549 0.451 
10.5000 0.875 0.530 0.470 
11.0743 0.833 0.502 0.498 
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Cut-off point Sensitivity 1-Specificity Specificity 
11.5743 0.833 0.500 0.500 
12.1583 0.806 0.484 0.516 
12.6583 0.806 0.481 0.519 
13.0603 0.806 0.458 0.542 
13.5603 0.792 0.458 0.542 
14.2371 0.792 0.425 0.575 
14.7075 0.792 0.423 0.577 
14.9703 0.792 0.421 0.579 
15.2358 0.792 0.400 0.600 
15.5193 0.792 0.397 0.603 
15.7835 0.792 0.395 0.605 
16.0867 0.792 0.383 0.617 
16.5203 0.792 0.381 0.619 
16.9336 0.792 0.379 0.621 
17.5000 0.736 0.362 0.638 
18.5000 0.694 0.343 0.657 
19.0208 0.681 0.327 0.673 
19.5208 0.667 0.327 0.673 
20.5000 0.667 0.304 0.696 
21.5000 0.625 0.273 0.727 
22.5000 0.611 0.243 0.757 
23.3289 0.597 0.227 0.773 
23.8289 0.597 0.224 0.776 
24.5000 0.583 0.208 0.792 
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Cut-off point Sensitivity 1-Specificity Specificity 
25.0322 0.528 0.199 0.801 
25.3678 0.528 0.196 0.804 
25.8356 0.514 0.196 0.804 
26.5000 0.458 0.185 0.815 
27.5000 0.431 0.168 0.832 
28.5000 0.431 0.161 0.839 
29.1294 0.431 0.143 0.857 
29.6294 0.431 0.140 0.860 
30.3760 0.431 0.121 0.879 
30.8760 0.431 0.119 0.881 
31.5000 0.417 0.100 0.900 
32.5000 0.375 0.093 0.907 
33.0320 0.361 0.084 0.916 
33.1915 0.361 0.082 0.918 
33.3776 0.361 0.079 0.921 
33.5839 0.361 0.077 0.923 
33.8658 0.361 0.075 0.925 
34.5000 0.319 0.063 0.937 
35.1305 0.264 0.058 0.942 
35.6305 0.264 0.056 0.944 
36.5000 0.250 0.051 0.949 
37.0305 0.236 0.044 0.956 
37.5305 0.236 0.042 0.958 
38.5000 0.208 0.040 0.960 
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Cut-off point Sensitivity 1-Specificity Specificity 
39.5000 0.194 0.037 0.963 
40.5000 0.194 0.030 0.970 
41.5000 0.167 0.026 0.974 
42.1032 0.111 0.016 0.984 
42.5828 0.111 0.014 0.986 
42.9796 0.097 0.014 0.986 
43.5000 0.083 0.009 0.991 
45.0000 0.056 0.009 0.991 
47.5000 0.042 0.007 0.993 
49.0000 0.028 0.007 0.993 
50.2471 0.014 0.002 0.998 
50.4992 0.014 0.000 1.000 
51.5041 0.000 0.000 1.000 
 
Sensitivity, specificity, and predictive values of the BDI with reference to the optimal 
cut-off point of 19.5. In Table 22, 72 (14.40%) participants of the total sample scored above the 
optimal cut-off point of 19.5 on the BDI. Of this number, 48 (67.00%) participants also met the 
diagnostic criteria for major depression using the SCID, in other words they were true positive 
cases. On the other hand, of the 72 participants, 24 (33.33%) participants scored below the optimal 
cut-off point on the BDI, but met the diagnostic criteria for major depression on the SCID, so they 
were false negatives. 
Furthermore, 428 (85.60%) participants of the total sample scored below the optimal cut-off 
point on the BDI. Of these 428 participants, 287 (67.05%) participants also did not meet the 
diagnostic criteria for MDD using the SCID, in other words they were true negatives. Of the 428 
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participants, 141 (32.95%) participants scored above the optimal cut-off point on the BDI, but did 
not meet the diagnostic criteria for major depression on the SCID, so they were false positives.  
As can be seen in Table 23, the optimal cut-off score of 19.5 yielded a positive predictive 
value (PPV) of 25.39%, indicating that only 25.39% of those who scored above the optimal cut-off 
point on the BDI were confirmed true cases with the SCID as the gold standard. Conversely, the 
cut-off point of 19.5 yielded a negative predictive value (NPV) of 92.28%, indicating that 92.28% 
of those who scored below the optimal cut-off point on the BDI were confirmed true non-cases. 
Table 22 










C a+c = 
189 



















Sensitivity, specificity and predictive values of the BDI with reference to the optimal cut-off point of 
19.5 
 Formula  n % 95% CI 
Sensitivity = a / (a+b) 48/72 0.67 67.00% [62.88, 
71.12] 










= d / (b+d) 287/311 0.92 92.28% [89.94, 
94.62] 
 
Odds ratio of current MDD with regard to past MDD compared to no past MDD. 
In Table 24, 72 participants (14.40%) of the total sample were diagnosed with current 
major depression. Of these participants, 40 (55.56%) also met the criteria for past MDD and 32 
(44.44%) did not. Conversely, 428 (85.6%) of all participants in the sample did not meet the criteria 
for current MDD. Of these 428 participants, 51 (11.92%) met the criteria for past MDD and 377 
(88.08%) did not.  
As can be seen in Table 25, the odds ratio for past MDD as a risk factor for current MDD was 
9.24 (OR = 9.24; 95% CI = 5.34, 16.00). This means that persons who had current MDD were 9 
times more likely to have had past MDD than persons with no current MDD.  
  




Two-by-two table of current MDD vs Past MDD  
Current MDD 
(positive) 
N Current MDD 
(negative) 
N Total 


























Odds Ratio of Current MDD vs Past MDD 
 Formula   OR 95% CI 











 = 9.24 [5.34, 16.00] 
a = Number of exposed cases 
 = participants with current MDD assessed as having past MDD 
b = Number of exposed non-cases 
 = participants with no current MDD assessed as having past MDD 
c = Number of unexposed cases 
 = participants with current MDD not assessed as having past MDD 
d = Number of unexposed non-cases 
 = participants with no current MDD not assessed as having past MDD 
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Receiver operating characteristic curve (ROC) analysis for the HSCL-25 in screening 
for persistent depressive disorder (PDD). In Figure 11, the area under the ROC curve (AUC) is a 
measurement of the ability of the BDI to discriminate between PDD caseness and non-caseness. 
The AUC of 82% (AUC = 0.82, 95% CI = 0.76-0.89) indicates that the BDI is an excellent 
screening tool in identifying those with or without PDD.  
 
Figure 11 Receiver operating characteristic (ROC) curve for the diagnosis of persistent 
depressive disorder (PDD) among the 500 people seeking HIV testing based on the 
HSCL-25 
Accuracy of the HSCL cut-off points. In Table 26, the highlighted optimal cut-off point of 
54.5 yielded optimal sensitivity (0.78) and specificity (0.79). The optimal cut-off point of 54.5 
shows that the HSCL-25 correctly identified 78% of individuals with PDD and correctly identified 
79% of individuals who did not have PDD.  




ROC curve coordinates of the HSCL-25 using the SCID as the gold standard 
Cut-off point Sensitivity 1-Specificity Specificity 
23.0000 1.000 1.000 0.000 
24.5000 1.000 0.959 0.041 
25.5000 1.000 0.929 0.071 
26.5000 1.000 0.899 0.101 
27.5000 1.000 0.866 0.134 
28.5000 1.000 0.838 0.162 
29.5000 0.972 0.791 0.209 
30.5000 0.972 0.744 0.256 
31.5000 0.944 0.716 0.284 
32.5000 0.944 0.681 0.319 
33.5000 0.944 0.642 0.358 
34.5000 0.944 0.610 0.390 
35.5000 0.944 0.575 0.425 
36.5000 0.917 0.558 0.442 
37.5000 0.917 0.534 0.466 
38.5000 0.917 0.496 0.504 
39.5000 0.889 0.468 0.532 
40.5000 0.889 0.440 0.560 
41.5000 0.889 0.418 0.582 
42.5000 0.889 0.392 0.608 
43.5000 0.889 0.375 0.625 
44.5000 0.889 0.364 0.636 
45.5000 0.861 0.356 0.644 
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Cut-off point Sensitivity 1-Specificity Specificity 
46.5000 0.861 0.332 0.668 
47.5000 0.833 0.317 0.683 
48.5000 0.833 0.297 0.703 
49.5000 0.833 0.284 0.716 
50.5000 0.833 0.276 0.724 
51.5000 0.833 0.265 0.735 
52.5000 0.833 0.248 0.752 
53.5000 0.806 0.231 0.769 
54.5000 0.778 0.207 0.793 
55.5000 0.750 0.198 0.802 
56.5000 0.750 0.188 0.813 
57.5000 0.639 0.179 0.821 
58.5000 0.639 0.168 0.832 
59.5000 0.611 0.159 0.841 
60.5000 0.611 0.155 0.845 
61.5000 0.611 0.147 0.853 
62.5000 0.611 0.134 0.866 
63.5000 0.528 0.125 0.875 
64.5000 0.528 0.121 0.879 
65.5000 0.500 0.112 0.888 
66.5000 0.444 0.103 0.897 
67.5000 0.417 0.099 0.901 
68.5000 0.361 0.091 0.909 
69.5000 0.278 0.082 0.918 
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Cut-off point Sensitivity 1-Specificity Specificity 
70.5000 0.278 0.078 0.922 
71.5000 0.278 0.073 0.927 
72.5000 0.250 0.067 0.933 
73.5000 0.250 0.063 0.938 
74.5000 0.222 0.052 0.948 
75.5000 0.222 0.039 0.961 
76.5000 0.222 0.034 0.966 
77.5000 0.194 0.034 0.966 
78.5000 0.194 0.030 0.970 
79.5000 0.167 0.022 0.978 
81.0000 0.167 0.019 0.981 
82.5000 0.111 0.015 0.985 
83.5000 0.111 0.011 0.989 
84.5000 0.083 0.011 0.989 
86.0000 0.056 0.009 0.991 
87.5000 0.056 0.006 0.994 
89.0000 0.028 0.006 0.994 
90.5000 0.028 0.004 0.996 
91.5000 0.028 0.002 0.998 
92.5000 0.000 0.002 0.998 
94.0000 0.000 0.000 1.000 
 
Stellenbosch University  https://scholar.sun.ac.za
 118 
 
Sensitivity, specificity, and predictive values with reference to the cut-off point of 54.5. 
Thirty-six (7.20%) participants of the total sample scored above the optimal cut-off point of 54.5 on 
the HSCL-25. Of this number, 28 (78.00%) participants also met the diagnostic criteria for PDD on 
the SCID, in other words they were true positives. However, of the 36 participants, 8 (22.22%) 
participants scored below the optimal cut-off point on the HSCL-25, but met the diagnostic criteria 
for PDD on the SCID, so they were false negatives. 
Furthermore, 464 (92.80%) participants of the total sample scored below the optimal cut-off 
point of 54.5 on the HSCL-25. Of this number, 367 (79.09%) participants did not meet the 
diagnostic criteria for PDD on the SCID, in other words they were true negatives. Of these 464 
participants, 97 (20.91%) participants scored above the optimal cut-off point on the HSCL-25, but 
did not meet the diagnostic criteria for PDD on the SCID, so they were false positives.  
The PPV was 22.00%, indicating that 22.00% of the participants who scored above the 
optimal cut-off point of 54.5 on the HSCL-25 were correctly identified cases for PDD. The NPV 
was 98.00%, indicating that 98.00% of the participants who scored below the optimal cut-off point 
of 54.5 on the HSCL-25 were correctly identified as non-cases for PDD.  
Table 27 










c a+c = 
125 



















Sensitivity, specificity and predictive values of the HSCL-25 with reference to the optimal cut-off 
point of 54.5 
 Formula  n % 95% CI 
Sensitivity = a / (a+b) 28/36 0.78 78.00% [74.37, 
81.63] 










= d / (b+d) 362/370 0.98 98.00% [96.77, 
99.23] 
 
ROC analysis in determining PDD based on the HSCL-25 depression subscale. In 
Figure 12, the ROC curve shows that the HSCL-25 depression subscale performed excellently as a 
predictor of PDD, with an AUC of 82% (AUC = 0.82, 95% CI = 0.75-0.88). 




Figure 12 Receiver operating characteristic (ROC) curve for the diagnosis of PDD among the 
500 people seeking HIV testing based on the HSCL-25 depression subscale 
 
Accuracy of the HSCL depression cut-off points. Table 29 shows the sensitivity and 
specificity values for every likely cut-off point on the HSCL-25 depression subscale. The Youdin’s 
J statistic was used to calculate the optimal sensitivity and specificity. The highlighted cut-off point 
of 33.5 yielded optimal sensitivity (0.72) and specificity (0.77). 
 




ROC curve coordinates of the HSCL-25 depression subscale using the SCID as the gold standard 
Cut-off point Sensitivity 1-Specificity Specificity 
13.0000 1.000 1.000 0.000 
14.5000 1.000 0.935 0.065 
15.5000 1.000 0.881 0.119 
16.5000 1.000 0.841 0.159 
17.5000 0.972 0.780 0.220 
18.5000 0.944 0.713 0.287 
19.5000 0.944 0.672 0.328 
20.5000 0.944 0.612 0.388 
21.5000 0.944 0.552 0.448 
22.5000 0.944 0.498 0.502 
23.5000 0.917 0.463 0.537 
24.5000 0.889 0.435 0.565 
25.5000 0.861 0.405 0.595 
26.5000 0.861 0.373 0.627 
27.5000 0.861 0.360 0.640 
28.5000 0.861 0.321 0.679 
29.5000 0.861 0.295 0.705 
30.5000 0.861 0.276 0.724 
31.5000 0.833 0.267 0.733 
32.5000 0.806 0.250 0.750 
33.5000 0.722 0.233 0.767 
34.5000 0.667 0.211 0.789 
35.5000 0.667 0.194 0.806 
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Cut-off point Sensitivity 1-Specificity Specificity 
36.5000 0.667 0.170 0.830 
37.5000 0.639 0.162 0.838 
38.5000 0.611 0.149 0.851 
39.5000 0.583 0.129 0.871 
40.5000 0.444 0.116 0.884 
41.5000 0.444 0.103 0.897 
42.5000 0.361 0.097 0.903 
43.5000 0.278 0.088 0.912 
44.5000 0.222 0.071 0.929 
45.5000 0.222 0.063 0.938 
46.5000 0.167 0.047 0.953 
47.5000 0.167 0.041 0.959 
48.5000 0.167 0.037 0.963 
49.5000 0.111 0.032 0.968 
50.5000 0.083 0.030 0.970 
51.5000 0.083 0.013 0.987 
52.5000 0.083 0.009 0.991 
53.5000 0.056 0.006 0.994 
55.0000 0.056 0.002 0.998 
57.0000 0.000 0.000 1.000 
 
Sensitivity, specificity, and predictive values. Thirty-six (7.20%) participants of the total 
sample scored above the optimal cut-off point of 33.3 on the HSCL-25 depression subscale. Of this 
number, 26 (72.22%) participants also met the diagnostic criteria for PDD on the SCID, so they 
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were true positives. Of these 36 participants, 10 (27.78%) participants scored below the optimal cut-
off point on the HSCL-25 depression subscale, but met the diagnostic criteria for PDD, in other 
words they were false negatives.  
Conversely, 464 participants of the total sample scored below the optimal cut-off point of 
33.5 on the HSCL-25 depression subscale. However, 357 (77.00%) of these participants did not 
meet the diagnostic criteria for PDD, so they were true negatives. Of the 464, 107 (23.06%) 
participants scored above the optimal cut-off point on the HSCL-25 depression subscale, but did not 
meet the diagnostic criteria for PDD, in other words they were false positives.  
The PPV was 20.00%, indicating that 20.00% of those participants who scored above the 
optimal cut-off point of 33.5 on the HSCL-25 depression subscale were correctly identified as cases 
for PDD. The NPV was 97.27%, indicating that 97.27% of the participants who scored below the 
optimal cut-off point of 33.5 were correctly identified as non-cases for PDD. 
Table 30 











c a+c = 
133 



















Sensitivity, specificity and predictive values of the HSCL-25 depression subscale with reference to 
the optimal cut-off point of 33.5 
 Formula  n %  
Sensitivity = a / (a+b) 26/36 0.72 72.22% [68.29, 
76.15] 










= d / (b+d) 357/367 0.97 97.27% [95.84, 98.7] 
 
ROC analysis to determine PDD based on the BDI. In Figure 13, the ROC curve displays 
the area under the curve. The area under the curve of 82% (AUC = 0.82, 95% CI = 0.757-0.885) 
shows that the BDI is highly accurate in discriminating between PDD caseness and non-caseness. 




Figure 13 Receiver operating characteristic (ROC) curve for the diagnosis of PDD among the 
500 people seeking HIV testing based on the BDI 
Accuracy of the BDI cut-off points. Table 32 shows the sensitivity and specificity values for 
each possible cut-off point on the BDI. The highlighted cut-off point of 23.3 yielded optimal 
sensitivity (0.75) and specificity (0.76).  
  




ROC curve coordinates of the BDI using the SCID as the gold standard 
Cut-off point Sensitivity 1-Specificity Specificity 
-1.0000 1.000 1.000 0.000 
.5000 1.000 0.942 0.058 
1.0425 1.000 0.903 0.097 
1.1942 1.000 0.901 0.099 
1.6517 1.000 0.899 0.101 
2.2138 1.000 0.862 0.138 
2.5011 1.000 0.860 0.140 
2.7872 1.000 0.858 0.142 
3.4326 1.000 0.797 0.203 
3.8925 1.000 0.795 0.205 
3.9599 1.000 0.793 0.207 
4.0247 1.000 0.748 0.252 
4.5247 1.000 0.746 0.254 
5.5000 1.000 0.731 0.269 
6.5000 1.000 0.685 0.315 
7.1165 0.972 0.640 0.360 
7.6165 0.972 0.638 0.362 
8.5000 0.944 0.610 0.390 
9.5000 0.944 0.578 0.422 
10.5000 0.917 0.554 0.446 
11.0743 0.917 0.522 0.478 
11.5743 0.917 0.519 0.481 
12.1583 0.917 0.500 0.500 
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Cut-off point Sensitivity 1-Specificity Specificity 
12.6583 0.917 0.498 0.502 
13.0603 0.889 0.478 0.522 
13.5603 0.889 0.476 0.524 
14.2371 0.889 0.446 0.554 
14.7075 0.889 0.444 0.556 
14.9703 0.889 0.442 0.558 
15.2358 0.889 0.422 0.578 
15.5193 0.889 0.420 0.580 
15.7835 0.889 0.418 0.582 
16.0867 0.889 0.407 0.593 
16.5203 0.889 0.405 0.595 
16.9336 0.889 0.403 0.597 
17.5000 0.833 0.384 0.616 
18.5000 0.833 0.360 0.640 
19.0208 0.806 0.345 0.655 
19.5208 0.806 0.343 0.657 
20.5000 0.778 0.323 0.677 
21.5000 0.750 0.291 0.709 
22.5000 0.750 0.261 0.739 
23.3289 0.750 0.244 0.756 
23.8289 0.750 0.241 0.759 
24.5000 0.722 0.226 0.774 
25.0322 0.722 0.209 0.791 
25.3678 0.722 0.207 0.793 
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Cut-off point Sensitivity 1-Specificity Specificity 
25.8356 0.722 0.205 0.795 
26.5000 0.639 0.192 0.808 
27.5000 0.639 0.172 0.828 
28.5000 0.611 0.168 0.832 
29.1294 0.528 0.157 0.843 
29.6294 0.528 0.155 0.845 
30.3760 0.500 0.140 0.860 
30.8760 0.500 0.138 0.862 
31.5000 0.500 0.119 0.881 
32.5000 0.444 0.110 0.890 
33.0320 0.417 0.101 0.899 
33.1915 0.417 0.099 0.901 
33.3776 0.417 0.097 0.903 
33.5839 0.417 0.095 0.905 
33.8658 0.417 0.093 0.907 
34.5000 0.389 0.078 0.922 
35.1305 0.389 0.065 0.935 
35.6305 0.389 0.063 0.938 
36.5000 0.389 0.056 0.944 
37.0305 0.389 0.047 0.953 
37.5305 0.389 0.045 0.955 
38.5000 0.333 0.043 0.957 
39.5000 0.306 0.041 0.959 
40.5000 0.306 0.034 0.966 
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Cut-off point Sensitivity 1-Specificity Specificity 
41.5000 0.278 0.028 0.972 
42.1032 0.167 0.019 0.981 
42.5828 0.167 0.017 0.983 
42.9796 0.167 0.015 0.985 
43.5000 0.167 0.009 0.991 
45.0000 0.139 0.006 0.994 
46.5000 0.111 0.006 0.994 
47.5000 0.111 0.004 0.996 
49.0000 0.083 0.004 0.996 
50.2471 0.028 0.002 0.998 
50.4992 0.028 0.000 1.000 
51.5041 0.000 0.000 1.000 
 
Sensitivity, specificity, and predictive values with reference to the optimal cut-off point 
of 23.3. Thirty-six (7.20%) participants of the sample scored above the optimal cut-off point of 23.3 
on the BDI. Of these participants, 27 (75.00%) participants also met the diagnostic criteria for PDD, 
showing that they were true positives. Of the 36 participants, 9 (25.00%) participants scored below 
the optimal cut-off point on the BDI, but met the diagnostic criteria for PDD, so they were false 
negatives.  
Conversely, 464 (92.80%) participants of the total sample scored below the optimal cut-off 
point of 23.3 on the BDI. Of these participants, 353 (76.07%) did not meet the diagnostic criteria 
for PDD on the SCID, so they were true negatives. However, of the 464 participants, 111 (23.92%) 
participants scored above the optimal cut-off point on the BDI, but did not meet the diagnostic 
criteria for PDD, in other words they were false positives.  
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The PPV of 20.00% indicated that 20.00% of those participants who scored above the optimal 
cut-off point of 23.3 on the BDI were correctly identified as cases for PDD. The NPV of 98.00% 
indicated that 98.00% of the participants who scored below the optimal cut-off point of 23.3 were 
correctly identified as non-cases for PDD. 
Table 33 










c a+c = 
138 
















Sensitivity, specificity and predictive values of the BDI with reference to the optimal cut-off point of 
23.3 
 Formula  n % 95% CI 
Sensitivity = a / (a+b) 27/36 0.75 75.00% [71.2, 78.8] 










= d / (b+d) 353/362 0.98 98.00% [96.77, 
99.23] 
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Screening for Anxiety Disorders 
This section reports on the performance of the HSCL-25, HSCL-25 anxiety subscale and BAI 
as screening tools for the accurate detection of generalized anxiety disorder. 
ROC curve in determining generalized anxiety disorder based on the HSCL-25. In 
Figure 14, the ROC curve displays the area under the curve. The ROC curve shows that the HSCL-
25 performed very well as a predictor of generalized anxiety disorder (GAD), with an AUC of 87% 
(AUC = 0.87, 95% CI = 0.796-0.935). 
 
Figure 14 Receiver operating characteristic (ROC) curve for the diagnosis of GAD among the 
500 people seeking HIV testing based on the HSCL-25 
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Accuracy of the HSCL-25 cut-off points. Table 35 shows the sensitivity and specificity values for 
each possible cut-off point on the HSCL-25. The highlighted cut-off point of 54.5 yielded optimal 
sensitivity (0.77) and specificity (0.77). 
Table 35 
ROC curve coordinates of the HSCL-25 using the SCID as the gold standard 
Cut-off point Sensitivity 1-Specificity Specificity 
23.0000 1.000 1.000 0.000 
24.5000 1.000 0.961 0.039 
25.5000 1.000 0.932 0.068 
26.5000 1.000 0.903 0.097 
27.5000 1.000 0.872 0.128 
28.5000 1.000 0.845 0.155 
29.5000 1.000 0.797 0.203 
30.5000 1.000 0.752 0.248 
31.5000 1.000 0.723 0.277 
32.5000 1.000 0.689 0.311 
33.5000 1.000 0.652 0.348 
34.5000 1.000 0.621 0.379 
35.5000 1.000 0.588 0.412 
36.5000 1.000 0.569 0.431 
37.5000 1.000 0.547 0.453 
38.5000 1.000 0.509 0.491 
39.5000 1.000 0.480 0.520 
40.5000 0.941 0.455 0.545 
41.5000 0.941 0.435 0.565 
42.5000 0.882 0.412 0.588 
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Cut-off point Sensitivity 1-Specificity Specificity 
43.5000 0.882 0.395 0.605 
44.5000 0.882 0.385 0.615 
45.5000 0.882 0.375 0.625 
46.5000 0.882 0.352 0.648 
47.5000 0.882 0.335 0.665 
48.5000 0.882 0.317 0.683 
49.5000 0.882 0.304 0.696 
50.5000 0.882 0.296 0.704 
51.5000 0.882 0.286 0.714 
52.5000 0.882 0.269 0.731 
53.5000 0.824 0.253 0.747 
54.5000 0.765 0.230 0.770 
55.5000 0.706 0.222 0.778 
56.5000 0.706 0.211 0.789 
57.5000 0.706 0.195 0.805 
58.5000 0.706 0.184 0.816 
59.5000 0.647 0.176 0.824 
60.5000 0.647 0.172 0.828 
61.5000 0.647 0.164 0.836 
62.5000 0.647 0.151 0.849 
63.5000 0.647 0.137 0.863 
64.5000 0.647 0.133 0.867 
65.5000 0.588 0.124 0.876 
66.5000 0.588 0.112 0.888 
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Cut-off point Sensitivity 1-Specificity Specificity 
67.5000 0.588 0.106 0.894 
68.5000 0.529 0.095 0.905 
69.5000 0.529 0.081 0.919 
70.5000 0.529 0.077 0.923 
71.5000 0.529 0.072 0.928 
72.5000 0.529 0.064 0.936 
73.5000 0.529 0.060 0.940 
74.5000 0.529 0.048 0.952 
75.5000 0.412 0.039 0.961 
76.5000 0.353 0.037 0.963 
77.5000 0.294 0.037 0.963 
78.5000 0.235 0.035 0.965 
79.5000 0.235 0.025 0.975 
81.0000 0.176 0.025 0.975 
82.5000 0.118 0.019 0.981 
83.5000 0.118 0.014 0.986 
84.5000 0.118 0.012 0.988 
86.0000 0.118 0.008 0.992 
87.5000 0.059 0.008 0.992 
89.0000 0.059 0.006 0.994 
90.5000 0.059 0.004 0.996 
91.5000 0.059 0.002 0.998 
92.5000 0.059 0.000 1.000 
94.0000 0.000 0.000 1.000 
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Sensitivity, specificity, and predictive values with reference to the optimal cut-off point 
of 54.5. Seventeen (3.40%) participants of the total sample scored above the optimal cut-off point of 
54.5 on the HSCL-25. Of these 17 participants, 13 (77.00%) also met the diagnostic criteria for 
GAD, meaning that they were true positives. Of the 17 participants, 4 (23.53%) scored below the 
optimal cut-off point on the HSCL-25, but met the diagnostic criteria for GAD, so they were false 
negatives. 
Conversely, 483 (96.60%) participants of the total sample scored below the optimal cut-off 
point of 54.5 on the HSCL-25. Of these 483 participants, 372 (77.02%) did not meet the diagnostic 
criteria for GAD as they were true negatives. However, of the 483 participants, 111 (22.98%) 
participants scored above the optimal cut-off point on the HSCL-25, but did not meet the diagnostic 
criteria for GAD, in other words they were false positives.  
The PPV of 10.48% indicated that 10.48% of those participants who scored above the optimal 
cut-off point of 54.5 on the HSCL-25 were correctly identified as cases for GAD. The NPV of 
99.00% indicated that 99.00% of the participants who scored below the optimal cut-off point of 
54.5 were correctly identified as non-cases for GAD. 
Table 36 










c a+c = 
124 



















Sensitivity, specificity and predictive values of the HSCL-25 with reference to the optimal cut-off 
point of 54.5 
 Formula  n % 95% CI 
Sensitivity = a / (a+b) 13/17 0.77 77.00% [73.31, 
80.69] 








= d / (b+d) 372/376 0.99 99.00% [98.13, 
99.87] 
 
ROC curve in determining generalized anxiety disorder based on the HSCL-25 anxiety 
subscale. In Figure 15, the ROC curve displays the area under the curve. The ROC curve shows 
that the HSCL-25 anxiety subscale performed very well as a predictor of generalized anxiety 
disorder (GAD), with an AUC of 88% (AUC = 0.88, 95% CI = 0.825-0.934). 




Figure 15 Receiver operating characteristic (ROC) curve for the diagnosis of GAD among the 
500 people seeking HIV testing based on the HSCL-25 anxiety subscale 
Accuracy of the HSCL-25 anxiety subscale cut-off points. Table 38 shows the sensitivity 
and specificity values for each possible cut-off point on the HSCL-25 anxiety subscale. The 
highlighted optimal cut-off point of 21.5 yielded optimal sensitivity (0.77) and specificity (0.78). 
The optimal cut-off point of 21.5 shows that the HSCL-anxiety subscale correctly identified 77% of 
individuals who had GAD and 78% who did not have GAD. 
  




ROC curve coordinates of the HSCL-25 anxiety subscale using the SCID as the gold standard 
Cut-off point Sensitivity 1-Specificity Specificity 
9.0000 1.000 1.000 0.000 
10.5000 1.000 0.907 0.093 
11.5000 1.000 0.812 0.188 
12.5000 1.000 0.723 0.277 
13.5000 1.000 0.625 0.375 
14.5000 1.000 0.557 0.443 
15.5000 1.000 0.493 0.507 
16.5000 1.000 0.439 0.561 
17.5000 1.000 0.387 0.613 
18.5000 1.000 0.333 0.667 
19.5000 0.882 0.302 0.698 
20.5000 0.882 0.261 0.739 
21.5000 0.765 0.224 0.776 
22.5000 0.706 0.190 0.810 
23.5000 0.706 0.170 0.830 
24.5000 0.588 0.141 0.859 
25.5000 0.529 0.106 0.894 
26.5000 0.529 0.085 0.915 
27.5000 0.471 0.077 0.923 
28.5000 0.412 0.050 0.950 
29.5000 0.412 0.035 0.965 
30.5000 0.353 0.033 0.967 
31.5000 0.235 0.029 0.971 
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Cut-off point Sensitivity 1-Specificity Specificity 
32.5000 0.176 0.023 0.977 
33.5000 0.176 0.017 0.983 
34.5000 0.176 0.014 0.986 
35.5000 0.059 0.012 0.988 
36.5000 0.059 0.008 0.992 
37.5000 0.059 0.006 0.994 
38.5000 0.059 0.002 0.998 
40.0000 0.000 0.000 1.000 
 
Sensitivity, specificity, and predictive values with reference to the optimal cut-off point 
of 21.5. In Table 39, 17 (3.40%) participants of the total sample (n=500) scored above the optimal 
cut-off point of 21.5 on the HSCL-25 anxiety subscale. Of these 17 participants, 13 (77.00%) 
participants also met the diagnostic criteria for GAD, in other words they were true positives. 
However, of the 17 participants, 4 (23.53%) scored below the optimal cut-off point on the HSCL-25 
anxiety subscale, but met the diagnostic criteria for GAD, so they were false negatives. 
Conversely, 483 (96.60%) participants of the total sample scored below the optimal cut-off 
point of 21.5 on the HSCL-25 anxiety subscale. Of these 483 participants, 377 (78.05%) did not 
meet the diagnostic criteria for GAD as they were true negatives. Of the 483 participants, 106 
(21.95%) participants scored above the optimal cut-off point on the HSCL-25 anxiety subscale, but 
did not meet the diagnostic criteria for GAD, indicating that they were false positives.  
Table 40 shows that the PPV was 11.00%, indicating that 11.00% of those participants who 
scored above the optimal cut-off point of 21.5 on the HSCL-25 anxiety subscale were correctly 
identified as cases for GAD. The NPV of 99.00% indicated that 99.00% of the participants who 
scored below the optimal cut-off point of 21.5 were correctly identified as non-cases for GAD. 
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Sensitivity, specificity and predictive values of the HSCL-25 anxiety subscale with reference to the 
optimal cut-off point of 21.5 
 Formula  n % 95% CI 
Sensitivity = a / (a+b) 13/17 0.77 77.00% [73.31, 
80.69] 









= d / (b+d) 377/381 0.99 99.00% [98.13, 
99.87] 
 
ROC curve in determining generalized anxiety disorder based on the BAI. Figure 16 
displays the area under the curve as calculated by ROC analysis. The ROC curve shows that the 
BAI performed excellently as a predictor of generalized anxiety disorder (GAD), with an AUC of 
86% (AUC = 0.86, 95% CI = 0.762-0.950). 




Figure 16 Receiver operating characteristic (ROC) curve for the diagnosis of GAD among the 
500 people seeking HIV testing based on the BAI 
 
Accuracy of the BAI cut-off points. Table 41 shows the sensitivity and specificity values for 
each possible cut-off point on the BAI. The highlighted cut-off point of 21.5 yielded optimal 
sensitivity (0.82) and specificity (0.80).  
  




ROC curve coordinates of the BAI using the SCID as the gold standard 
Cut-off point Sensitivity 1-Specificity Specificity 
-1.0000 1.000 1.000 0.000 
.5000 1.000 0.874 0.126 
1.5000 1.000 0.805 0.195 
2.5000 0.941 0.735 0.265 
3.5000 0.941 0.692 0.308 
4.5000 0.941 0.627 0.373 
5.5000 0.941 0.590 0.410 
6.5000 0.941 0.538 0.462 
7.5000 0.941 0.497 0.503 
8.5000 0.882 0.470 0.530 
9.5000 0.882 0.435 0.565 
10.5000 0.882 0.414 0.586 
11.5000 0.882 0.383 0.617 
12.5000 0.882 0.356 0.644 
13.5000 0.882 0.335 0.665 
14.5000 0.882 0.311 0.689 
15.5000 0.882 0.288 0.712 
16.5000 0.882 0.271 0.729 
17.5000 0.824 0.253 0.747 
18.5000 0.824 0.238 0.762 
19.5000 0.824 0.222 0.778 
20.5000 0.824 0.213 0.787 
21.5000 0.824 0.197 0.803 
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Cut-off point Sensitivity 1-Specificity Specificity 
22.5000 0.765 0.182 0.818 
23.5000 0.765 0.161 0.839 
24.5000 0.765 0.145 0.855 
25.5000 0.765 0.137 0.863 
26.5000 0.765 0.130 0.870 
27.5000 0.706 0.126 0.874 
28.5000 0.647 0.118 0.882 
29.5000 0.647 0.110 0.890 
30.5000 0.588 0.095 0.905 
31.5000 0.529 0.085 0.915 
32.5000 0.529 0.081 0.919 
33.5000 0.529 0.079 0.921 
34.5000 0.529 0.075 0.925 
35.5000 0.529 0.066 0.934 
36.5000 0.529 0.056 0.944 
37.5000 0.412 0.046 0.954 
39.0000 0.353 0.043 0.957 
40.5000 0.353 0.041 0.959 
41.5000 0.176 0.037 0.963 
42.5000 0.176 0.035 0.965 
43.5000 0.176 0.029 0.971 
44.5000 0.176 0.021 0.979 
45.5000 0.176 0.019 0.981 
46.5000 0.176 0.017 0.983 
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Cut-off point Sensitivity 1-Specificity Specificity 
48.0000 0.059 0.017 0.983 
50.5000 0.059 0.014 0.986 
53.0000 0.059 0.012 0.988 
55.0000 0.059 0.010 0.990 
56.5000 0.059 0.008 0.992 
58.5000 0.059 0.006 0.994 
61.0000 0.059 0.002 0.998 
62.5000 0.000 0.002 0.998 
64.0000 0.000 0.000 1.000 
 
Sensitivity, specificity, and predictive values with reference to the optimal cut-off point 
of 21.5. In Table 42, 17 (3.40%) participants of the total sample scored above the optimal cut-off 
point of 21.5 on the BAI. Of these 17 participants, 14 (82.35%) participants also met the diagnostic 
criteria for GAD, so they were true positives. Conversely, of the 17 participants, 3 (17.65%) scored 
below the optimal cut-off point on the BAI, but met the diagnostic criteria for GAD, in other words 
they were false negatives. 
Conversely, 483 (96.60%) participants of the total sample scored below the optimal cut-off 
point of 21.5 on the BAI. Of these 483 participants, 386 (80.00%) did not meet the diagnostic 
criteria for GAD as they were true negatives. However, of the 483 participants, 97 (20.08%) 
participants scored above the optimal cut-off point on the HSCL-25 anxiety subscale, but did not 
meet the diagnostic criteria for GAD, so they were false positives.  
As can be seen in Table 43, the PPV of 13.00% indicates that 13.00% of those participants 
who scored above the optimal cut-off point of 21.5 on the BAI were correctly identified as cases for 
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GAD. The NPV of 99.23% indicates that 99.23% of the participants who scored below the optimal 
cut-off point of 21.5 on the BAI were correctly identified as non-cases for GAD. 
Table 42 










c a+c = 
111 
















Sensitivity, specificity and predictive values of the BAI with reference to the optimal cut-off point of 
21.5 
 Formula  n % 95% CI 
Sensitivity = a / (a+b) 14/17 0.82 82.35% [79.01, 
85.69] 










= d / (b+d) 386/389 0.99 99.23% [98.46, 100] 
 
Screening for alcohol use disorder 
This section reports on the performance of the AUDIT as screening tool for the accurate 
detection of alcohol use disorder (AUD). 
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ROC curve in determining alcohol use disorder based on the AUDIT. Figure 17 displays 
the area under the curve yielded by the ROC analysis. The ROC curve shows that the AUDIT 
performed excellently as a predictor of alcohol use disorder (AUD), with an AUC of 91% (AUC = 
0.91, 95% CI = 0.879-0.933). 
 
Figure 17 Receiver operating characteristic (ROC) curve for the diagnosis of AUD among the 
500 people seeking HIV testing based on the AUDIT 
Accuracy of the AUDIT cut-off points. Table 44 shows the sensitivity and specificity values 
for each possible cut-off point on the AUDIT. The cut-off point of 8.5 yielded the optimal 
sensitivity (0.81) and specificity (0.81). 




ROC curve coordinates of the AUDIT using the SCID as the gold standard 
Cut-off point Sensitivity 1-Specificity Specificity 
-1.0000 1.000 1.000 0.000 
.5000 1.000 0.550 0.450 
1.5000 1.000 0.498 0.502 
2.5000 1.000 0.440 0.560 
3.5000 0.980 0.381 0.619 
4.5000 0.939 0.323 0.677 
5.5000 0.929 0.289 0.711 
6.5000 0.888 0.254 0.746 
7.5000 0.867 0.219 0.781 
8.5000 0.806 0.194 0.806 
9.5000 0.776 0.154 0.846 
10.5000 0.735 0.117 0.883 
11.5000 0.673 0.100 0.900 
12.5000 0.653 0.085 0.915 
13.5000 0.602 0.077 0.923 
14.5000 0.571 0.067 0.933 
15.5000 0.541 0.062 0.938 
16.5000 0.480 0.057 0.943 
17.5000 0.459 0.042 0.958 
18.5000 0.418 0.032 0.968 
19.5000 0.398 0.032 0.968 
20.5000 0.357 0.022 0.978 
21.5000 0.327 0.020 0.980 
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Cut-off point Sensitivity 1-Specificity Specificity 
22.5000 0.316 0.015 0.985 
23.5000 0.265 0.012 0.988 
24.5000 0.235 0.012 0.988 
25.5000 0.194 0.012 0.988 
26.5000 0.102 0.007 0.993 
27.5000 0.082 0.007 0.993 
28.5000 0.071 0.007 0.993 
29.5000 0.051 0.007 0.993 
30.5000 0.031 0.007 0.993 
31.5000 0.020 0.007 0.993 
32.5000 0.010 0.005 0.995 
33.5000 0.010 0.002 0.998 
36.0000 0.000 0.002 0.998 
39.0000 0.000 0.000 1.000 
 
Sensitivity, specificity, and predictive values with reference to the optimal cut-off point 
of 8.5. In Table 45, 98 (19.60%) participants of the total sample scored above the optimal cut-off 
point of 8.5 on the AUDIT. Of these 98 participants, 79 (81.00%) participants also met the 
diagnostic criteria for AUD, so they were true positives. Conversely, of the 98 participants, 19 
(19.39%) scored below the optimal cut-off point on the AUDIT, but met the diagnostic criteria for 
AUD, which means they were false negatives. 
Of the total sample of 500 participants, 402 (80.40%) scored below the optimal cut-off point 
of 8.5 on the AUD. Of these 402 participants, 326 (81.09%) did not meet the diagnostic criteria for 
AUD, so they were true negatives. However, of the 402 participants, 76 (18.91%) participants 
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scored above the optimal cut-off point on the AUDIT, but did not meet the diagnostic criteria for 
AUD, so they were false positives.  
As can be seen in Table 46, the PPV was 51.00%, indicating that 51.00% of those participants 
who scored above the optimal cut-off point of 8.5 on the AUDIT were correctly identified as cases 
for AUD. The NPV of 95.00% indicates that 95.00% of the participants who scored below the 
optimal cut-off point of 8.5 on the AUDIT were correctly identified as non-cases for AUD. 
Table 45 
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Sensitivity, specificity and predictive values of the AUDIT with reference to the optimal cut-off point 
of 8.5 
 Formula  n % 95% CI 
Sensitivity = a / (a+b) 79/98 0.81 81.00% [77.56, 
84.44] 










= d / (b+d) 326/345 0.95 95.00% [93.09, 
96.91] 
 
Odds ratio of alcohol use disorder with regard to past alcohol use disorder compared to 
no past alcohol use disorder. In Table 47, 98 (19.60%) participants of the total sample met the 
criteria for current alcohol use disorder (AUD). Of these 98 participants, 67 (68.37%) also met the 
criteria for past AUD and 28 (28.57%) did not. Conversely, 402 (80.40%) participants of the total 
sample did not meet the diagnostic criteria for current AUD. Of these 402 participants, 110 
participants met the criteria for past AUD and 236 did not.  
As can be seen in Table 48, the odds ratio for past AUD as a risk factor for current AUD was 
5.13 (OR = 5.13, 95% CI= 3.13, 8.43; p = 0.0001). This means that persons who had current AUD 
were more than 5 times more likely to have had past AUD than persons with no current AUD.  
  




Two-by-two table of current AUD vs Past AUD  
Current AUD 
(positive) 
n Current AUD 
(negative) 
N Total 


























Odds Ratio of Current AUD vs Past AUD 
 Formula  OR 95% CI 











 = 5.13 [3.13, 8.43] 
a = Number of exposed cases 
 = participants with current AUD assessed as having past AUD 
b = Number of exposed non-cases 
 = participants with no current AUD assessed as having past AUD 
c = Number of unexposed cases 
 = participants with current AUD not assessed as having past AUD 
d = Number of unexposed non-cases 
 = participants with no current AUD not assessed as having past AUD 
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Summary of the test characteristics of the mood disorders, generalized anxiety, and alcohol 
use disorders 
The results show that 28.40% (95% CI [24.45, 32.35]) of the sample met the diagnostic 
criteria for at least one of CMDs, with no significant difference in the prevalence rates regarding 
gender. Of the sample, 41.20% had elevated levels of distress as assessed with the HSCL-25; 
21.40% scored in the moderate to severe ranges on the BDI, and 13.60% scored in the moderate to 
severe range on the BAI. It is evident that a greater percentage of the sample reported the symptoms 
of depression (21.40%) rather than anxiety (13.60%). The results also demonstrated that the 
Hopkins Symptom Checklist (HSCL-25), HSCL-Depression and anxiety-subscales, BDI, BAI, and 
AUDIT were effective in identifying major depressive, persistent depressive, generalized anxiety, 
and alcohol use disorder. However, a high number of false positive cases was identified for these 
scales and a specificity rate of 100% would be ideal to avoid false positive cases (Sheehan and 
McGee, 2013). For the present study, the specificity rates for most of the scales were further from 
100% and yielded high false positives. Notably, the AUDIT had a lower proportion of false 
positives compared to the other scales. A possible reason may be that the specificity of 81% for the 
AUDIT was higher than those for the other scales. Lastly, it is noteworthy that past MDD and past 
AUD were highly effective risk factors for current MDD (OR = 9.24; 95% CI= 5.34, 16.00) and 
current AUD (OR = 5.13; 95% CI = 3.13, 8.43), respectively. These results are discussed in more 
detail in the next chapter. 
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Chapter 5: Discussion 
Introduction 
The present chapter discusses the prevalence and the symptomatology of major depression, 
past major depression, persistent depressive, generalized anxiety, and alcohol use disorder in the 
context of the existing literature. Thereafter, a discussion on the performance of the self-report 
measures as screening tools for psychological distress, major depressive, persistent depressive, 
generalized anxiety, and alcohol use disorder against the structured clinical interview for the DSM 
(SCID) as gold standard is presented. The chapter ends with a brief summary of the main findings 
of the research.  
The prevalence of common mental disorders compared to previous studies 
The prevalence of any diagnosis compared to previous studies. The findings of the SCID 
data demonstrate that 28.40% of the sample of individuals seeking HIV testing were diagnosed with 
at least one common mental disorder (CMD). In the current study, no significant differences were 
found in the prevalence of CMDs with regard to gender. Similarly, among South African HIV-
infected individuals no significant gender differences were found in the prevalence of mood 
disorders when using the MINI International Neuropsychiatric Interview (MINI) (Olley et al., 
2003). However, Olley et al. (2003) report that more females were likely to have a significant 
diagnosis of PTSD than males (x2 = 5.18, df = 1, p = 0.02). These authors also found that compared 
to females, males were more likely to have met the diagnostic criteria for alcohol abuse (x2 = 24.56, 
df = 1, p < 0.001) or alcohol dependence (x2 = 16.08, df = 1, p < 0.001) (Olley et al., 2003). No 
significant differences were found between employment and unemployment and the prevalence 
estimates of current MDD, current and past AUD, except for past MDD, PDD and MIDD. 
Surprisingly, these results are different from those in the general population, which showed that the 
unemployed had significantly higher rates of psychopathology (Jenkins, Mbatia, Singleton, & 
White, 2010). I also found no significant association between Afrikaans and English speakers and 
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the rate of CMDs, except for MIDD and current AUD. This finding is in contrast with a study done 
by Spies et al. (2009), where the prevalence rates for psychiatric disorders were higher for 
Afrikaans-speaking individuals across all disorders. Spies et al. (2009) speculated that Afrikaans-
speaking individuals may have been more comfortable speaking about emotional symptoms. 
Furthermore, the most common mental disorder found among the present sample was past alcohol 
use disorder (35.40%), followed by current alcohol use disorder (19.60%), past major depression 
(18.20%), current major depression (14.40%), persistent depressive disorders (7.20%), generalized 
anxiety disorder (3.40%) and medication-induced depressive disorder (0.80%).  
The prevalence rates estimated in the present study are higher than those reported in the South 
African Stress and Health (SASH) study using the CIDI (Herman et al., 2009). In this nationally 
representative study conducted in the general population, the overall prevalence of any mental 
disorder was 16.5%, among which 11% had only one disorder. In the SASH study, the 12-month 
prevalence of MDD was estimated at 4.9%, followed by alcohol abuse (4.5%), GAD (1.4%), 
alcohol dependence (1.2%) and PTSD (0.6%) (Herman et al., 2009). Conversely, the prevalence 
rates in the current sample were lower than among South African HIV-infected individuals using 
the MINI (Olley et al., 2003). Olley et al. (2003) reported that 56% of patients were diagnosed with 
a mental disorder. These authors further reported that major depression (34.9%), dysthymic disorder 
(21.5%), post-traumatic stress disorder (14.8%), and alcohol dependence were most common 
(10.1%) (Olley et al., 2003). The high rates of CMDs among people seeking HIV testing compared 
to the CIDI rates in the general population may have several reasons. It is likely that individuals 
going for an HIV test may have experienced significant distress, which is in keeping with the study 
by Sahay et al. (2007). The individuals may also have been engaging in high-risk behaviours that 
encouraged them to go for an HIV test (Sahay et al., 2007). The higher MINI rates, on the other 
hand, may be attributable to the increased association between HIV and CMDs due to the continued 
stigma of HIV and poverty (Myer et al., 2008). 
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The prevalence rates of CMDs reported in the present study also exceeded those reported 
among an American general population sample of men and women in the National Comorbidity 
Survey Replication (NCS-R). In the NCS-R, for any disorder the sample reported a 12-month 
prevalence rate of 26.6%, while 14.4% of the sample met the diagnostic criteria for at least one 
disorder (Kessler et al., 2005). Kessler et al. (2005) found that the 12-month prevalence of specific 
phobia was 8.7%, followed by social phobia (6.8%), and major depressive disorder (6.7%). These 
authors also reported lower prevalence rates than the current study for generalized anxiety disorder 
(3.1%), alcohol abuse (3.1%), alcohol dependence (1.3%) and dysthymia (1.5%) (Kessler et al. 
2005). Therefore, it appears that the prevalence of CMDs among the sample of HIV test seekers in 
this study was higher than that found among both USA and South African general population 
samples (Kessler et al., 2005; Herman et al., 2009). 
The wide variability in the rates of CMDs, such as MDD, PDD, GAD and AUD, can be 
attributed to several factors. These factors include methodological challenges in assessing CMDs. 
For example, the SCID-5 is time-consuming and has to be administered by a trained healthcare 
professional (APA, 2014). The CIDI and MINI, on the other hand, are diagnostic interviews 
administered by non-specialized interviewers (Lecrubier et al., 1997). Furthermore, different 
population groups of interest were included, whether the study population consisted of individuals 
living with HIV or individuals seeking HIV testing.  
The prevalence of specific diagnosis compared to previous studies 
The prevalence of major depression. The prevalence of major depressive disorder (MDD) 
obtained in this study was 14.40% among persons seeking HIV testing. The observed prevalence of 
the present study was also comparable to that of 8.1% reported by Kinyanda et al. (2011) in 
Uganda, 11.4% reported by Adewuya et al. (2007) in Nigeria, 14% reported by Myer et al. (2008) 
in South Africa, and 11.1% reported by Freeman et al. (2007) in South Africa. All four studies 
mentioned above were conducted in sub-Saharan Africa among HIV-positive patients and used 
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structured clinical interviews, such as the CIDI and MINI, to make a diagnosis of MDD. However, 
other studies undertaken in both South Africa and Uganda using structured clinical interviews such 
as the MINI and the CIDI among HIV/AIDS samples, reported rates of MDD as high as 40.0% 
(Olley et al., 2006; Nakimuli-Mpungu, & Munyaneza, 2011).  
Similar results were found among an American end-stage renal disease (ESRD) sample using 
the SCID (Hedayati et al., 2006). Hedayati et al. (2005) reported the prevalence of a depressive 
disorder to be 26.5% and the prevalence of MDD as 17.3%. The prevalence of MDD in patients 
with HIV/AIDS in the USA was 72.9% using the SCID (Berger-Greenstein et al., 2007). Berger-
Greenstein et al. (2007) and other researchers (e.g. Rabkin et al., 2000; Atkinson et al., 1988; Dew 
et al., 1997) argue that demographic or behavioural factors such as socio-economic factors, gender, 
intravenous drug use and traumatic exposure to things other than HIV increases the vulnerability to 
mental illness. For example, the available evidence suggests that the prevalence of major depression 
was found to be highest among those at the lowest socio-economic levels (Bhagwanjee et al., 1998).  
In addition, in keeping with previous research, past major depression was 18.2%. For 
example, among newly diagnosed breast cancer patients in the USA, the prevalence of a history of 
MDD on the SCID was 20% (Palmer et al., 2012). Moreover, evidence gathered from this study 
suggests that lifetime history of major depression (past major depression) increases the likelihood of 
current major depression prior to HIV testing. Similarly, even though different samples were used, 
Kagee and Martin (2010) reported that lifetime history of depression augmented the odds of 
depression following an HIV diagnosis. Furthermore, no research on major depression among 
persons seeking HIV testing in South Africa using diagnostic interviews was available. However, 
the baseline study of 242 women (Rochat et al., 2006) found high rates of depressed mood (41%) 
among individuals coming for HIV testing using the EPDS screening measure.  
The prevalence of persistent depressive disorder. The prevalence found for PDD (7.20%) 
in this sample was higher than that found in the SASH study (Willams et al., 2007). For example, 
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Williams et al. (2007) found PDD (dysthymia) rates of 0.7% among 4351 South African adults in 
the general population using the WMH-CIDI. This finding was important as there was increasing 
evidence that PDD may cause significant somatic, social and occupational impairment (Weissman 
et al., 1988; Friedman, 1993, Leader & Klein, 1996; Browne et al., 1999). However, the baseline 
prevalence of PDD among 149 HIV-positive South African individuals using the MINI was higher 
than that of the current study (Olley et al., 2006). Olley et al. (2006) report that 21.5% of their 
sample were diagnosed with PDD. At the follow-up visit six months after the baseline assessment, 
the prevalence rate of PDD (3.1%) was much lower than that of the current study (Olley et al., 
2006). In the USA among newly diagnosed breast cancer patients using the SCID, the prevalence of 
PDD (2%) was lower than the current prevalence rate (Palmer et al., 2012). The differences in 
prevalence rates can be attributed to the differences in the socio-economic statuses of the 
individuals and the discrepancies in the measuring instruments used. Furthermore, no research on 
PDD among people seeking HIV testing was available in South Africa.  
The prevalence of generalized anxiety disorder. As mentioned previously, the prevalence 
of GAD in the current study (3.40%) was higher than among the sample of South African adults in 
the SASH study, which was 1.4%. On the contrary, Olley et al. (2006) found higher GAD rates 
among HIV-positive individuals at both baseline (6.7%) and the six-month follow-up (6.2%) visits, 
compared to the current study of 3.4%. Similarly, the prevalence rate found in existing research on 
GAD among adults in the Western Cape, South Africa, was higher (6.0%) than that of the current 
study (Kleintjes et al., 2006).  
The prevalence of GAD (3.4%) in the current study was consistent with the prevalence rate 
found among breast cancer patients in the USA (3.0%) using the SCID (Palmer et al., 2012). On the 
other hand, SCID diagnoses revealed an even higher rate of GAD of 30% among 288 women in the 
USA (Eack et al., 2008). Higher prevalence rates of GAD (14%) compared to the current study was 
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found among 193 adults recruited from anxiety research and treatment centres in the USA (Leyfer 
et al., 2006). 
A possible explanation for the differences in prevalence rates may be due to the inclusion of 
diverse population groups of interest (i.e. general population, PLWH, specific gender groups, etc.) 
compared to the current population of interest (i.e. individuals seeking HIV testing). Also, no 
studies were found among people seeking HIV testing. 
The prevalence of alcohol use disorder. Studies in South Africa found that the prevalence of 
alcohol use disorders (alcohol abuse and alcohol dependence) in PLWH, which ranges between 7% 
and 12.9%, was lower than that of the current study (19.80) (Olley et al., 2003; Freeman et al., 
2007; Myer et al., 2008). Similarly, 7.8% of HIV-positive individuals in western Uganda met the 
diagnostic criteria for alcohol abuse (7.8%) were found among HIV-positive individuals in western 
Uganda (Nakimuli-Mpungu, & Munyaneza, 2011). However, higher AUD estimates (62%) were 
found among shebeen patrons in the Western Cape, South Africa, using the Alcohol Use Disorder 
and Associated Disabilities Interview Schedule DSV-IV Version (AUDADIS-IV) (Scott-Sheldon et 
al., 2014). Although the rates of AUD in the current sample were not significantly different with 
regard to gender, within other samples men most likely have a higher prevalence of AUD than 
women. For example, in a South African study among HIV-infected individuals, the rate of male 
alcohol dependence was 22.7%, while the rate of female alcohol dependence was 4.7% (Olley et al., 
2003).  
Furthermore, the prevalence of alcohol use disorder (AUD) (19.6%) among persons seeking 
HIV testing was comparable to the prevalence (18.2%) found among bipolar patients in a university 
hospital in Malaysia using the MINI (Hway et al., 2013). Results from another international study 
found a lower rate of alcohol dependence (10.1%) in PLWH (Sullivan et al., 2008). Research 
concerning the prevalence of AUDs among people seeking HIV testing was scarce in the literature.  
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Self-reported symptoms of psychological distress, depression, anxiety and alcohol use 
disorders 
Reliability of the scales: The results indicated that all four scales, the HSCL-25, BDI, BAI, 
and AUDIT, have excellent reliability with alpha coefficients ranging from 0.89 to 0.95. 
Consequently, the items in each of the scales displayed excellent internal consistency. Previous 
studies also demonstrated high internal consistencies for these scales (Kagee, 2008; Kagee & 
Martin, 2010; Steele & Edwards, 2008).  
Self-reported psychological distress. More than a fourth (41.20%) of the sample fell in the 
clinically significant range on the HSCL-25. The finding suggests that a significant percentage of 
the sample may have experienced clinically significant psychological distress. Similarly, in other 
South African studies, 38.5% of patients living with hypertension and diabetes and 52.9% of 
individuals receiving care for HIV scored in the elevated range on the HSCL-25 (Kagee & Martin, 
2010). Likewise, Antelman et al. (2007) reported that 57% of their sample of HIV-infected 
individuals fell in the clinically significant range on the HSCL-25. These datasets indicate that both 
HIV-infected individuals and patients living with diabetes and hypertension were not significantly 
more distressed than those individuals seeking HIV testing.  
However, only 14.2% of South African former political detainees scored above the cut-off 
point of 44 on the HSCL-25 (Kagee, 2005). In a study conducted by Coyne et al. (2004) among 113 
female breast cancer patients, 29.2% of the sample scored above the HSCL-25 cut-off point of 44. 
A possible explanation for the lower rates of distress evident in the study by Coyne et al. (2004) 
may be because over half of the sample (52%) received psychotropic medication during the course 
of their treatment.  
The prevalence of distress in the current sample was also higher than that found among 
international samples (Zabora et al., 2001; Trask; 2004; Palmer et al., 2012). For example, among 
newly diagnosed breast cancer patients in the USA, the prevalence of distress was 33% using the 
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HSCL-25 (Palmer et al., 2012). Therefore, these rates of distress were lower than that found in the 
present study.  
It is further assumed that there were several reasons for the high rate of psychological distress 
among the sample in the current study. For example, most of the individuals in the sample lived 
under poor socio-economic conditions, which suggests that distress may be due to poverty and other 
related factors such as unemployment. The distressing nature of living in poverty was in keeping 
with a previous study by Kagee (2005), suggesting that distress among former detainees may be due 
to circumstantial factors such as unemployment and a lack of social development in post-apartheid 
society.   
Symptoms of depression. The BDI has been used in various epidemiological studies, but the 
present study is to my knowledge the first to use it among people seeking HIV testing. On the BDI, 
the average score (16.20) of the sample, which was similar to that of Kagee, Nel and Saal (2014), 
fell in the mild depression range. Nevertheless, 21.40% of the sample fell in the moderate to severe 
range on this measure, suggesting that a considerable percentage of the sample may have endured 
clinically significant depression. This finding was in keeping with a study by Kagee (2008) 
conducted among their sample of patients living with a chronic illness. Kagee (2008) indicates that 
19.8% of the sample scored in or above the moderate range on the BDI. This study emphasizes that 
depressive symptoms are common and that these symptoms have an adverse effect on the 
individual’s quality of life.  
The reporting of high levels of depressive symptoms in South Africa and other samples were 
also common in the literature. For instance, Kagee and Martin (2010) indicate that among HIV-
infected patients in South Africa, 37.6% of the sample fell in the moderate range on the BDI. 
Research with patients receiving antiretroviral treatment in South Africa by Nel and Kagee (2013) 
also indicates that 40.4% of the participants scored in or above the moderate to severe range on the 
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BDI II. Mkize et al. (1998) report depressive symptoms of 53%, suggesting mild to moderate 
depression among university students who made use of clinic services on the BDI.  
Even though the prevalence of depressive symptoms in this study was in keeping with other 
South African studies, the majority of aforementioned studies have screened HIV-infected 
individuals for depression, rather than HIV test seekers. Very few studies have assessed depressive 
symptoms prior to HIV testing. For instance, Ramirez-Avila et al. (2012) found that 55 % of their 
sample of people seeking HIV testing in Durban, South Africa, had depressive symptoms using a 
domain of the SF-36, namely the five-item Mental Health Index (MHI-5). Cholera et al. (2014) 
indicate that among their sample of HIV test seekers in Johannesburg, South Africa, 32 % of the 
study sample reported no depression; 18 % had moderate depression; 5 % had severe depression; 
and 1 % had very severe depression when measured using the PHQ. Furthermore, high rates of 
depressed mood were found among 242 women coming for HIV testing in Kwa-Zulu Natal, South 
Africa, using the EPDS (Rochat et al., 2006). In addition, among HIV test seekers at a Voluntary 
Counselling and Testing (VCT) facility in Pune, India, the rates for depression was 45% using the 
Hospital Anxiety and Depression scale (HADS) (Sahay et al., 2007).  
The varied prevalence rates may be due to diverging measurement tools. For example, the 
MHI-5, PHQ, and EPDS were used to determine depression prior to an HIV diagnosis in diverse 
settings in South Africa and India, compared to the BDI in the current study. Even though these 
measurement tools were used to determine the elevated levels of depressive symptoms, different 
cut-off scores were utilized. Nonetheless, the diverse prevalence rates of depressive symptoms 
highlight that efforts are needed to combine depression and mental health screening at the time of 
HIV testing and diagnosis.  
Symptoms of anxiety. The mean total score (12.58) of the BAI fell in the range of minimal 
anxiety. However, a minority (13.60%) of the sample scored in the moderate to severe range, 
suggesting that anxiety was definitely a concern for these individuals. The data further suggests that 
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for these individuals it was possible that anxiety may have been generated by the prospect of 
undergoing an HIV test. This finding was in keeping with those of previous studies that found 
elevated levels of anxiety (19.5%) among South Africans living with HIV (Kagee, Coetzee, Saal, & 
Nel, 2015). Furthermore, among Ghanaian undergraduate students, the mean score of the BAI was 
17.6, suggesting mild to moderate anxiety (Krafona, 2014). Krafona (2014) also reported that 
20.8% of his sample scored in the severe range on the BDI due to the financial pressures these 
students may experience to pay for accommodation, food, etc. Even among 133 adults recruited 
from an anxiety and treatment centre in the USA, the mean score of the BAI was 12.3 (i.e. minimal 
anxiety) (Leyfer, Ruberg, & Woodruff-Borden, 2005). 
Conversely, higher estimates of anxiety symptoms (28.7%) were found among South African 
antiretroviral therapy users (Nel, & Kagee, 2013). Sahay et al. (2007) also report high rates of 
anxiety (62%) among VCT attendees coming for HIV testing in Pune, India using the HADS 
(Sahay et al., 2007). A possible explanation for these high rates might be that the South African 
sample included HIV-positive individuals whereas the current sample included HIV test seekers. 
Furthermore, the Indian sample made use of a different measuring tool, namely the HADS, whereas 
the current study made use of the BAI to screen for anxiety. No South African literature regarding 
the symptomatology of anxiety disorders among people seeking HIV testing exists.  
Symptoms of alcohol use disorder. For this study, 34.60% of the sample scored at the 
clinically significant cut-off score of ≥8 on the AUDIT, implying hazardous or harmful drinking 
and possible alcohol dependence. This finding was consistent with findings from a study that 
reported that just under half of all participants (46.0%) fell in the clinically significant range on the 
AUDIT (Kader, Govender, Seedat, & Parry, 2015).  
In contrast to previous studies, the prevalence of hazardous and harmful use of alcohol was 
much higher among PLWH in sub-Saharan Africa, where hazardous and harmful use of alcohol 
range between 2.6% to 24.3% (Farley et al., 2010; Yunusa, Obembe, Ibrahim, & Njoku, 2011; Do 
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et al., 2010; Sebit et al., 2003). In comparison with the current study, studies in South Africa have 
reported lower rates of alcohol abuse and dependence among PLWH, ranging from 7% to 12.9% 
(Olley et al., 2003; Myer et al., 2007; Freeman, Nkomo, Kafaar, & Kelly, 2007). These 
discrepancies can partly be explained by diverse settings. Although hazardous and harmful use of 
alcohol was prevalent among HIV-infected individuals, no literature among individuals seeking 
HIV testing was found.  
Comparison of the SCID data vs the self-report data 
For this study, the rates of the common mental disorders, which include major depression, 
persistent depressive, generalized anxiety and alcohol use disorder, rates were higher on the self-
report measures than the clinical interview method. This finding was consistent with previous 
research (Coyne et al., 2000; Lustman et al., 2001). For example, Lustman et al. (2001) found that 
11.4% of their sample had a depressive disorder using diagnostic interview methods, while 31.0% 
had elevated depressive symptoms using self-report instruments. Therefore, screening for CMDs 
prior to the receipt of an HIV test result should be considered to help inform health care providers 
about the risk of untreated CMDs (Halverson & Chan, 2004). As reported by Halverson and Chan 
(2004), the advantages of routine screening include cost-effectiveness and enhanced quality of life. 
A criticism on routine screening includes the over-detection of CMDs (Coyne at al., 2000), which 
can lead to the incorrect treatment of healthy individuals. 
The performance of self-report measures in comparison to the gold standard in the context of 
previous studies 
In addition to establishing the prevalence and symptomatology of the above-mentioned 
CMDs, the study examined the screening characteristics of the HSCL-25, BDI, BAI, and AUDIT 
with respect to the SCID interview.  
The performance of the HSCL-25 in predicting depression and anxiety. For this study, 
the area under the curve (AUC) result of 0.85 in predicting MDD was in keeping with area under 
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the curve scores among other samples. For example, among HIV-positive pregnant women in 
Tanzania, the AUC of the total HSCL-25 in predicting MDD was 0.86 (0.86, 95%CI = 0.72-0.99) 
(Kaaya et al., 2002). The optimal cut-off point (51.5) on the total HSCL-25 and yielding optimal 
sensitivity (0.79) and specificity (0.78) was higher than the cut-off point reported among HIV-
positive pregnant women in Tanzania of 1.06 (Kaaya et al., 2002). It therefore appears that the 
optimal cut-off point of the current study was effective at identifying non-cases of MDD and true 
cases of MDD among individuals seeking HIV testing.  
This study also indicated that the total HSCL-25 was an adequate screening tool for 
diagnosing PDD with an area under the curve value of 0.82. However, results from the study 
performed in Eastern Afghanistan among primary care patients demonstrated an area under the 
curve value of 0.73 with respect to a gold standard semi-structured psychiatric interview, the 
Psychiatric Assessment Schedule (PAS) (Ventevogel et al., 2007). The optimal cut-off point for 
detecting PDD of 54.5 yielding the best sensitivity and specificity values was higher than the cut-off 
point of 2.0 in the study done by Ventevogel et al. (2007). Given this finding, it appears that the 
optimal cut-off point of 56.5 was very useful in identifying cases and non-cases of PDD among the 
population of interest.  
Findings from the current study further indicate that the total HSCL-25 was an adequate 
screening tool for GAD caseness and non-caseness with an AUC of 0.87. This AUC was higher 
than that found among a Norwegian general population (AUC = 0.78) (Sandanger et al., 1998). 
Despite this difference in AUC values, both studies indicated that the total HSCL-25 has 
moderately high accuracy (Swets, 1988) in identifying generalized anxiety disorder. In addition, the 
optimal cut-off point of 54.5, which was higher than that found by Sandanger et al. (1998), resulted 
in acceptable sensitivity (0.77) and specificity (0.77). (1998). Nevertheless, evidence from this 
study and others (Sandanger et al., 1998) suggests that the optimal cut-off point was useful at 
distinguishing cases from non-cases of generalized anxiety disorder among HIV test seekers.  
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Findings from this study further show that the total HSCL-25 yielded high negative 
predictive values for MDD (0.96), PDD (0.99), and GAD (0.99) and low positive predictive values 
when identifying MDD (0.38), PDD (0.22) and GAD (0.10). Therefore, as was also the case with 
other samples (Veijola et al., 2002), it appears that individuals scoring below the optimal cut-off 
point may indeed be regarded as true non-cases. Conversely, the low positive predictive values 
suggest that a high number of false positive cases may have been captured. These low positive 
predictive values therefore limit the effectiveness of the HSCL-25 in identifying depression and 
anxiety disorders in this population of interest.  
In summary, the findings in the current study indicate that the total HSCL-25 may correctly 
be used as a screening instrument for MDD, PDD, and GAD among South African community 
samples, in this case individuals seeking HIV testing. However, the low positive predictive values 
indicated that the total HSCL-25 had difficulties with case over-identification. Therefore, those 
individuals who scored below the cut-off point on the total HSCL-25 may indeed be true non-cases, 
while those who scored above the optimal cut-off point may benefit from follow-up assessments 
where they undergo a diagnostic interview to establish whether they meet the diagnostic criteria for 
MDD, PDD and GAD. Given that the HSCL-25 cannot be used as the only method to gather 
diagnostic information, the HSCL-25 does appear to be sensitive in detecting individuals with 
MDD, PDD and GAD, and may be useful as an initial screening measure. 
The performance of the subscales of the HSCL-25 in predicting depression and 
anxiety. The comparable area under the curve estimates for the total HSCL-25 (0.85) and the 
depression subscale of the HSCL-25 (0.86) suggest that both screening tools had moderately high 
accuracy (Swets, 1988) in detecting MDD and PDD. Correspondingly, Kaaya et al. (2002) showed 
that the depression subscale demonstrated a comparable accuracy to the total HSCL in identifying 
MDD. The optimal cut-off points for detecting major depression using the HSCL depression 
subscale and the total HSCL-25 were 51.5 and 32.5, respectively. Conversely, a slightly lower area 
under the curve value (0.74) was reported among primary care patients in Afghanistan, yielding an 
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optimal cut-off point of 1.75 (sensitivity of 0.84, specificity of 0.48) (Ventevogel et al., 2007), 
suggesting that the depression subscale of the HSCL-25 was limited in detecting major depression. 
These authors argued that among Afghan primary patients, the cultural differences between men 
and women are vast, therefore men have a tendency to under-report mental distress (Ventevogel et 
al., 2007).  
Even the anxiety subscale of the HSCL-25 was satisfactory in predicting GAD caseness and 
non-caseness (AUC = 0.88). Similarly, the anxiety subscale for males in the longitudinal Lungby 
study in a Swedish population yielded an AUC value of 0.85, suggesting that the anxiety subscale 
of the HSCL-25 may be of some use for identifying anxiety disorders (Mattison, Borgen, & 
Horstmann, 2013). The anxiety subscale of the HSCL-25 also performed reasonably well for men 
(AUC = 0.81) in primary care settings in Afghanistan compared to women (AUC = 0.65) 
(Ventevogel et al., 2007). These authors found that the area under curve value for their sample was 
0.61 and yielded an optimal cut-off score of 2 (sensitivity of 0.75, specificity of 0.43), suggesting 
that the anxiety subscale of the HSCL-25 was limited in discriminating between anxiety caseness 
and non-caseness (Ventevogel et al., 2007). As mentioned previously, a contributing factor to this 
poor performance of the anxiety subscale in the Afghan primary care patients was the cultural 
difference between men and women as men tend to under-report mental distress (Ventevogel et al., 
2007).  
In summary, the depression and anxiety subscales of the HSCL-25 did not improve the 
prediction of depression or anxiety compared to the total HSCL-25. This is noteworthy because 
theoretically a cluster of symptoms should be the more crucial focus of depression and anxiety. 
These results were in keeping with the findings of Sandinger et al. (1998) when using the HSCL-25 
against the CIDI. Furthermore, the high negative and low positive predictive values obtained using 
the subscales of the HSCL-25 in the present study revealed that when used in a population context, 
these scales miss fairly few cases of persons meeting diagnostic criteria of CMDs, but they may 
represent a high number of false positive cases. The findings suggest that the subscales of the 
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HSCL-25 can be used as a proxy in identifying depression and anxiety, but have difficulties with 
case over-identification. Therefore, it appears that those individuals who scored above the optimal 
cut-off point of the subscales of the HSCL-25 may benefit from a more extensive follow-up 
assessment.  
The performance of the BDI in predicting depression 
The screening performance of the BDI was adequate among the sample of HIV test seekers 
in this study. The AUC statistic of 0.77 indicated that persons who have MDD are 67.00% more 
likely to have an elevated total score on the BDI than those who do not have MDD. The BDI was 
similar to other samples in its ability to discriminate between MDD caseness and non-caseness. For 
example, among cardiology inpatients the BDI yielded an AUC of 0.83 (CI: 0.75; 0.89) (Forkmann 
et al., 2009). The Spanish version of the BDI yielded a somewhat higher AUC of 0.99 and with a 
cut-off point of 12/13 obtained 100% sensitivity, 99% specificity and a positive predictive value of 
0.72 (Lasa et al., 2000). Viinamaki et al. (2004) found that for a diagnostic cut-off point of 14/15, 
the BDI was able to identify 85% of individuals who were diagnosed by the SCID accurately as 
having a major depressive episode. The findings suggest that the BDI was a useful screening 
measure in the contest of routine HIV testing to reveal which individuals need follow-up 
psychological assessment and possible treatment for MDD. 
Furthermore, the BDI was found to be a useful screening tool in discriminating between 
persistent depressive disorder (PDD) caseness and non-caseness. The AUC of 0.82 indicated that 
persons who have PDD are 75.00% more likely to have an elevated score on the BDI than those 
who do not have PDD. These results were in keeping with findings by Eack et al. (2008) (AUC = 
0.83). These authors also found that those persons who scored above an optimal cut-off point of 18 
on the BDI, identified 88% of true cases of dysthymic disorder and over-identified 33% of assessed 
cases (Eack et al., 2008).  
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It is also important to note that those participants who scored below the optimal cut-off point 
of 23.3 on the BDI were accurately identified as not having PDD. The PPV of 0.20, on the other 
hand, indicates that the BDI was significantly less effective in predicting PDD caseness. The PPV 
(0.20) of the BDI suggests that individuals would need to be followed up with more intensive 
assessment. However, the fact that the sensitivity and the NPV were high, indicate that very few 
cases would go undetected using the BDI.  
Given that the BDI showed good sensitivity for MDD and PDD respectively, they can be 
considered as possible diagnostic tools for these disorders at primary care facilities. However, the 
low positive predictive values suggest that it would be more appropriate to identify persons who 
could benefit from follow-up assessment, where they would undergo a diagnostic interview to 
determine whether they meet the diagnostic criteria for MDD and PDD. 
Those individuals who have met the diagnostic criteria for MDD and PDD can be referred for 
treatment. However, it is assumed that properly trained healthcare workers are available to receive 
referrals. Therefore, routine screening can be recommended at the five non-government 
organizations (NGO’S) that formed part of this study. Routine screening may also be required for 
all testing sites in South Africa, not only at the above-mentioned testing sites.  
The performance of the BAI 
As a screening tool, the BAI performed excellently as a predictor of GAD caseness and non-
caseness (AUC = 0.86). This area under the curve value was higher than that found among 
insomnia patients in the USA, suggesting that the BAI has moderately high accuracy (Swets, 1988) 
in identifying generalized anxiety disorder (Carney, Moss, Harris, Edinger, & Krystal, 2011). 
Carney et al. (2011), for example, found an area under the curve value of 0.71, indicating that the 
BAI is useful screening measure in identifying anxiety disorders. The best cut-off point that yielded 
optimal sensitivity (82%) and specificity (80%) values was 21.5, suggesting that the cut-off point 
was suitable for identifying generalized anxiety disorder cases and non-cases among HIV test 
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seekers. For this study, the optimal cut-off point of 21.5 was higher than the optimally efficient BAI 
cut-off point of 12 found by Eack et al. (2008), where sensitivity and specificity are both as high as 
possible (Eack et al., 2008). Eack et al. (2008) reported that at a cut-off point of 12, both sensitivity 
and specificity values were somewhat low. A possible reason be that the BAI under-identified 30% 
of the cases and over-identifying nearly 25% of these cases. Conversely, Carney at al. (2011) 
suggest that a BAI clinical cut-off point of 16 resulted in very low sensitivity (0.50) but acceptable 
specificity (0.78), indicating that the clinical cut-off point was good at identifying non-cases rather 
than detecting anxiety disorders among insomnia patients in the USA.  
For the current study, the PPV of 13.00% indicated a high number of false positive cases 
(20.08%) for the optimal cut-off point of 21.5. This low positive predictive value limit the 
performance of the BAI in detecting GAD. 
The performance of the AUDIT 
As a screening instrument using an optimal cut-off point of 8.5, similar to traditional cut-off 
points for discriminating between AUD caseness and non-caseness, the AUDIT showed excellent 
sensitivity (0.81) and specificity (0.81). In addition, the negative predictive value (95.00%) in the 
current study was high, while the positive predictive value was fair (51.00%), indicating that few 
cases would be missed during screening. However, among Nigerian university students, the cut-off 
point of 5 and above yielded higher sensitivity (0.94), specificity (0.92), positive predictive (0.89), 
and negative predictive (0.95) values (Adewuya, 2005). For a study with a similar cut-off point of 8, 
the AUDIT had a sensitivity of 61% and a specificity of 90% for a current alcohol use disorder 
(Barry, & Fleming, 1993). Although a different measuring instrument was used, the findings were 
consistent with the results reported by Breuer et al. (2014). These authors report high sensitivity 
(93.8%) and specificity (85.3%) values among PLWH in South Africa using the substance abuse 
and mental illness symptom screener (SAMISS) against the MINI as gold standard. Therefore, the 
AUDIT was an excellent tool for predicting alcohol use disorders in persons seeking HIV testing. 
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However, the use of the AUDIT was not without challenges. The modest PPV in this study 
indicated that cases were over-detected by the AUDIT. Therefore, those participants who scored 
above the optimal cut-off point of 8.5 on the AUDIT could benefit from follow-up assessment, 
where they would undergo a comprehensive diagnostic interview to determine whether or not they 
meet the diagnostic criteria for AUD.  
Summary of findings 
High prevalence rates of MDD (14.4%), PDD (7.2%), GAD (3.4%), and AUD (19.6%) were 
found among the sample prior to the receipt of an HIV test result. It appears that the prevalence of 
CMDs is higher among people seeking HIV testing, compared to the general population. This may 
be due to the different population groups of interest included, which consisted of individuals living 
with HIV or seeking an HIV test result.  
Evidence from this study and others (Coyne et al., 2000; Lustman et al., 2001) suggests that 
elevated levels of psychological distress (41.2%), moderate to severe depression (21.0%), moderate 
to severe anxiety (13.6%) and hazardous alcohol use (34.6%) were common among the sample. 
Notably, the findings demonstrate that the screening instruments yielded higher prevalence rates 
than the structured diagnostic interview, in this case the SCID, which is in keeping with previous 
research (Coyne et al., 2000; Lustman et al., 2001). A plausible explanation may be that a highly 
trained and expert interviewer using clinical judgement can use probes to determine whether a 
symptom is really present at the threshold level or not, while participants checking response options 
on a self-report checklist cannot. On the self-report measure, the participant usually checks the 
severity of the item, which is consistent with the symptom and a total score is assessed. In this case, 
no clinical judgement is applied.  
In the settings where the present study was conducted, screening tools were sensitive enough 
to reflect the severity of the common mental disorder. Although the depression subscale (AUC = 
0.85) and the anxiety subscale (AUC = 0.88) of the HSCL-25 were found to be able to identify 
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CMD caseness and non-caseness, the subscales did not improve the predictive abilities of the total 
HSCL. The high negative and low positive predictive values found in the present study suggest that 
when used in a population context, these scales miss relatively few cases of persons meeting 
diagnostic criteria of CMDs, but they may capture a high number of false positive cases. A possible 
reason for the high false positive cases may be that the specificity values are low. As reported by 
Sheehan and McGee (2013), a specificity value of 100% would have been ideal to circumvent false 
positive cases. Therefore, these scales perform well in screening and in epidemiological research. 
More accurate methods are needed for diagnostic purposes. For example, Eack et al. (2008) suggest 
a two-tiered approach. The two-tiered diagnostic approach involves screening people to identify 
who scored above and below the cut-off point. Those individuals who scored below the cut-off 
point are true non-cases. Those individuals, on the other hand, who scored above the cut-off point 
should be further assessed using a clinical diagnostic interview, the SCID, to determine whether 
they are a true case for a CMD. Subsequently, those who are considered a case may be referred for 
treatment (Eack et al., 2008). In the next chapter the strengths, limitations, as well as 
recommendations for practice and research are presented. 
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Chapter 6: Conclusion 
Study strengths 
The study has specific strengths. First, the research provides high rates of CMDs among 
individuals seeking HIV testing, which can guide decisions about which psychological interventions 
would help alleviate symptoms of CMDs.  
Second, the use of the gold standard assessment in identifying CMD caseness, specifically the 
SCID-RV, contributes to the body of knowledge regarding HIV and mental health research, which 
is scarce. In addition, to my knowledge this is one of the first studies in the world utilizing the 
structured clinical interview for the DSM-5 (SCID-5). Previous studies made use of the structured 
clinical interview for the DSM-IV (SCID-4). One major change in the diagnosis of mental disorders 
from the DSM-IV to the DSM-5 is the combination of alcohol dependence and alcohol abuse into 
one disorder, namely alcohol use disorder (APA, 2013). 
Third, a further contribution of the research is that participants were recruited prior to their 
receipt of an HIV test rather than following one. Therefore, the findings of the study provide 
evidence about the baseline psychiatric state of individuals seeking HIV testing. 
My findings contradict the assumption that an HIV infection precipitates the development of a 
common mental disorder (Brandt, 2009; Freeman, 2004, Olley et al., 2003). Future research 
regarding psychological intervention strategies should concentrate on those individuals who were 
already psychologically disordered prior to an HIV-positive diagnosis. It is likely that among 
psychologically disordered HIV test seekers, treatment may increase their quality of life, those 
individuals testing positive for HIV have a better chance of adhering to ART, and engaging in 
positive health behaviours. Those individuals, on the other hand, who tested negative for HIV and 
who are already receiving treatment for their psychiatric disorder are more likely to engage in safe 
sex, get tested frequently, engage in health behaviours, etc. For example, research has shown that 
mental health treatment may decrease sexual risk behaviour and improve adherence to HIV 
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treatment (Safren et al., 2009; Sikkema et al., 2011). It is therefore possible that they will continue 
to be HIV negative if their CMD is treated.  
Fifth, the subscales of the HSCL-25 may also have relevance for screening in primary 
healthcare contexts. The findings of the study illustrate that the depression and anxiety subscales of 
the HSCL-25 can successfully detect most of the cases of depression (e.g., MDD and PDD) and 
generalized anxiety disorder. Therefore, an important contribution of the research study is that it 
shows that in settings where resources are limited, the above-mentioned screening instruments may 
assist with the identification of those individuals in need of follow-up assessment and referrals for 
treatment. 
Finally, those participants identified as psychiatrically disordered received a mental health 
referral. Even though there was a lack of a referral trajectory at the five non-medical testing sites, I 
was able to refer those individuals who screened positive for a CMD to nearby clinics in the 
surrounding areas that provide the necessary psychiatric services.  
Study Limitations 
Despite these strengths, the study had several limitations that deserve mention. In the context 
of people seeking HIV testing, the sample was selected from the Cape Metropole area of the 
Western Cape and the results presented may have limited generalizability to other regions in South 
Africa. A possible explanation may be that demographic, class, culture and linguistic factors in 
other provinces in South Africa may differ from those in the Western Cape, making generalization 
problematic.  
Another limitation is that a convenience sample was used consisting of people seeking HIV 
testing. Thus, generalizability to other population samples in South Africa is restricted. A possible 
way forward could be to include a control group consisting of people not seeking HIV testing. This 
will facilitate much richer inferences regarding people seeking and not seeking HIV testing.  
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Moreover, due to few resources and time constraints, the SCID and self-report questionnaires 
were not translated to Afrikaans and Xhosa. Only those participants who understood English were 
enrolled in the research study. Although English was not their first language, most of the 
participants were interviewed in English only and 40 prospective non-English speaking participants 
were excluded from the study. A way forward could be to translate and back-translate the SCID and 
self-report measures into multiple languages in order to evaluate how people report behavioural and 
emotional symptoms.  
Evidence showed that both versions of the BDI, the BDI-I and the BDI-II, have comparable 
reliability and convergent validity (Beck, Steer, & Ball, 1996; Steer, Clark, Beck, & Ranieri, 1999). 
The BDI-II is different from the BDI-I, with four items replaced to correspond with DSM-IV-
related symptoms (Nuevo, Lehtinen, Reyna-Liberato, & Ayuso-Mateos, 2009). The BDI-I items, 
namely weight loss, distorted body image, somatic preoccupation, and inability to work, were 
replaced by agitation, worthlessness, difficulty concentrating and energy loss to measure the level 
of depression (Wang & Gorenstein, 2013). Nonetheless, the copyright of the BDI-I, retained by the 
American Psychological Association, is less restrictive (Beck et al., 1961), while the BDI-II has 
stricter copyright laws enforced by the original copyright holder, the Harcourt Assessment, 
controlled by Pearson Education (Wang & Gorenstein, 2013). As I was unable to procure a license 
for the use of the BDI-II, the BDI-I was chosen for the current study. 
The interviewers for this study were highly trained and have the skills to decide whether a 
symptom is present or not by carefully evaluating a person’s response. A highly-trained interviewer 
is able to elicit psychiatric symptoms more accurately than a poorly trained interviewer. It is 
unlikely that such training will be implemented as part of routine care in testing sites as the level of 
skill among the community healthcare staff to conduct psychiatric assessments is low. As such, 
symptoms of CMDs may not be recognized in the absence of considerable training. Future research 
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should focus on the training of community healthcare staff in resource-constrained settings 
nationwide. 
It is also possible that there may have been local idioms of distress that were not integrated in 
the SCID and self-report measures may have relevance in improving the sensitivity and specificity 
for identifying true cases and non-cases of CMDs in this population. Qualitative research is needed 
to investigate idioms of distress among people seeking HIV testing.  
Recommendations for practice. Although those individuals who screen positive for CMDs 
would benefit from referral to treatment, a positive screen on its own is inadequate to produce a 
diagnosis of a psychiatric disorder (Kagee, Tsai, Lund, & Tomlinson, 2012). Moreover, given 
imperfect sensitivity and specificity of screening instruments such as the HSCL-25, BDI, BAI, and 
AUDIT, those individuals who scored above the optimal cut-off point of the screening instruments 
should undergo follow-up assessments with a diagnostic interview such as the SCID to confirm the 
diagnosis of a CMD. Therefore, a two-tiered diagnostic approach would be more feasible. It would 
include both screening measures and diagnostic interviews, such as the SCID (Kagee et al., 2012; 
Eack et al., 2008). Screening instruments cannot be used as the only method to gather diagnostic 
information. However, they may be useful as the first step of this two-tiered system. Those 
individuals who scored below the cut-off point on the screening instruments may indeed be true 
non-cases. Those who scored above the optimal cut-off point should continue to the second stage 
where they undergo a more extensive diagnostic interview to determine caseness or non-caseness of 
CMDs. Related to the above, Eack et al. (2008) argue that the BDI and the BAI would be better 
utilized in a community setting by combining these measures with the more extensive SCID 
diagnostic interview in a tiered diagnostic approach. These authors recommend that the BDI and the 
BAI may be effective during the first step for identifying individuals in need for follow-up 
assessments (Eack et al., 2008). Furthermore, during the second step of the two-tiered method, the 
SCID could provide more extensive diagnostic data (Eack et al., 2008). Therefore, future research is 
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needed that explores the applicability of this two-tiered diagnostic approach within resource-
constrained South African public health facilities. 
An example of the above-mentioned two-tiered method in practice would be for health 
professionals, such as lay counsellors and social workers, to make use of the optimal cut-off points 
of these screening instruments to identify individuals who could benefit from further diagnostic 
evaluation. The relevant modules of the SCID should be administered using all the information 
available (e.g., the screening instrument scores, or SCID diagnostic estimations) to reach a 
diagnosis (Eack et al., 2008). Other studies also making use of the tiered diagnostic approach report 
that, although not perfect, this method may significantly increase diagnostic precision in population 
settings (Shear et al., 2000; Zimmerman, 2003; Eack et al., 2008). However, a diagnosis of a 
psychiatric disorder is only useful if treatment is available. In resource-constrained environments in 
South Africa, a clear referral trajectory for psychiatric treatment may not be available (Lund, 
Kleintjies, Kakuma, Flisher, & MHaPP Research Program Consortium, 2010). Screening is 
important as it can detect psychiatric disorders early enough and provide a concise overview of 
symptoms (Ali, Ryan, & De Silva). Early detection is necessary as it offers a cost-effective 
approach to deal with mental illness early on and may consequently alleviate the strains on an 
already overburdened healthcare system (Ali, Ryan, & De Silva, 2016). Henceforth, studies should 
focus on integrating referral trajectories with routine screening and HIV testing in resource-
constrained communities in South Africa. 
Previous research has shown that there is an unmet need for treatment among persons 
diagnosed with a psychiatric disorder, in this case CMDs (Siddiqu, & Siddiqi, 2007; Lusskin et al., 
2007). Lund et al. (2015) have shown that there is a large treatment gap between individuals with a 
CMD diagnosis in need of treatment and those already receiving treatment. A task sharing method 
is needed to reduce the treatment gap in LMIC (WHO, 2008). In this way, mental healthcare 
services are provided by community health workers who are trained and supervised by mental 
healthcare professionals. The possible benefits of task sharing include greater access to healthcare, 
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decreased stigma, and adding staff that may have a better comprehension of the local idioms of 
distress (Lund et al., 2015). However, this task sharing approach has limited data in terms of its 
usefulness in sub-Saharan Africa, specifically South Africa. Therefore, further research is needed to 
investigate the effectiveness of the task-sharing method in resource-limited populations in South 
Africa.  
Although person-centred counselling was useful in alleviating psychological distress and 
depression among South African diabetes and hypertension patients (Kagee & Le Roux, 2009), 
further research should focus on more robust psychological interventions such as an altered type of 
cognitive behavioural therapy because it is an empirically supported treatment. For example, Safren 
et al. (2012) provide rather robust evidence for an adapted cognitive behavioural therapy for 
adherence and depression (CBT-AD), which has the ability to increase adherence to ART and 
decrease depression among HIV-positive individuals. Similarly, a study done by Andersen et al. 
(2016) investigated a nurse-delivered CBT-AD, called Ziphamandla, among HIV-positive 
individuals with depression who are already receiving ART’s. Using a task-sharing method, the 
authors also found a decrease in depressive symptoms, but no significant difference in ART 
adherence (Andersen et al., 2016). Given the high prevalence rate of CMDs and elevated levels of 
distress, depression, anxiety and alcohol use among the population of interest, further research is 
needed for the development of cost-effective evidence-based treatments such as an adapted 
cognitive behavioural therapy, which focuses on improving adherence to treatment and reduces 
CMDs. These evidence-based treatments may be used to alleviate the symptoms of CMDs 
experienced by the sample in the current study. 
Recommendations for research. As the prevalence rates of common mental disorders in the 
sample were found to be higher than those reported in the general population, risk factors associated 
with the high prevalence rates of common mental disorders and symptomatology need to be 
investigated further in a quantitative analysis. Further epidemiological research is also needed to 
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determine whether the high 12-month prevalence rates of CMDs among the sample in the current 
study occur nationally.  
Regarding the training of testing site health professionals, the sample of HIV test seekers 
may benefit if the healthcare professionals received the necessary training in detecting and referring 
those individuals who present with the symptoms of CMDs. Training of healthcare providers should 
therefore be a priority when conducting future research. 
Based on the findings of this study, further research is required to measure the extent to which 
the self-report measures continue to be a valid measure of general distress or symptoms of common 
mental disorders in other regions of South Africa. Future research should also include assessing 
briefer screening instruments, such as the PHQ2 or 9 and the GAD7, among people seeking HIV 
testing nationwide. In addition, individuals who score above an optimal cut-off point on the HSCL-
25, BDI, BAI, and AUDIT should be referred for follow-up assessments and referred for mental 
healthcare. 
Conclusion 
Despite the above-mentioned limitations, the current study nonetheless enhances our 
knowledge of the nature and prevalence of distress and CMDs and the usefulness of screening 
instruments in the Western Cape, South Africa. Within a South African context, this research is one 
of a few studies to determine the prevalence of CMDs among people seeking HIV testing.  
Regarding limited resources, there is no integration between HIV testing and mental health, 
which are indicative of a fragmented healthcare system. Mental health screening during HIV testing 
might be useful to identify ordinarily overlooked and exceedingly common CMDs in resource-
constrained settings. Although the interaction with the healthcare system may present an 
opportunity for the management of CMDs, limited evidence-based treatments are available while 
testing for HIV. However, given the high rates of distress and CMDs among persons seeking HIV 
testing, decisions can be made about which psychological interventions and psychiatric services are 
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more appropriate for improved health outcomes. Subsequently, the findings from this research that 
the screening instruments adequately detected CMDs in non-medical settings in the Western Cape 
have vital public health applicability, as those individuals who would have otherwise gone 
undetected were identified with a psychiatric disorder. Considering the fragmented services 
provided in public health facilities, since HIV testing and mental health services are available 
separately, it is important to integrate referral trajectories with routine screening and HIV testing. 
Furthermore, people seeking HIV testing is an important group, since psychological interventions 
implemented prior to knowledge of their HIV status may enhance their quality of life.  
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a person seeking HIV testing, you are invited to participate in a study conducted by researchers at 
Stellenbosch University. 
To be eligible to participate, you need to be 18 and above. 
You will be asked to participate in a structured interview about your mental health and to 
complete a set of questionnaires. 
If you are interested in learning more about the study, please ask the receptionist to introduce you 
to the researcher who is running the study. You will also be able to contact the researcher at: 073 740 
9723 
Participants will receive a token of appreciation on completion of the interview. 
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Appendix B: Informed consent  
 
TITLE OF THE RESEARCH PROJECT: Common mental health problems among persons seeking 





PRINCIPAL INVESTIGATOR: Wylene Saal 
 
ADDRESS: Department of Psychology, Stellenbosch University, Private Bag X1, Matieland, 7602 
 
CONTACT NUMBER: 0737409723 
 
You are being invited to take part in a research project. Please take some time to read the 
information presented here, which will explain the details of this project.  Please ask the study staff 
any questions about any part of this project that you do not fully understand.  It is very important 
that you clearly understand what this research entails and how you could be involved.  Also, your 
participation is entirely voluntary and you are free to decide not to participate.  If you say no, this 
will not affect you negatively in any way. You are also free to withdraw from the study at any point, 
even if you do agree to take part. 
This study has been approved by the Health Research Ethics Committee at Stellenbosch University 
and will be conducted according to the ethical guidelines and principles of the international 
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Declaration of Helsinki, South African Guidelines for Good Clinical Practice and the Medical 
Research Council (MRC) Ethical Guidelines for Research. You have the right to be told of any new 
information that arises during the course of the study.  
What is this research study all about? 
The study will be conducted at Living Hope (Mfuleni), Masincedane (Somerset West), Reliable 
Action (Eersteriver), Sizophila (Nomzamo, Strand), and Phambili (Broadlands, Strand) Wellness 
Centres. We plan to have a total of 500 take part. The aim of the study is to understand common 
mental health problems among persons who are taking an HIV test and to follow them after 
receiving their test results over a period of one year.  
Participants will be assessed for common mental disorders before they receive an HIV test. Two 
weeks after the HIV test, participants will be assessed again for psychological distress and then six 
and twelve months later. If you choose to participate in the study, your participation will be for one 
year.  
The research results will help to identify ways to support persons who experience psychological 
difficulties after receiving an HIV positive test result.  
Procedures 
When someone comes to the clinic for an HIV test, the person will register at the clinic reception. 
The person will then be given a flyer informing them of the study and inviting them to meet with a 
researcher in a private room. If you agree to meet with the researcher you will be informed about 
the study in person and will be invited to participate in the study. You will be asked to complete a 
number of questionnaires three times over the course of one year. You will thus be contacted six 
months and one year after today.  
Once you sign the informed consent form, you will be asked to participate in a diagnostic interview 
and complete some questionnaires. The diagnostic interview will be audio recorded. You will then 
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be taken to the clinic nurse to receive an HIV test and will be given post-test counselling. After 
receipt of your HIV test result, you will again be asked to complete a questionnaire.  
You will then be contacted six and twelve months later to complete a further battery of tests  
Why have you been invited to participate? 
You have been invited to participate in the research because you are taking an HIV test and will be 
receiving your test results today. 
What will your responsibilities be? 
At the first time point, you will be asked to participate in a clinical interview and to complete self-
report questionnaires that will take approximately about an hour. At the second and third time 
points, six and twelve months later, you will be asked to complete set of self-report questionnaires 
that will take about twenty minutes.  
Will you benefit from taking part in this research? 
There are no direct benefits to participants for taking part in this study as it is a descriptive and not 
an intervention study. However, if you are identified as being psychologically distressed, you will 
be referred for mental health services at Mfuleni Clinic. Also, answering questions related to 
psychological symptoms will give you information about your psychological state.  The research 
will help researchers understand the psychological concerns of persons who receive their test 
results. It may help inform future psychological interventions for persons living with HIV. If you 
complete the assessment today, you will receive a grocery voucher.  
Are there in risks involved in your taking part in this research? 
There are no major risks associated with this study as participants will only be asked to complete a 
paper and pencil questionnaire battery. Some participants might become distressed after receiving 
an HIV positive test result. They will be counselled by clinic staff. It is possible that some 
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participants might become distressed by completing the questionnaire battery. These participants 
will be referred for psychological counselling at the clinic.    
If you do not agree to take part, what alternatives do you have? 
If you do not take part, you will still receive HIV testing. You have the alternative not to take part in 
the study. 
Who will have access to your medical records? 
The researchers who will be conducting the study will have access to your records. The information 
collected will be treated as confidential and protected. If it is used in a publication or thesis, the 
identity of the participant will remain anonymous.  Only the researchers and no one else will have 
access to your medical information. Member of the Research Ethics Committee may need to inspect 
research records. 
What will happen in the unlikely event of some form injury occurring as a direct result of your 
taking part in this research study? 
There are no injuries that could occur as a result of participation in the study. No compensation will 
be available to persons who injure themselves during the time of study participation. 
Will you be paid to take part in this study and are there any costs involved? 
No, you will not be paid to take part in the study but your transport costs will be covered for each 
study visit.  There will be no costs involved for you, if you do take part. You will, however, receive 
a R50 shopping voucher as a token of gratitude for your participation in the study.  
Is there anything else that you should know or do? 
You can contact Prof. Ashraf Kagee at tel 0834433002 if you have any further queries or encounter 
any problems. 
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You can contact the Health Research Ethics Committee at 021-938 9207 if you have any concerns 
or complaints that have not been adequately addressed by your study doctor. 
You will receive a copy of this information and consent form for your own records. 
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Declaration by participant 
By signing below, I …………………………………..…………. agree to take part in a research 
study entitled Common mental health problems among persons seeking HIV testing.  
I declare that: 
I have read or had read to me this information and consent form and it is written in a language with 
which I am fluent and comfortable. 
I have had a chance to ask questions and all my questions have been adequately answered. 
I understand that taking part in this study is voluntary and I have not been pressurised to take part. 
I may choose to leave the study at any time and will not be penalised or prejudiced in any way. 
I may be asked to leave the study before it has finished, if the study doctor or researcher feels it is in 
my best interests, or if I do not follow the study plan, as agreed to. 
Signed at (place) ......................…........…………….. on (date) …………....……….. 2014. 
 
…………………………… …………………………… 
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Declaration by investigator 
I (name) ……………………………………………..……… declare that: 
I explained the information in this document to ………………………………….. 
I encouraged him/her to ask questions and took adequate time to answer them. 
I am satisfied that he/she adequately understands all aspects of the research, as discussed above 
I did/did not use an interpreter.  (If an interpreter is used then the interpreter must sign the 
declaration below. 
Signed at (place) ......................…........…………….. on (date) …………....……….. 2014. 
 
…………………………… …………………………… 
Signature of investigator Signature of witness 
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Declaration by interpreter 
I (name) ……………………………………………..……… declare that: 
I assisted the investigator (name) ………………………………………. to explain the information 
in this document to (name of participant) ……………..…………………………….. using the 
language medium of Afrikaans/Xhosa. 
We encouraged him/her to ask questions and took adequate time to answer them. 
I conveyed a factually correct version of what was related to me. 
I am satisfied that the participant fully understands the content of this informed consent document 
and has had all his/her question satisfactorily answered. 
 
Signed at (place) ......................…........…………….. on (date) …………....……………….. 
 
…………………………… …………………………… 
Signature of investigator Signature of witness 
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Appendix C: Demographic questionnaire 
DEMOGRAPHIC INFORMATION 
1.   LAST NAME  
2.   FIRST NAME  
3.   AGE  
 
4.   DATE OF BIRTH:  ……/ …………………../ 19… 
 Day Month Year 
 
PLEASE INDICATE THE FOLLOWING ANSWERS BY MAKING AN (X) IN THE 
APPROPRIATE BOX. 
 
5. GENDER:        Male        Female 
 
6. RACE:         African       Coloured        White       Indian 
       Other (Please state: ________________________). 
 
7. MARITAL STATUS:      Single      Widowed      Separated 
       Divorced       Married/ living together 
 
8. LIVING SITUATION:   
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     Live alone      Live with other adults(s), no children 
     Live with other adults and children      Live with children  
     Live in an institution or retirement home 
 
9. WHAT IS THE HIGHEST EDUCATION LEVEL YOU HAVE COMPLETED? 
     No formal education 
     Completed primary school 
     Attended high school but did not complete matric 
     Completed matric 
     Attended university, college or technikon but did not graduate 
     Graduated from university, college or technikon 
 
10. WHAT IS YOUR CURRENT WORK SITUATION? 
     Employed full time      Employed part time 
     Student      Unemployment 
     Disabled       Homemaker 
     Retired 
 
11. WHICH OF THE FOLLOWING BEST DESCRIBES YOUR APPROXIMATE ANNUAL 
FAMILY INCOME FROM ALL SOURCES, BEFORE TAXES?  
     Less than R10 000      R10 001-R40 000 
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     R40 001-R80 000      R80 001-R110 000 
     R110 001-R170 000      R170 001-R240 000 
     R240 001 and above      Don’t know 
 
12. WHERE WERE YOU BORN? 
     Town      City      Farm 
 
13. WHAT IS YOUR FIRST LANGUAGE?  ________________________ 
 
14. WHICH OTHER LANGUAGES DO YOU SPEAK?  ________________________ 
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Appendix D:  Hopkins Symptom Checklist 
Listed below are some symptoms of strain that people sometimes have.  Please read each one 
carefully and check the answer that best reflects how much that symptom has bothered you during 
the past month. 
 1= 




Quite a bit 
4= 
Extremely 
1.Suddenly scared for no reason 1 2 3 4 
2.Feeling fearful 1 2 3 4 
3.Faintness, dizziness, or 
weakness 
1 2 3 4 
4.Nervousness or shakiness 
inside 
1 2 3 4 
5.Heart pounding or racing 1 2 3 4 
6.Trembling 1 2 3 4 
7.Feeling tense or keyed up 1 2 3 4 
8.Headaches 1 2 3 4 
9.Spells of terror or panic 1 2 3 4 
10.Feeling restless, can’t sit 
down 
1 2 3 4 
11.Feeling low in energy – 
slowed down 
1 2 3 4 
12.Blaming yourself for things 1 2 3 4 
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13.Crying easily 1 2 3 4 
14.Loss of sexual interest or 
pleasure 
1 2 3 4 
15.Poor appetite 1 2 3 4 
16.Difficulty falling asleep or 
staying asleep 
1 2 3 4 
17.Feeling hopeless about the 
future 
1 2 3 4 
18.Feeling blue 1 2 3 4 
19.Feeling lonely 1 2 3 4 
20.Feeling trapped or caught 1 2 3 4 
21.Worrying too much about 
things 
1 2 3 4 
22.Feeling no interest in things 1 2 3 4 
23.Thoughts of ending your life 1 2 3 4 
24.Feeling everything is an 
effort 
1 2 3 4 
25.Feelings of worthlessness 1 2 3 4 
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Appendix E:  Beck Depression Inventory 
Directions: On this questionnaire are groups of statements. Please read each group of statements 
carefully. Then pick the one statement in each group that best describes the way you have been 
feeling the past week, including today. Circle the number beside the statement you picked. If 
several statements in the group seem to apply equally well, circle each one. Be sure to read all the 
statements in each group before making your choice. 
 
1. 0 I do not feel sad. 
 1 I feel sad. 
 2 I am sad all the time and I can’t snap out of it. 
 3 I am so sad or unhappy that I can’t stand it. 
   
2.  0 I am not particularly discouraged about the future. 
 1 I feel discouraged about the future. 
 2 I feel I have nothing to look forward to. 
 3 I feel that the future is hopeless and that things cannot improve. 
   
3.  0 I do not feel like a failure. 
 1 I feel I have failed more than the average person. 
 2 As I look back on my life, all I can see is a lot of failures. 
 3 I feel I am a complete failure as a person. 
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4.  0 I get as much satisfaction out of things as I used to. 
 1 I don’t enjoy things the way I used to. 
 2 I don’t get real satisfaction out of anything anymore. 
 3 I am dissatisfied or bored with everything. 
   
5 0 I don’t feel particularly guilty. 
 1 I feel guilty a good part of the time. 
 2 I feel guilty most of the time. 
 3 I feel guilty all of the time. 
   
6.  0 I don’t feel I am being punished. 
 1 I feel I may be punished. 
 2 I expect to be punished. 
 3 I feel I am being punished. 
   
7.  0 I don’t feel disappointed in myself. 
 1 I am disappointed in myself. 
 2 I am disgusted in myself. 
 3 I hate myself. 
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8. 0 I don’t feel I am any worse than anybody else. 
 1 I am critical of myself for my weakness or mistakes. 
 2 I blame myself for my faults. 
 3 I blame myself for everything. 
   
9. 0 I don’t have any thoughts of killing myself. 
 1 I have thoughts of killing myself but I would not carry them out. 
 2 I would like to kill myself. 
 3 I would like to kill myself if I had the chance. 
   
10.  0 I don’t cry any more than usual. 
 1 I cry now more than I used to. 
 2 I cry all the time now. 
 3 I used to be able to cry, but now I can’t cry even though I want to. 
   
11. 0 I am no more irritated than I ever am. 
 1 I get annoyed or irritated more easily than I used to. 
 2 I feel irritated all the time now. 
 3 I don’t get irritated at all by the things that used to irritate me. 
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12. 0 I have not lost interest in other people. 
 1 I am less interested in other people than I used to be. 
 2 I have lost most of interest in other people. 
 3 I have lost all of my interest in other people. 
   
13. 0 I make decisions about as well as I ever could. 
 1 I put off making decisions more than I used to. 
 2 I have greater difficulty in making decisions than before. 
 3 I can’t make decisions at all anymore. 
   
14.  0 I don’t feel any worse than I used to. 
 1 I am worried that I am looking old or unattractive. 
 2 I feel that there are permanent changes in my appearance that make me 
look unattractive. 
 3 I believe I look ugly. 
   
15. 0 I can work out as well as before. 
 1 It takes extra effort to get started at doing something. 
 2 I have to push myself very hard to do anything. 
 3 I can’t do any work at all. 
16.  0 I can sleep as well as usual. 
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 1 I don’t sleep as well as I used to. 
 2 I wake up one or two hours earlier than usual and find it hard to get back 
to sleep. 
 3 I wake up several hours earlier than I used to and cannot get back to sleep. 
   
17. 0 I don’t get any more tired than usual. 
 1 I get tired more easily than I used to. 
 2 I get tired from doing almost anything. 
 3 I am too tired to do anything. 
   
18. 0 My appetite is no worse than usual. 
 1 My appetite is not as good as it used to be 
 2 My appetite is much worse now. 
 3 I have no appetite at all anymore. 
   
19. 0 I haven’t lost much weight, I any, lately. 
 1 I have lost more than 5 pounds. 
 2 I have lost more than 10 pounds. 
 3 I have lost more than 15 pounds. 
20.  0 I am no more worried about my health than usual. 
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 1 I am worried about physical problems such as aches and pains, or upset 
stomach, or constipation. 
 2 I am very worried about physical problems and it is hard to think of 
much else. 
 3 I am so worried about my physical problems that I cannot think about 
anything else. 
   
21. 0 I have not noticed any recent change in my interest in sex. 
 1 I am less interested in sex than I used to be. 
 2 I am much less interested in sex now. 
 3 I have lost interest in sex completely. 
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Appendix F:  Beck Anxiety Inventory 
Instructions: Below is a list of common symptoms of anxiety. Please read each item in the list 
carefully. Indicate how often you experienced each symptom during the past week, including today, 
by circling the corresponding number in the column next to each symptom. 
 0 =  
Not at all 
1 =  
Mildly- but it 
didn’t bother 
me 





3 =  
Severely- it 
bothered me a 
lot 
1.Numbness or tingling 0 1 2 3 
2.Feeling hot 0 1 2 3 
3.Wobbliness in legs 0 1 2 3 
4.Unable to relax 0 1 2 3 
5.Fear of the worst happening 0 1 2 3 
6.Dizzy or lightheaded 0 1 2 3 
7.Heart pounding or racing 0 1 2 3 
8.Unsteady 0 1 2 3 
9.Terrified 0 1 2 3 
10.Nervous 0 1 2 3 
11.Feelings of choking 0 1 2 3 
12.Hands trembling 0 1 2 3 
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13.Shaky 0 1 2 3 
14.Fear of losing control 0 1 2 3 
15.Difficulty breathing 0 1 2 3 
16.Fear of dying 0 1 2 3 
17.Scared 0 1 2 3 
18. Indigestion or discomfort 0 1 2 3 
19.Faint 0 1 2 3 
20.Face flushed 0 1 2 3 
21.Sweating (not due to heat) 0 1 2 3 
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Appendix G:  The Alcohol Use Disorder Identification Test: Self 
Report Version 
Because alcohol use can affect your health and can interfere with certain medications and 
treatments, it is important that we ask some questions about your use of alcohol. Your answers will 
remain confidential so please be honest. 
Place an X in one box that best describes your answer to each question. 
 0 1 2 3 4 
How often do you have a 
drink containing alcohol? 
Never Monthly or 
less 
2-4 times a 
month 
2-3 times a 
week 
4 or more 
times a week 
How many drinks 
containing alcohol do you 
have on a typical day 
when you are drinking? 
1 or 2 3 or 4 5 or 6 7 to 9 10 or more 
How often do you have 
six or more drinks on one 
occasion?  
Never Less than 
monthly 
Monthly Weekly Daily or 
almost daily 
How often during the last 
year have you found that 
you were not able to stop 
once you had started? 
Never Less than 
monthly 
Monthly Weekly Daily or 
almost daily 
How often during the last 
year gave you failed to do 
what was normally 
Never Less than 
monthly 
Monthly Weekly Daily or 
almost daily 
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expected of you because 
of drinking?  
How often during the last 
year have you needed a 
first drink in the morning 
to get yourself going after 
a heavy drinking session? 
Never Less than 
monthly 
Monthly Weekly Daily or 
almost daily 
How often during the last 
year have you had a 
feeling of guilt or remorse 
after drinking? 
Never Less than 
monthly 
Monthly Weekly Daily or 
almost daily 
How often during the last 
year have you been unable 
to remember what 
happened the night before 
because of your drinking? 
Never Less than 
monthly 
Monthly Weekly Daily or 
almost daily 
Have you or someone else 
been injured because of 
your drinking? 
No  Yes, but not 
in the last 
year 
 Yes, during 
the last year 
Has a relative, friend, 
doctor, or other health 
care worker been 
concerned about your 
No  Yes, but not 
in the last 
year 
 Yes, during 
the last year 
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drinking or suggested you 
cut down? 
    Total  
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Appendix H: Structured Clinical Interview for Major Depressive 
Disorder  
SCID: Depressed Mood 
Since (ONE MONTH AGO), has there been a period of time when you were feeling 
depressed or down most of the day nearly every day?  (Has anyone said that you look sad, 
down, or depressed?) 
IF NO: What about feeling empty or hopeless most of the day nearly every day?   
IF YES TO EITHER OF ABOVE: What has that been like? How long has it lasted?  (As long 
as 2 weeks?) 
SCID: Loss of interest or Anhedonia 
v IF PREVIOUS ITEM CODED “3”: During that time, did you lose interest or pleasure 
in things you usually enjoyed?  (What has that been like? Give me some examples.) 
vi IF PREVIOUS ITEM NOT CODED “3”: What about a time since (ONE MONTH 
AGO) when you lost interest or pleasure in things you usually enjoyed?  (What has that 
been like? Give me some examples.) 
vii IF YES: Has it been nearly every day?  How long has it lasted?  (As long as 2 weeks?) 
viii IF UNKNOWN:  Since (ONE MONTH AGO), during which two-week period would 
you say you have been doing the worst? 
SCID: Weight Disturbance or Appetite Changes 
During (2-WEEK PERIOD)…how has your appetite been? (What about compared to your 
usual appetite? Have you had to force yourself to eat?  Eat [less/more] than usual?  Has that 
been nearly every day?  Have you lost or gained any weight?  How much?  
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IF YES: Have you been trying to [lose/gain] weight?) 
SCID: Sleep Disturbance 
During (2-WEEK PERIOD)…how have you been sleeping?  (Trouble falling asleep, waking 
frequently, trouble staying asleep, waking too early, OR sleeping too much? 
How many hours of sleep (including naps) have you been getting?   
How many hours of sleep did you typically get before you got (DEPRESSED/OWN 
WORDS)?  Has it been nearly every night?) 
SCID: Agitation/Retardation 
During (2-WEEK PERIOD)… have you been so fidgety or restless that you were unable to 
sit still?  
What about the opposite -- talking more slowly, or moving more slowly than is normal for 
you, as if you’re moving through molasses or mud? (Has it been so bad that other people 
have noticed it?   
What have they noticed?   
Has that been nearly every day?) 
SCID: Fatigue/Anergia 
During (2-WEEK PERIOD)…what has your energy level been like? 
(Tired all the time?  Nearly every day?)  
SCID: Worthlessness/Guilt 
During this time…have you been feeling worthless?  
What about feeling guilty about things you have done or not done? 
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IF YES:  What things?  (Is this only because you can’t take care of things since you have 
been sick?) 
IF YES TO EITHER OF ABOVE: Nearly every day?  
SCID: Concentration impaired 
During (2-WEEK PERIOD)…have you had trouble thinking or concentrating?   
Has it been hard to make decisions about everyday things?   
(What kinds of things has it been interfering with?  Nearly every day?) 
SCID: Suicidal ideation 
During (2-WEEK PERIOD)…have things been so bad that you thought a lot about death or 
that you would be better off dead?   
Have you thought about taking your own life? 
IF YES: Have you done something about it? (What have you done? Have you made a specific 
plan? Have you taken any action to prepare for it? Have you actually made a suicide 
attempt?) 
SCID: significant distress or impairment in social, occupational, or other important areas of 
functioning 
What effect have (DEPRESSIVE SXS) had on your life?   
ASK THE FOLLOWING QUESTIONS AS NEEDED TO RATE CRITERION B:  
How have (DEPRESSIVE SXS) affected your relationships or your interactions with other 
people? (Has this caused you any problems in your relationships with your family, romantic 
partner or friends?) 
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How have (DEPRESSIVE SXS) affected your work/school? (How about your attendance at 
work or school?  Did (DEPRESSIVE SXS) make it more difficult to do your 
work/schoolwork? How have (DEPRESSIVE SXS) affected the quality of your 
work/schoolwork?) 
How have (DEPRESSIVE SXS) affected your ability to take care of things at home?  How 
about doing simple everyday things like getting dressed, bathing, or brushing your teeth? 
What about doing other things that are important to you like religious activities, physical 
exercise, or hobbies? Have you avoided doing anything because you felt like you weren’t up 
to it?  
Have (DEPRESSIVE SXS) affected any other important part of your life? 
IF DOES NOT INTERFERE WITH LIFE:  How much have you been bothered or upset by 
having (DEPRESSIVE SXS)? 
SCID: Primary Depressive Episode: The episode is not attributable to the physiological 
effects of a substance (e.g., a drug of abuse, medication) or to another medical condition. 
Just before this began, were you physically ill? 
IF YES: What did the doctor say? 
Just before this began, were you using any medications? 
IF YES: Any change in the amount you were using?  
Just before this began, were you drinking or using any drugs? 
SCID: Total number of Major Depressive Episodes 
How many separate times in your life have you been (depressed/ OWN WORDS) nearly 
every day for at least 2 weeks and had several of the symptoms that you described, like (SXS 
OF WORST EPISODE)? 




1.  Did this begin shortly after someone close to you dies? 
SCID: Postpartum depression 
1.  Did the mood systems start within the 4 weeks of having a baby? 
SCID: Medication or drug induced 
1.  Were you taking any drugs? 
 
  




Appendix I: Structured Clinical Interview for Persistent Depressive 
Disorder 
SCID: Depressed Mood 
1.  Since (TWO YEARS AGO), have you been bothered by depressed mood most of 
the day, more days than not? (More than half of the time?) 
2.  IF YES TO ABOVE: What was that like?  
SCID: Duration 
How old were you when you were first bothered by depression? 
Do you remember the month and year? 
SCID: Presence, while depressed, of two (or more) of the following: 
Lose your appetite? (What about overeating?)  
Have trouble sleeping or sleep too much? 
Have little energy to do things or feel tired a lot? 
Feel down on yourself? ... (Feel worthless, or a failure?) 
Have trouble concentrating or making decisions? 
Feel hopeless? 
SCID: During the 2-year period (1 year for children or adolescents) of the disturbance, 
the person has never been without the symptoms in criteria A and B for more than 2 
months at a time. 
What is the longest period of time, during this period of long-lasting depression, that 
you felt OK*?  
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SCID: Age of onset of current Persistent Depressive Disorder 
How old were you when you first started feeling this way (persistently depressed)?  
Code the following:  
1- Early Onset: Onset before age 21  
2- Late Onset: Onset age 21 or older  
SCID: Not due to the direct physiological effects of a substance (e.g., a drug of abuse, 
medication) or to a general medical condition. 
Just before this began, were you physically ill?  
IF YES: What did the doctor say? 
Just before this began, were you using any medication? 
IF YES: Any change in the amount you were using? 
Just before this began, were you drinking or using any street drugs? 
SCID: Worthlessness/Guilt 
During this time…have you been feeling worthless?  
What about feeling guilty about things you have done or not done? 
IF YES:  What things?  (Is this only because you can’t take care of things since you 
have been sick?) 
IF YES TO EITHER OF ABOVE: Nearly every day?  
SCID: Concentration impaired 
During (2-WEEK PERIOD)…have you had trouble thinking or concentrating?   
Has it been hard to make decisions about everyday things?   
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(What kinds of things has it been interfering with?  Nearly every day?) 
SCID: The symptoms cause clinically significant distress or impairment in social, 
occupational, or other important areas of functioning 
How much do your depressed feelings interfere with your life? Have you thought about 
taking your own life? 
IF DOES NOT INTERFERE WITH LIFE: How much have you been bothered or 
upset by having depressed feelings? 
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Appendix J: Structured Clinical Interview for Generalised Anxiety 
Disorder 
Over the last several months, have you been feeling anxious and worried for a lot of the time? 
(Tell me about that.) 
SCID: Excessive anxiety and worry 
What kinds of things have you worried about? (What about your job, your health, your family 
members, your finances, or other smaller things like being late for appointments?)  
How much did you worry about [EVENTS OR ACTIVITIES]? 
What else have you worried about? 
Have you worried about [EVENTS OR ACTIVITIES] even when there was no reason?  (Have 
you worried more than most people would in your circumstances?  Has anyone else thought you 
worried too much?   Have you worried more than you should have given your actual 
circumstances?) 
During the last six months, since (SIX MONTHS AGO), would you say that you have been 
worrying more days than not? 
SCID: The person finds it difficult to control the worry 
When you’re worrying this way, have you found that it’s hard to stop yourself? 
SCID: Restlessness or feeling keyed up or on edge 
Thinking about those periods since (SIX MONTHS AGO) when you have been feeling nervous, 
anxious, or worried… 
…have you often felt physically restless, like you couldn’t sit still? 
SCID: Being easily fatigued 
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…have you often tired easily? 
SCID: Difficulty concentration 
…have you often had trouble concentrating or has your mind often gone blank? 
SCID: Irritability 
1.  …have you often been irritable? 
SCID: Muscle tension 
1.  …have your muscles often been tense? 
SCID: Sleep disturbance 
…have you often had trouble falling or staying asleep?   
How about often feeling tired when you woke up because you didn’t get a good night’s sleep? 
SCID: clinically significant distress or impairment in social, occupational, or other important 
areas of functioning. 
What effect has this anxiety or worry had on your life? 
How have (GAD SXS) affected your relationships or your interactions with other people? (Have 
(GAD SXS) caused you any problems in your relationships with your family, romantic partner or 
friends?) 
How have (GAD SXS) affected your work/schoolwork? (How about your attendance at work or 
school?   
Did (GAD SXS) make it more difficult to do your work/schoolwork? How have (GAD SXS) 
affected the quality of your work/schoolwork?) 
How have (GAD SXS) affected your ability to take care of things at home?   
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How about doing other things that are important to you like religious activities, physical 
exercise, or hobbies? Have you avoided doing anything because you felt like you weren’t up to 
it? 
Has your anxiety or worry affected any other important part of your life? 
IF DOES NOT INTERFERE WITH LIFE:  How much have you been bothered or upset by 
having (GAD SXS)? 
SCID: Primary Anxiety Disorder: The disturbance is not attributable to the physiological effects 
of a substance 
F UNKNOWN:  When did this anxiety begin? 
Just before you began having this anxiety, were you taking any drugs, caffeine, diet pills, or 
other medicines? 
(How much coffee, tea, or caffeinated soda do you drink a day?) 
Just before these problems began, were you physically ill? 
IF YES:  What did the doctor say 
SCID: Age at onset 
How old were you when you first started having (SXS OF GAD)? 
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Appendix K: Structured Clinical Interview for Alcohol Use Disorders 
So tell me about your alcohol use now. How much do you drink a day?  
Has there ever been a time in your life when you had 5 or more drinks than intended on any 
occasion over the past 12 months? (apply clinical judgment here- if you think the patient is not 
truthful then proceed with the module 
SCID: Alcohol use disorder 
Have you consumed alcohol in larger amounts or over a longer period of time than you 
intended? 
How many drinks do you have in a typical week? 
SCID: Over the past 12 months… 
Have you persistently wanted to or made unsuccessful efforts to control or cut down your 
alcohol use? 
Have you spent a lot of time trying to obtain alcohol, use alcohol, or recover from its effects? 
Have you experienced cravings or a strong desire or urge to use alcohol? 
Has your drinking ever resulted in a failure to meet obligations at work, school, or home? 
Have you continued using alcohol even though you had interpersonal problems caused by or 
made worse by using alcohol? 
Have you ever given up social or recreational activities because of your alcohol use? 
a. Have you ever used alcohol in situations in which it is physically dangerous? 
b. If yes to 8a: Have you continued to use alcohol in situations in which it is physically 
dangerous? 
a. Have you ever experienced a physical or psychological problem that was likely to have been 
made worse or caused by alcohol? 
Stellenbosch University  https://scholar.sun.ac.za
 273 
 
b If yes to 9a: Have you continued using alcohol despite knowing that it causes or makes the 
problem worse? 
a. Have you noticed that you need more alcohol than previously to become intoxicated or create 
the desired effect? 
b. Have you noticed that the effect that the alcohol has on you has decreased even though you 
drank the same amount? 
a. When you stopped drinking or reduced your drinking, did you ever (as a result of this) have 
any of the following: 
Sweating or pulse rate increase 
Difficulty sleeping 
Seen, felt, or heard things that were not there 
Fidgetiness or restlessness 
Anxiety 
Seizures 
b. Have you taken another substance to relieve or avoid any of these symptoms? 
IF CLIENT ANSWERED YES TO E10b: 
What substance did you take? 
SCID: IF CLIENT ANSWERED YES TO E11b: 
1.  What substance did you take? 
SCID: Note to interviewer: If so, the interviewer must go back to the beginning and ask: 
BEFORE the last 12 months... 
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1.  Have any of these things been true BEFORE the last 12months? 
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Common mental health problems amongst persons seeking HIV testing:  
Implications for mental healthcare 
 
Should you wish to go for counselling or require any psychiatric services, these are 
the clinics and contact persons available for referral: 
 
Idas Valley: Sr Chanel Nothling (psychiatric nurse) – 0218872721 or 
Chanel.nothling@westerncape.gov.za 
Cloetesville: Sr N. Toffar (psychiatric nurse) – 021 883 2676 or 
ntoffar@westerncape.gov.za 
Stellenbosch Provincial Hospital - 021 887 0310 (Corner Roux Rd & Merriman 
Street)  
Vlottenburg Mobile Clinic - 021 888 5825 
Kylemore Clinic - 021 885 2504 
Welgevallen Clinic, Stellenbosch – 021 808 2696 
Jamestown clinic - 021 880 1390 
 
For further information please contact the researcher at: 
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Appendix M: Rules for the Algorithm (Coding) 
RULES FOR THE ALGORITHIM: IN ORDER TO MEET DIAGNOSIS  CODING  
MAJOR DERPESSIVE DISORDER 
In order for a diagnosis of MDD to be endorsed, the following critical criteria (A, B & C) have 
to be met: 
Criterion A:  
If both A1 (depressed mood) and A2 (anhedonia) are met, then at least 3 out of 7 of the rest of 
the symptoms of MDD have to be met 
If either A1 (depressed mood) or A2 (anhedonia) are met, then at least 4 out of 7 of the rest of 
the symptoms of MDD have to be met 
Criterion A - 5 or more out of 9 symptoms of MDD 
either depressed mood or anhedonia must be met (coded a 3 ‘threshold’) 
Duration of at least two weeks has to be met (coded a 3 ‘threshold’) 
Plus either 3 or 4 of the following symptoms must be met (coded a 3 ‘threshold’). 
A3- increase or decrease in appetite 
A6- insomnia or hypersomnia nearly every day 
A9- psychomotor agitation or retardation nearly every day 
A12-fatigue or loss of energy nearly every day  
A13- feelings of worthlessness or excessive or inappropriate guilt 
A16- diminished ability to think or concentrate, or indecisiveness, nearly every day 
A19- recurrent thoughts of death  
Criterion B  
A25- The symptoms cause clinically significant distress or impairment or 
impairment in social, occupational, or other important areas of functioning. 
 
PAST MAJOR DEPRESSIVE EPISODE (PMD) 
The critical criteria (A, B & C) that have to be endorsed are:  
Criterion A:  
If both A52 and A53 are met, then at least 3 out of 7 of the rest of the symptoms have to be met 
If either A52 or A53 are met, then at least 4 out of 7 of the rest of the symptoms have to be met 
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Criterion A – 5 or more out of 9  
Either one of A52a (depressed mood) or A52b (feels sad or empty) has to be coded 
a 3 
 
A52c (duration of at least two weeks) has to be coded 3  
and/or  
Either one A53a (anhedonia)or A53b (loss of interest or pleasure in their lifetime) 
has to be coded 3 
 
A53c (duration of symptoms of at least two weeks) has to be coded 3  
Plus either 3 or 4 of the following symptoms  
A54– appetite  
A57– sleep difficulty  
A60 - fidgety  
A63 - energy  
A64 - worthlessness  
A67 - concentration  
A70 - Suicide   
Criterion B (“Criterion C”)  
A76- The symptoms cause clinically significant distress or impairment in social, 
occupational, or other important areas of functioning. 
 
PERSISTENT DEPRESSIVE DISORDER (PDD): (all must be coded 3) 
The critical criteria (A, B, C, G & H) that have to be endorsed are:  
 Criterion A  
A163a- depressed mood for at least two years  
 Criterion B - 2 or more out of 6 symptoms have to present in Criteria B  
A164 - appetite  
A165 - insomnia  
A166 – energy  
A167– self-esteem  
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A168 - concentration  
A169 - hopelessness   
Criterion C  
A171- During the 2-year period (1 year for children or adolescents) of the 
disturbance, the person has never been without the symptoms in criteria A and B for 
more than 2 months at a time 
 
ALCOHOL USE  
Criterion A (at least 2 out of 11 symptoms need to be met)  
E1a- Alcohol screening asking how much a person drink a day  
E1b- 1. Alcohol is often taken in larger amounts or over a longer period than was 
intended. 
 
E2- There is a persistent desire or unsuccessful efforts to cut down or control 
alcohol use. 
 
E3- A great deal of time is spent in activities necessary to obtain alcohol, use 
alcohol, or recovôr from its effects 
 
E4- Craving, or a strong desire or urge to use alcohol  
E5- Recurrent alcohol use resulting in a failure to fulfill major role obligations at 
work, school, or home 
 
E6- Continued alcohol use despite having persistent or recurrent social or 
interpersonal problems caused or exacerbated by the effects of alcohol. 
 
E7- Important social, occupational, or recreational activities are given up or reduced 
because of alcohol use. 
 
E8a- Recurrent alcohol use in situations in which it is physically hazardous.  
E8b- Alcohol use is continued despite knowledge of having a persistent or recurrent 
physical or psychological problem that is likely to have been caused or exacerbated 
by alcohol. 
 
E9a- A physical or psychological problem that was likely to have been made worse 
or caused by alcohol. 
 
E9b- Continued using alcohol despite knowing that it causes or makes the problem 
worse 
 
E10a- A need for markedly increased amounts of alcohol to achieve intoxication or 
desired effect 
 
E10B- A markedly diminished effect with continued use of the same amount of 
alcohol. 
 
E11a- The characteristic withdrawal syndrome for alcohol  
E11b- Alcohol (or a closely related substance, such as a benzodiazepine) is taken to 
relieve or avoid withdrawal symptoms 
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ALCOHOL USE (recurrent) 
If any of the above are true before the last 12 months,  go back to the beginning and ask: 
BEFORE the last 12 months 
 
GENERALISED ANXIETY DISORDER (GAD) (All must be coded “3”):  
In order to meet diagnostic criteria for Generalised Anxiety Disorder, the following critical 
criteria (A, B, C, D, E & F) HAVE TO BE present: 
Criterion A - F134- Excessive anxiety and worry (apprehensive expectation), 
occurring more days than not for at least 6 months 
 
Criterion B - F135- Anxiety about a number of activities 
 Plus  F136- The individual finds it difficult to control the worry 
 
Criterion F – F137- The disturbance is not better explained by another mental 
disorder 
 
Criterion C, 3 or more out of 6 symptoms  
F138- Restlessness or feeling keyed up or on edge.  
F139- Being easily fatigued  
F140- Difficulty concentrating or mind going blank  
F141- Irritability.  
F142- Muscle tension  
F143- Sleep disturbance  
Criterion D - F146b- The anxiety, worry, or physical symptoms cause clinically 
significant distress or impairment in social, occupational, or other important areas of 
functioning 
 
Criterion E - either one or both of F147a- The disturbance is not attributable to the 
physiological effects of a substance (e.g., a drug of abuse, a medication) or another 
medical condition 
and F147c- Physical illness 
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Appendix P: Reliable Action Permission Letter 
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Appendix Q: Sizophila Permission letter 
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Appendix R: Phambili Permission Letter 
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